| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Sep―13 |
An exploratory analysis of associations of genetic variation with the efficacy of tocilizumab in severe COVID-19 patients. A pharmacogenetic study based on next-generation sequencing |
Alejandro Durán-Sotuela, Jorge Vázquez-García, Sara Relaño-Fernández, Vanesa Balboa-Barreiro, Juan Fernández-Tajes, Francisco J. Blanco, Ignacio Rego-Pérez |
| 2 |
[GO] |
2024―Sep―13 |
Quantitative pulmonary pharmacokinetics of tetrandrine for SARS-CoV-2 repurposing: a physiologically based pharmacokinetic modeling approach |
Furun Wang, Liuhan Dong, Juanwen Hu, Shijie Yang, Lingchao Wang, Zhiwei Zhang, Wenpeng Zhang, Xiaomei Zhuang |
| 3 |
[GO] |
2024―Aug―28 |
Model informed dose regimen optimizing in development of leritrelvir for the treatment of mild or moderate COVID-19 |
Kun Wang, Haijun Li, Youyun Li, Fengyan Xu, Zhongyi Sun, Yuting Yang, Jufang Huang, Xiaoxin Chen |
| 4 |
[GO] |
2024―Aug―19 |
Real-world effectiveness and safety of nirmatrelvir-ritonavir (Paxlovid)-treated for COVID-19 patients with onset of more than 5 days: a retrospective cohort study |
Ye Qiu, Hao Wen, Haoru Wang, Wenjun Sun, Guangchao Li, Shaoqiang Li, Yan Wang, Jingnan Zhai, Yangqing Zhan, Yutian Su, Zhiwei Long, Zhengtu Li, Feng Ye |
| 5 |
[GO] |
2024―Aug―08 |
Neurological manifestations of immune origin after COVID-19 vaccination: retrospective case study |
Juan Granja López, Carlos Estebas Armas, Manuel Lorenzo Dieguez, Inmaculada Puertas Muñoz, Elena De Celis Ruiz, Ricardo Rigual, Mireya Fernández-Fournier, Gabriel Torres Iglesias, Sara Sánchez Velasco, Antonio Tallón Barranco, Olga Rogozina, Elena Ramírez, Miguel González-Muñoz, Laura Lacruz Ballester |
| 6 |
[GO] |
2024―Aug―01 |
The effect of convalescent plasma therapy on the rate of nucleic acid negative conversion in patients with persistent COVID-19 test positivity |
Yixuan Wang, Zhe Xu, Xue Xu, Shuwen Yang, Yuanyuan Li, Hanwen Zhang, Yufeng Zhang, Fu-Sheng Wang, Ying Wang, Jingfeng Bi |
| 7 |
[GO] |
2024―Jul―31 |
Status and hotspot analysis of Qingfei Paidu Decoction for the prevention and treatment of COVID-19 based on bibliometric analysis |
Huifang Zhang, Yang Liu, Xiyu Shang, Yuqing Cao, Jiajia Li, Guangkun Chen, Xinyu Ji, Lei Zhang, Yipin Fan, Yan Ma |
| 8 |
[GO] |
2024―Jul―31 |
Evaluating the protective effectiveness and risk factors of ursodeoxycholic acid on COVID-19 among outpatients |
Di Li, Qimei Fang, Zhiwei Chen, Jing Tang, Haoling Tang, Nan Cai, Ke Qiu, Mingyang Zhu, Xuemei Yang, Lu Yang, Yujie Yang, Yong Huang, Xiaomei Lei, Huanhuan Zhang, Qiankai Lin, Qiang Mao, Te Xu, Yan Li, Yang Zheng, Mingli Peng, Peng Hu |
| 9 |
[GO] |
2024―Jul―29 |
Genetic variability in the glucocorticoid pathway and treatment outcomes in hospitalized patients with COVID-19: a pilot study |
Patricija Štampar, Tanja Blagus, Katja Goričar, Petra Bogovič, Gabriele Turel, Franc Strle, Vita Dolžan |
| 10 |
[GO] |
2024―Jul―26 |
The therapeutic potential of gelsolin in attenuating cytokine storm, ARDS, and ALI in severe COVID-19 |
Juan Zhi, Kai-Xuan Zhao, Ju-Hui Liu, Dong Yang, Xiao-Ming Deng, Jin Xu, Haoyue Zhang |
| 11 |
[GO] |
2024―Jul―22 |
Comparative analysis of the safety and effectiveness of Nirmatrelvir-Ritonavir and Azvudine in older patients with COVID-19: a retrospective study from a tertiary hospital in China |
Nan Shang, Xianlin Li, Zhiyu Guo, Lan Zhang, Shanshan Wang |
| 12 |
[GO] |
2024―Jul―17 |
Identifying plant-derived antiviral alkaloids as dual inhibitors of SARS-CoV-2 main protease and spike glycoprotein through computational screening |
Ramsha Yamin, Iqra Ahmad, Hira Khalid, Asia Perveen, Sumra Wajid Abbasi, Umar Nishan, Sheheryar Sheheryar, Arlindo Alencar Moura, Sarfraz Ahmed, Riaz Ullah, Essam A. Ali, Mohibullah Shah, Suvash Chandra Ojha |
| 13 |
[GO] |
2024―Jul―12 |
Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19 |
Yasmin Silva-Santos, Roberta Liberato Pagni, Thais Helena Martins Gamon, Marcela Santiago Pacheco de Azevedo, Mônica Bielavsky, Maria Laura Goussain Darido, Danielle Bruna Leal de Oliveira, Edmarcia Elisa de Souza, Carsten Wrenger, Edson Luiz Durigon, Maria Cecília Rui Luvizotto, Hans Christian Ackerman, Claudio Romero Farias Marinho, Sabrina Epiphanio, Leonardo José Moura Carvalho |
| 14 |
[GO] |
2024―Jul―05 |
Medicinal plants used in Gabon for prophylaxis and treatment against COVID-19-related symptoms: an ethnobotanical survey |
Marlaine Michel Boukandou Mounanga, Annais Mezui, Ludovic Mewono, Jean Bertrand Mogangué, Sophie Aboughe Angone |
| 15 |
[GO] |
2024―Jul―04 |
Effectiveness of molnupiravir for treating COVID-19 in patients with psychiatric disorders |
Ting-Hui Liu, Hsuan-Yi Liao, Chih-Cheng Chang, Chih-Cheng Lai |
| 16 |
[GO] |
2024―Jun―20 |
Evaluating myelophil, a 30% ethanol extract of Astragalus membranaceus and Salvia miltiorrhiza, for alleviating fatigue in long COVID: a real-world observational study |
Jin-Yong Joung, Jin-Seok Lee, Yujin Choi, Yoon Jung Kim, Hyeon-Muk Oh, Hyun-Sik Seo, Chang-Gue Son |
| 17 |
[GO] |
2024―Jun―12 |
An overview and single-arm meta-analysis of immune-mediated adverse events following COVID-19 vaccination |
Donghua Yang, Jinhui Tian, Caiyi Shen, Qin Li |
| 18 |
[GO] |
2024―Jun―11 |
The last 3 decade of vaccination coverage in the Balkan and Eastern Europe countries with reference to the impact of the COVID-19 pandemic |
Milos Stepovic, Viktorija Dragojevic Simic, Ivana Zivanovic Macuzic, Radoje Simic, Stefan Vekic, Marija Sekulic, Snezana Radovanovic, Milena Maricic, Marija Sorak, Vesna Suljagic, Radisa Vojinovic, Nemanja Rancic |
| 19 |
[GO] |
2024―Jun―01 |
The efficacy of herbal medicines on the length of stay and negative conversion time/rate outcomes in patients with COVID-19: a systematic review |
Irma Rahayu Latarissa, Anna Meiliana, Ida Paulina Sormin, Erizal Sugiono, Nasrul Wathoni, Melisa Intan Barliana, Keri Lestari |
| 20 |
[GO] |
2024―May―27 |
Therapeutic effects of vitamin D supplementation on COVID-19 aggravation: a systematic review and meta-analysis of randomized controlled trials |
Yiyuan Yang, Wanli Sun, Fan Yang, Guoxia Zhang, Xinye Li, Shipeng Sun, Yanwei Xing |
| 21 |
[GO] |
2024―May―27 |
Chinese herbal medicine Shufeng Jiedu capsule for mild to moderate COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase II trial |
Chun-li Lu, Liu-qing Yang, Xin-yan Jin, Thomas Friedemann, Yu-fei Li, Xue-han Liu, Xiao-ying Chen, Xiang-yun Zou, Bing-rui Zhang, Fu-xiang Wang, Yuan-long Lin, Yi-min Tang, Meng-li Cao, Ya-lin Jiang, You-fang Gao, Kui Liu, Zhen-gang Tao, Nicola Robinson, Sven Schröder, Jian-ping Liu, Hong-zhou Lu |
| 22 |
[GO] |
2024―May―22 |
COVID-19 vaccination-related tinnitus is associated with pre-vaccination metabolic disorders |
Weihua Wang, Anusha Yellamsetty, Robert M. Edmonds, Shaun R. Barcavage, Shaowen Bao |
| 23 |
[GO] |
2024―May―09 |
Vitamin D level in COVID-19 patients has positive correlations with autophagy and negative correlations with disease severity |
Hongna Dong, Yuqiu Hao, Peng Gao |
| 24 |
[GO] |
2024―Apr―09 |
Statins use amidst the pandemic: prescribing, dispensing, adherence, persistence, and correlation with COVID-19 statistics in nationwide real-world data from Poland |
Przemysław Kardas, Angelika Kwiatek, Piotr Włodarczyk, Filip Urbański, Beata Ciabiada-Bryła |
| 25 |
[GO] |
2024―Mar―27 |
Case report: Paralytic ileus resulted from nirmatrelvir/ritonavir-tacrolimus drug-drug interaction in a systemic lupus erythematosus patient with COVID-19 |
Wei Zhang, Xingguo Zhang, Jinming Han, Wen Zhang, Jiarui Xu, Xin Zhang, Hongjun Bian, Chong Meng, Deya Shang, Yi Zhou, Dawei Wang, Baobao Feng |
| 26 |
[GO] |
2024―Feb―28 |
Prenatal maternal inactivated COVID-19 vaccination: the maternal and neonatal outcomes, a retrospective cohort study |
Yaoyao Cai, Shenghao Wu, Sisi Zhang, Xinxin Xu, Fengfeng Xie, Lijun Gao, Weiting Xia |
| 27 |
[GO] |
2024―Feb―23 |
Identifying in-market application of Pelargonium root extract EPs 7630 for the treatment of COVID-19: analysis of pharmacovigilance data |
Fathi Abdul Malek, Petra Funk |
| 28 |
[GO] |
2024―Feb―20 |
The characteristics and operations of “online pharmacies” investigated in relation to medicines popularised during the coronavirus pandemic: a cross-sectional study |
Oria Jason Oriakhi, Hamzeh Almomani, Nilesh Patel, Parastou Donyai |
| 29 |
[GO] |
2024―Feb―15 |
The effectiveness of oral anti-SARS-CoV-2 agents in non-hospitalized COVID-19 patients with nonalcoholic fatty liver disease: a retrospective study |
Chun-Chi Yang, Ya-Wen Tsai, Su-Hung Wang, Jheng-Yan Wu, Ting-Hui Liu, Wan-Hsuan Hsu, Po-Yu Huang, Min-Hsiang Chuang, Ming-Jen Sheu, Chih-Cheng Lai |
| 30 |
[GO] |
2024―Feb―07 |
Pharmacological targeting of the hyper-inflammatory response to SARS-CoV-2-infected K18-hACE2 mice using a cluster of differentiation 36 receptor modulator |
Jade Gauvin, David N. Huynh, Isabelle Dubuc, Catherine Lê, Rafaela Tugores, Nicolas Flamand, Louis Flamand, William D. Lubell, Huy Ong, Sylvie Marleau |
| 31 |
[GO] |
2024―Feb―06 |
Individual ingredients of NP-101 (Thymoquinone formula) inhibit SARS-CoV-2 pseudovirus infection |
Abdelrahim Maen, Betul Gok Yavuz, Yehia I. Mohamed, Abdullah Esmail, Jianming Lu, Amr Mohamed, Asfar S. Azmi, Mohamed Kaseb, Osama Kasseb, Dan Li, Michelle Gocio, Mehmet Kocak, Abdelhafez Selim, Qing Ma, Ahmed O. Kaseb |
| 32 |
[GO] |
2024―Jan―22 |
Unraveling the impact of nitric oxide, almitrine, and their combination in COVID-19 (at the edge of sepsis) patients: a systematic review |
Ying Wang, Qian Yu, Yuan Tian, Shiying Ren, Liping Liu, Chaojie Wei, Renli Liu, Jing Wang, Dong Li, Kun Zhu |
| 33 |
[GO] |
2024―Jan―16 |
Efficacy and safety of aniseed powder for treating gastrointestinal symptoms of COVID-19: a randomized, placebo-controlled trial |
Maryam Mosaffa-Jahromi, Hossein Molavi Vardanjani, Andrea Fuzimoto, Jennifer Hunter, Kamran Bagheri Lankarani, Mehdi Pasalar |
| 34 |
[GO] |
2024―Jan―10 |
Pharmacokinetics of recombinant human annexin A5 (SY-005) in patients with severe COVID-19 |
Brent J. Tschirhart, Xiangru Lu, Aristide Laurel Mokale Kognou, Claudio M. Martin, Marat Slessarev, Douglas D. Fraser, Aleksandra Leligdowicz, Bradley Urquhart, Qingping Feng |
| 35 |
[GO] |
2024―Jan―08 |
Assessing the efficacy and safety of Yinqiao powder-maxing Ganshi decoction in the treatment of the major symptoms of mild and moderate COVID-19 by telemedicine-study protocol for a randomized, double-blind, placebo-controlled trial |
Chi Him Sum, Tong Wendy Li, Hongwei Zhang, Hing Yu Hung, Ben Yuk Fai Fong, Wai Ling Lin, Tak Yee Chow, Ka Chun Leung, Cho Wing Lo, Chon Pin Chia, Kam Leung Chan, Zhi-xiu Lin |
| 36 |
[GO] |
2024―Jan―03 |
Klotho-derived peptide KP1 ameliorates SARS-CoV-2-associated acute kidney injury |
Jie Xu, Enqing Lin, Xue Hong, Li Li, Jun Gu, Jinghong Zhao, Youhua Liu |
| 37 |
[GO] |
2023―Dec―22 |
Identification of oral therapeutics using an AI platform against the virus responsible for COVID-19, SARS-CoV-2 |
Adam Bess, Frej Berglind, Supratik Mukhopadhyay, Michal Brylinski, Chris Alvin, Fanan Fattah, Kishor M. Wasan |
| 38 |
[GO] |
2023―Dec―08 |
Efficacies of S-nitrosoglutathione (GSNO) and GSNO reductase inhibitor in SARS-CoV-2 spike protein induced acute lung disease in mice |
Judong Kim, Fei Qiao, Avtar K. Singh, Jeseong Won, Inderjit Singh |
| 39 |
[GO] |
2023―Dec―06 |
Evaluation of the efficacy and safety of nirmatrelvir/ritonavir co-administration inpatients with rheumatic disease infected with SARS-CoV-2: a real-world study |
Xue Zhong, Chao Wang, Lin Huang, Yue Zhao, Tianyi Li, Jing He, Xiaohong Zhang |
| 40 |
[GO] |
2023―Dec―05 |
Association of antihypertensive drugs with COVID-19 outcomes: a drug-target Mendelian randomization study |
Kun Zhang, Hengxing Gao, Mingwei Chen |
| 41 |
[GO] |
2023―Dec―01 |
Safety and efficacy of lentinan nasal drops in patients infected with the variant of COVID-19: a randomized, placebo-controlled trial |
Wenhan Fan, Benming You, Xinyu Wang, Xu Zheng, Aijing Xu, Yangang Liu, Haoran Peng, Wei Yin, Mingxiao Xu, Xu Dong, Yayun Liu, Ping Zhao, Xuesong Liang |
| 42 |
[GO] |
2023―Nov―23 |
Efficacy and safety of tocilizumab and baricitinib among patients hospitalized for COVID-19: a systematic review and meta-analysis |
Jin Zhang, Xiongxiong Fan, Xiaoyu Zhang, Fengli Jiang, Yiping Wu, Beibei Yang, Xinghuan Li, Dong Liu |
| 43 |
[GO] |
2023―Nov―16 |
Efficacy and safety of molnupiravir in patients with Omicron variant vaccine breakthrough COVID-19 infection: a randomized, controlled trial |
Yayun Liu, Shiyong Fan, Aijing Xu, Lingling Ge, Xinyu Wang, Xu Dong, Mingxiao Xu, Wenhan Fan, Wu Zhong, Xuesong Liang |
| 44 |
[GO] |
2023―Nov―16 |
Diagnostics and treatments of COVID-19: two-year update to a living systematic review of economic evaluations |
Jamie Elvidge, Gareth Hopkin, Nithin Narayanan, David Nicholls, Dalia Dawoud |
| 45 |
[GO] |
2023―Nov―14 |
An updated meta-analysis of Chinese herbal medicine for the prevention of COVID-19 based on Western-Eastern medicine |
Siying Hu, Dan Luo, Qikui Zhu, Jie Pan, Bonan Chen, Michael Furian, Harsh Vivek Harkare, Shoukai Sun, Adel Fansa, Xiaoping Wu, Baili Yu, Tianhong Ma, Fei Wang, Shihua Shi |
| 46 |
[GO] |
2023―Nov―07 |
Computer-aided drug design for virtual-screening and active-predicting of main protease (Mpro) inhibitors against SARS-CoV-2 |
Renhui Dai, Hongwei Gao, Ruiling Su |
| 47 |
[GO] |
2023―Nov―03 |
Statutory health insurance-covered pre-exposure prophylaxis in Germany: changing trends in nationwide tenofovir disoproxil/emtricitabine prescriptions during the COVID-19 pandemic |
Henrieke Prins, Achim Dörre, Daniel Schmidt |
| 48 |
[GO] |
2023―Nov―01 |
Associations between COVID-19 outcomes and asthmatic patients with inhaled corticosteroid |
Su-Boon Yong, Shuo-Yan Gau, Chia-Jung Li, Chih-Wei Tseng, Shiow-Ing Wang, James Cheng-Chung Wei |
| 49 |
[GO] |
2023―Oct―30 |
Do disease-modifying antirheumatic drugs and non-steroidal anti-inflammatory drugs increase the burden on ankylosing spondylitis patients with mild-moderate COVID-19? evidence from a retrospective cohort study |
Yan Li, Zhengyuan Hu, Yufei Guo, Zheng Zhao, Kunpeng Li, Xiuru Wang, Jie Zhang, Dongfeng Liang, Jianglin Zhang, Xiaoyue Hu, Jian Zhu, Feng Huang |
| 50 |
[GO] |
2023―Oct―19 |
The effects of combination-therapy of tocilizumab and baricitinib on the management of severe COVID-19 cases: a randomized open-label clinical trial |
Farzaneh Dastan, Hamidreza Jamaati, Saghar Barati, Shahrzad Varmazyar, Sahar Yousefian, Elmira Niknami, Payam Tabarsi |
| 51 |
[GO] |
2023―Oct―13 |
Head-to-head comparison of azvudine and nirmatrelvir/ritonavir for the hospitalized patients with COVID-19: a real-world retrospective cohort study with propensity score matching |
An-Hua Wei, Lu Zeng, Lu Wang, Lin Gui, Wen-Ting Zhang, Xue-Peng Gong, Juan Li, Dong Liu |
| 52 |
[GO] |
2023―Oct―10 |
A retrospective real-world study of early short-course remdesivir in non-hospitalized COVID-19 patients at high risk for progression: low rate of hospitalization or death, regardless of immunocompetence status |
José Manuel Ramos-Rincón, Héctor Pinargote-Celorio, Jara Llenas-García, Oscar Moreno-Pérez, Inmaculada González-Cuello, Pilar Gonzalez-de-la-Aleja, Belén Martínez-López, Sergio Reus, María García-López, Juan Carlos Rodríguez, Vicente Boix, Esperanza Merino |
| 53 |
[GO] |
2023―Oct―09 |
Impact of domiciliary administration of NSAIDs on COVID-19 hospital outcomes: an unCoVer analysis |
Elena Salvador, Cristina Mazzi, Nicoletta De Santis, Giulia Bertoli, Antonija Jonjić, Miran Coklo, Marek Majdan, José L. Peñalvo, Dora Buonfrate |
| 54 |
[GO] |
2023―Sep―29 |
Corrigendum: Commentary: An evaluation of traditional Persian medicine for the management of SARS-CoV-2 |
Haniye Mirhosseini, Jale Aliasl, Fatemeh Eghbalian |
| 55 |
[GO] |
2023―Sep―19 |
Editorial: Re-emergence of neglected tropical diseases amid the COVID-19 pandemic: epidemiology, transmission, mitigation strategies, and recent advances in chemotherapy and vaccines |
Ranjan K. Mohapatra, Venkataramana Kandi, Veronique Seidel, Ali A. Rabaan |
| 56 |
[GO] |
2023―Aug―28 |
Corrigendum: The traditional Chinese medicine formula Jing Guan Fang for preventing SARS-CoV-2 infection: from clinical observation to basic research |
Yueh-Hsin Ping, Hsin Yeh, Li-Wei Chu, Zhi-Hu Lin, Yin-Chieh Hsu, Lie-Chwen Lin, Chung-Hua Hsu, Shu-Ling Fu, Tung-Yi Lin |
| 57 |
[GO] |
2023―Aug―25 |
Efficacy and safety evaluation of Azvudine in the prospective treatment of COVID-19 based on four phase III clinical trials |
Ke-Wei Zhu |
| 58 |
[GO] |
2023―Aug―16 |
Assessment of the proarrhythmic effects of repurposed antimalarials for COVID-19 treatment using a comprehensive in vitro proarrhythmia assay (CiPA) |
Seung-Hyun Yoon, Hyun-Lee Lee, Da Un Jeong, Ki Moo Lim, Seong-Jun Park, Ki-Suk Kim |
| 59 |
[GO] |
2023―Aug―04 |
A review of SARS-CoV-2 drug repurposing: databases and machine learning models |
Marim Elkashlan, Rahaf M. Ahmad, Malak Hajar, Fatma Al Jasmi, Juan Manuel Corchado, Nurul Athirah Nasarudin, Mohd Saberi Mohamad |
| 60 |
[GO] |
2023―Aug―03 |
COVID-19 vaccination-related autoimmune hepatitis-a perspective |
Consolato M. Sergi |
| 61 |
[GO] |
2023―Aug―03 |
Molecular mechanisms of COVID-19-induced pulmonary fibrosis and epithelial-mesenchymal transition |
Peng Pi, Zhipeng Zeng, Liqing Zeng, Bing Han, Xizhe Bai, Shousheng Xu |
| 62 |
[GO] |
2023―Jul―31 |
The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19 |
Binbin Xia, Li Zheng, Yali Li, Wenfang Sun, Yang Liu, Liushui Li, Jingyao Pang, Jing Chen, Jiaxin Li, Hua Cheng |
| 63 |
[GO] |
2023―Jul―26 |
Corrigendum: Host factor interaction networks identified by integrative bioinformatics analysis reveals therapeutic implications in COPD patients with COVID-19 |
Wenjiang Zheng, Ting Wang, Peng Wu, Qian Yan, Chengxin Liu, Hui Wu, Shaofeng Zhan, Xiaohong Liu, Yong Jiang, Hongfa Zhuang |
| 64 |
[GO] |
2023―Jul―26 |
In vitro and in vivo effects of Pelargonium sidoides DC. root extract EPs® 7630 and selected constituents against SARS-CoV-2 B.1, Delta AY.4/AY.117 and Omicron BA.2 |
Jackson Emanuel, Jan Papies, Celine Galander, Julia M. Adler, Nicolas Heinemann, Kathrin Eschke, Sophie Merz, Hannah Pischon, Ruben Rose, Andi Krumbholz, Žarko Kulić, Martin D. Lehner, Jakob Trimpert, Marcel A. Müller |
| 65 |
[GO] |
2023―Jul―21 |
A retrospective study of Reyanning mixture in elderly patients infected with SARS-CoV-2 Omicron variant |
Changya Liu, Xinxin Wu, Hongqiang Yang, Xiangru Xu, Caiyu Chen, Linguangjin Wu, Wen Zhang, Haimei Shi, Yuerong Fei, Yuting Sun, Hongze Wu, Shuang Zhou, Bangjiang Fang |
| 66 |
[GO] |
2023―Jul―15 |
Editorial: Opioids in the time of the COVID-19 pandemic: from cellular mechanisms to public health policy |
Scott John, David R. Walwyn, Kathryn DeFea, Tim G. Hales, Wendy Walwyn |
| 67 |
[GO] |
2023―Jul―14 |
Editorial: Coronavirus disease (COVID-19): mechanistic basic, translational, and clinical research aimed at identification of effective preventive and therapeutic strategies |
Paolo Montuschi, Fatih M. Uckun, Alastair George Stewart, Paola Patrignani |
| 68 |
[GO] |
2023―Jul―12 |
Potential pharmacokinetic interactions with concurrent use of herbal medicines and a ritonavir-boosted COVID-19 protease inhibitor in low and middle-income countries |
Dallas J. Smith, Huichang Bi, Josias Hamman, Xiaochao Ma, Constance Mitchell, Kumbukani Nyirenda, Tsitsi Monera-Penduka, Hellen Oketch-Rabah, Mary F. Paine, Syril Pettit, Wihan Pheiffer, Richard B. Van Breemen, Michelle Embry |
| 69 |
[GO] |
2023―Jun―30 |
Evaluation of safety and effectiveness of remdesivir in treating COVID-19 patients after emergency use authorization study |
Erlina Burhan, Elisna Syahruddin, Fathiyah Isbaniah, Ginanjar Arum Desianti, Fanny Fachrucha, Cut Yulia Indah Sari, Efriadi Ismail, Puji Astuti, Muhammad Farhan Maruli, Farhan Mubarak, Anggit Tresna Rengganis, Hazia Hanifa Bilqis, Imammurahman Taslim, Evan Sastria, Elvan Wiyarta |
| 70 |
[GO] |
2023―Jun―24 |
COVID-19 vaccination effectiveness and safety in vulnerable populations: a meta-analysis of 33 observational studies |
Hui-Jun Li, Qi-Chao Yang, Yang-Yang Yao, Cheng-Yang Huang, Fu-Qiang Yin, Chen-Yang Xian-Yu, Chao Zhang, Shao-Juan Chen |
| 71 |
[GO] |
2023―Jun―24 |
Association between genetic polymorphism, severity, and treatment response among COVID-19 infected Egyptian patients |
Abdelrahman Alaa, Neven Sarhan, Mohamed Gamal Lotfy El-Ansary, Naglaa Samir Bazan, Khaled Farouk, Raed Shahat Ismail, Mona Farag Schalaan, Adel R. A. Abd-Allah |
| 72 |
[GO] |
2023―Jun―22 |
Garbage in, garbage out: how reliable training data improved a virtual screening approach against SARS-CoV-2 MPro |
Santiago M. Ruatta, Denis N. Prada Gori, Martín Fló Díaz, Franca Lorenzelli, Karen Perelmuter, Lucas N. Alberca, Carolina L. Bellera, Andrea Medeiros, Gloria V. López, Mariana Ingold, Williams Porcal, Estefanía Dibello, Irina Ihnatenko, Conrad Kunick, Marcelo Incerti, Martín Luzardo, Maximiliano Colobbio, Juan Carlos Ramos, Eduardo Manta, Lucía Minini, María Laura Lavaggi, Paola Hernández, Jonas Šarlauskas, César Sebastian Huerta García, Rafael Castillo, Alicia Hernández-Campos, Giovanni Ribaudo, Giuseppe Zagotto, Renzo Carlucci, Noelia S. Medrán, Guillermo R. Labadie, Maitena Martinez-Amezaga, Carina M. L. Delpiccolo, Ernesto G. Mata, Laura Scarone, Laura Posada, Gloria Serra, Theodora Calogeropoulou, Kyriakos Prousis, Anastasia Detsi, Mauricio Cabrera, Guzmán Alvarez, Adrián Aicardo, Verena Araújo, Cecilia Chavarría, Lucija Peterlin Mašič, Melisa E. Gantner, Manuel A. Llanos, Santiago Rodríguez, Luciana Gavernet, Soonju Park, Jinyeong Heo, Honggun Lee, Kyu-Ho Paul Park, Mariela Bollati-Fogolín, Otto Pritsch, David Shum, Alan Talevi, Marcelo A. Comini |
| 73 |
[GO] |
2023―Jun―21 |
NRICM101 ameliorates SARS-CoV-2-S1-induced pulmonary injury in K18-hACE2 mice model |
Wen-Chi Wei, Keng-Chang Tsai, Chia-Ching Liaw, Chun-Tang Chiou, Yu-Hwei Tseng, Geng-You Liao, Yu-Chi Lin, Wen-Fei Chiou, Kuo-Tong Liou, I-Shing Yu, Yuh-Chiang Shen, Yi-Chang Su |
| 74 |
[GO] |
2023―Jun―16 |
Mendelian randomization analysis identified tumor necrosis factor as being associated with severe COVID-19 |
Hongfei Song, Na Lei, Ling Zeng, Xiuyan Li, Cen Jiang, Quansheng Feng, Yue Su, Jibin Liu, Jie Mu |
| 75 |
[GO] |
2023―Jun―15 |
Pharmacological approaches to pulmonary fibrosis following COVID-19 |
Stefan Lassan, Tomas Tesar, Jana Tisonova, Monika Lassanova |
| 76 |
[GO] |
2023―Jun―15 |
The impact of immunotherapies on COVID-19 case fatality rates during the US vaccination campaign: a multidisciplinary open data analysis using FDA Adverse Event Reporting System and Our World in Data |
Anke Salmen, Stefanie Marti, Andreas G. F. Hoepner, Andrew Chan, Robert Hoepner |
| 77 |
[GO] |
2023―Jun―14 |
A report on SARS-CoV-2 first wave in Ecuador: drug consumption dynamics |
Andrea Orellana-Manzano, Fernanda B. Cordeiro, Andrea Garcia-Angulo, Elizabeth Centeno, María José Vizcaíno-Tumbaco, Sebastián Poveda, Ricardo Murillo, Derly Andrade-Molina, Mariuxi Mirabá, Saurabh Mehta, Washington Cárdenas |
| 78 |
[GO] |
2023―Jun―06 |
Editorial: Pharmacological and biochemical perspectives of kinase inhibitors in cancer and COVID-19 therapeutics |
Balakumar Chandrasekaran, Muthupandian Saravanan |
| 79 |
[GO] |
2023―Jun―05 |
A retrospective analysis of factors associated with the length of hospital stay in COVID-19 patients treated with Nirmatrelvir / Ritonavir |
Jiantao Zheng, Wencong Hong, Chanjuan Zhou, Donghuang Hong, Hong Yan, Yanghui Shen |
| 80 |
[GO] |
2023―May―31 |
Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during long-term follow-up in hospitalized COVID-19 survivors |
Lukas Fiedler, Lukas J. Motloch, Anna-Maria Dieplinger, Peter Jirak, Paruir Davtyan, Diana Gareeva, Elena Badykova, Marat Badykov, Irina Lakman, Aleksandr Agapitov, Liana Sadikova, Valentin Pavlov, Fabian Föttinger, Moritz Mirna, Kristen Kopp, Uta C. Hoppe, Rudin Pistulli, Benzhi Cai, Baofeng Yang, Naufal Zagidullin |
| 81 |
[GO] |
2023―May―31 |
Corrigendum: COVIEdb: A Database for Potential Immune Epitopes of Coronaviruses |
Jingcheng Wu, Wenfan Chen, Jingjing Zhou, Wenyi Zhao, Yisheng Sun, Hanping Zhu, Pingping Yao, Shuqing Chen, Jianmin Jiang, Zhan Zhou |
| 82 |
[GO] |
2023―May―25 |
Opioid use in the era of COVID-19: a multifaceted study of the opioid epidemic in Canada |
Molly Hutchinson, Éric Lavigne, Zachary Patterson |
| 83 |
[GO] |
2023―May―19 |
Elevated INR in a COVID-19 patient after concomitant administration of azvudine and anticoagulants |
Xi Zhang, Fengwei Jiao, Guangrun Li, Xiaojia Yu, Yuqing Pei, Ying Zhang, Zihui Wang, Pengfei Li |
| 84 |
[GO] |
2023―May―18 |
In silico evidence implicating novel mechanisms of Prunella vulgaris L. as a potential botanical drug against COVID-19-associated acute kidney injury |
Xue-Ling Yang, Chun-Xuan Wang, Jia-Xing Wang, Shi-Min Wu, Qing Yong, Ke Li, Ju-Rong Yang |
| 85 |
[GO] |
2023―May―15 |
Impact of COVID-19 epidemic on antihypertensive drug treatment disruptions: results from a nationwide interrupted time-series analysis |
Clément Mathieu, Julien Bezin, Antoine Pariente |
| 86 |
[GO] |
2023―May―15 |
Olmesartan alleviates SARS-CoV-2 envelope protein induced renal fibrosis by regulating HMGB1 release and autophagic degradation of TGF-β1 |
Shilin Zhou, Zanzhe Yu, Zihui Chen, Fengling Ning, Xuetao Hu, Tiangang Wu, Mingxue Li, Hong Xin, Svetlana Reilly, Xuemei Zhang |
| 87 |
[GO] |
2023―May―12 |
Nirmatrelvir/Ritonavir for hemodialysis patients with COVID-19 |
Jiayue Lu, Hong Cai, Yujun Hao, Zhang Lin, Shang Liu, Yaping Zhan, Li Ding, Meilan Huang, Zhenyuan Li, Lan Xu, Xiujuan Yan, Li Yang, He Zhang, Wei Zhang, Li Zhao, Junli Zhao, Ting Wang, Leyi Gu |
| 88 |
[GO] |
2023―May―05 |
QSAR and molecular docking studies on designing potent inhibitors of SARS-CoVs main protease |
Fucheng Song, Haoyang Sun, Fangxiao Ma, Wei Wang, Mingyuan Luan, Honglin Zhai, Guanmin Su, Yantao Liu |
| 89 |
[GO] |
2023―May―04 |
One stone two birds: anti-inflammatory bronchodilators as a potential pharmacological strategy for COVID-19 |
Yuanyuan Yu, Bangjiang Fang, Xiao-Dong Yang, Yuejuan Zheng |
| 90 |
[GO] |
2023―Apr―27 |
Editorial: Emerging mechanistic insights of selective and Nonselective Autophagy in liver and gut diseases and their treatment strategies in the era of COVID-19 |
Md. Abdul Alim Al-Bari, Manoj B. Menon, Nabil Eid |
| 91 |
[GO] |
2023―Apr―27 |
Low molecular weight heparin in COVID-19: benefits and concerns |
Adham Makarem, Rana Zareef, Joseph Abourjeili, Joseph E Nassar, Fadi Bitar, Mariam Arabi |
| 92 |
[GO] |
2023―Apr―27 |
SARS-CoV-2 infection dysregulates the expression of clinically relevant drug metabolizing enzymes in Vero E6 cells and membrane transporters in human lung tissues |
Chukwunonso K. Nwabufo, Md. Tozammel Hoque, Lily Yip, Maliha Khara, Samira Mubareka, Michael S. Pollanen, Reina Bendayan |
| 93 |
[GO] |
2023―Apr―25 |
Trends and characteristics of COVID-19 and cardiovascular disease related studies |
Ao Cheng, Honghao Ren, Zeyao Ma, Naqash Alam, Linying Jia, Enqi Liu |
| 94 |
[GO] |
2023―Apr―17 |
Olive Leaves as a Potential Phytotherapy in the Treatment of COVID-19 Disease; A Mini-Review |
Shimaa M. Abdelgawad, Mahmoud A. El Hassab, Mohammed A. S. Abourehab, Eslam B. Elkaeed, Wagdy M. Eldehna |
| 95 |
[GO] |
2023―Apr―14 |
Real-world evidence of autoimmune hepatitis following COVID-19 vaccination: A population-based pharmacovigilance analysis |
Congqin Chen, Danfei Xie, Jie Xiao |
| 96 |
[GO] |
2023―Mar―24 |
Characterising the treatment of thromboembolic events after COVID-19 vaccination in 4 European countries and the US: An international network cohort study |
Aniek F. Markus, Victoria Y. Strauss, Edward Burn, Xintong Li, Antonella Delmestri, Christian Reich, Can Yin, Miguel A. Mayer, Juan-Manuel Ramírez-Anguita, Edelmira Marti, Katia M. C. Verhamme, Peter R. Rijnbeek, Daniel Prieto-Alhambra, Annika M. Jödicke |
| 97 |
[GO] |
2023―Mar―23 |
Prevalence of COVID-19 outcomes in patients referred to opioid agonist treatment centers |
Samira Khani, Javad Tafaroji, Mehdi Yaghoubi, Mohammad Javad Emami Kazemabad, Seyed Amir Hejazi |
| 98 |
[GO] |
2023―Mar―22 |
Nirmatrelvir/ritonavir for patients with SARS-CoV-2 infection and impaired kidney function during the Omicron surge |
Jiayi Yan, Hong Cai, Jieying Wang, Mingli Zhu, Ping Li, Peiying Li, Bin Wu, Xiajing Che, Leyi Gu, Shan Mou |
| 99 |
[GO] |
2023―Mar―17 |
Sales trends of psychotropic drugs in the COVID-19 pandemic: A national database study in Brazil |
Fernando de Sá Del Fiol, Cristiane de Cássia Bergamaschi, Luciane Cruz Lopes, Marcus Tolentino Silva, Silvio Barberato-Filho |
| 100 |
[GO] |
2023―Mar―15 |
Antibiotic consumption and antimicrobial resistance in the SARS-CoV-2 pandemic: A single-center experience |
Dragana Sokolović, Dragana Drakul, Vesna Vujić-Aleksić, Bojan Joksimović, Siniša Marić, Lana Nežić |
| 101 |
[GO] |
2023―Mar―13 |
Ginsenosides, potential TMPRSS2 inhibitors, a trade-off between the therapeutic combination for anti-PD-1 immunotherapy and the treatment of COVID-19 infection of LUAD patients |
Mei Meng, Rui Gao, Zixue Liu, Fengxiang Liu, Shiyu Du, Yizhi Song, Jian He |
| 102 |
[GO] |
2023―Mar―09 |
Editorial: Medication safety in COVID-19 management, Volume II |
Saibal Das |
| 103 |
[GO] |
2023―Mar―09 |
An update on SARS-CoV-2 immunization and future directions |
Rashmi Rana, Ravi Kant, Tanya Kumra, Sneha Gupta, Devinder Singh Rana, Nirmal Kumar Ganguly |
| 104 |
[GO] |
2023―Mar―01 |
Innovative, rapid, high-throughput method for drug repurposing in a pandemic-A case study of SARS-CoV-2 and COVID-19 |
Shaibu Oricha Bello, Abdulmajeed Yunusa, Adamu Ahmed Adamu, Mustapha Umar Imam, Muhammad Bashir Bello, Abdulmalik Shuaibu, Ehimario Uche Igumbor, Zaiyad Garba Habib, Mustapha Ayodele Popoola, Chinwe Lucia Ochu, Aishatu Yahaya Bello, Yusuf Yahaya Deeni, Ifeoma Okoye |
| 105 |
[GO] |
2023―Feb―27 |
Jin-Zhen oral liquid for pediatric coronavirus disease (COVID-19): A randomly controlled, open-label, and non-inferiority trial at multiple clinical centers |
Qian Dong, Hongmei Qiao, Huiyi Jiang, Lixiao Liu, Yanling Ge, Fang-Jiao Zong, Yanan Li, Bingzi Dong, Sujuan Hu, Dongmei Meng, Rong Jin, Xiangshi Wang, Hailing Chang, Xiaolong Xu, Chenjing Wang, Yu Cao, Han-Ting Zhang, Qingquan Liu |
| 106 |
[GO] |
2023―Feb―17 |
Evaluation of noscapine-licorice combination effects on cough relieving in COVID-19 outpatients: A randomized controlled trial |
Saghar Barati, Faezeh Feizabadi, Hakimeh Khalaj, Hakimeh Sheikhzadeh, Hamid R. Jamaati, Hirad Farajidavar, Farzaneh Dastan |
| 107 |
[GO] |
2023―Feb―16 |
Traditional Tibetan medicine to fight against COVID-19: Basic theory and therapeutic drugs |
Kun Zhang, Lijie Wang, Jiayan Peng, Kangzhuo Sangji, Yuting Luo, Yujiao Zeng, Yongzhong Zeweng, Gang Fan |
| 108 |
[GO] |
2023―Feb―15 |
In vitro metabolic characterization of the SARS-CoV-2 papain-like protease inhibitors GRL0617 and HY-17542 |
Hyunki Cho, Young Jun Kim, Jung-Woo Chae, Markus R. Meyer, Sang Kyum Kim, Chang Seon Ryu |
| 109 |
[GO] |
2023―Feb―09 |
How to use COVID-19 antiviral drugs in patients with chronic kidney disease |
Ajinath Kale, Vishwadeep Shelke, Neha Dagar, Hans-Joachim Anders, Anil Bhanudas Gaikwad |
| 110 |
[GO] |
2023―Feb―07 |
Variant-specific deleterious mutations in the SARS-CoV-2 genome reveal immune responses and potentials for prophylactic vaccine development |
Md. Aminul Islam, Shatila Shahi, Abdullah Al Marzan, Mohammad Ruhul Amin, Mohammad Nayeem Hasan, M. Nazmul Hoque, Ajit Ghosh, Abanti Barua, Abbas Khan, Kuldeep Dhama, Chiranjib Chakraborty, Prosun Bhattacharya, Dong-Qing Wei |
| 111 |
[GO] |
2023―Feb―02 |
Commentary: An evaluation of traditional Persian medicine for the management of SARS-CoV-2 |
Haniye Mirhosseini, Jale Aliasl |
| 112 |
[GO] |
2023―Feb―01 |
Incidence and potential risk factors for remdesivir-associated bradycardia in hospitalized patients with COVID-19: A retrospective cohort study |
Yazed Saleh Alsowaida, Fadi Shehadeh, Markos Kalligeros, Eleftherios Mylonakis |
| 113 |
[GO] |
2023―Feb―01 |
Editorial: Cell cycle control as a new therapeutic approach for SARS-CoV-2 infection |
Roberta Rizzo, Francesca Caccuri, Giuseppe Valacchi, Giorgio Zauli |
| 114 |
[GO] |
2023―Jan―20 |
Rational use of drugs for the elderly during the COVID-19 pandemic in China: Challenges and opportunities |
Qingqing Yin, Dandan Feng, Yong Zhao, Xiaojuan Zhu, Yan Dong, Jianchun Wang |
| 115 |
[GO] |
2023―Jan―19 |
Use of traditional Chinese medicine for the treatment and prevention of COVID-19 and rehabilitation of COVID-19 patients: An evidence mapping study |
Yanfei Li, Yu Qin, Nan Chen, Long Ge, Qi Wang, Taslim Aboudou, Jiani Han, Liangying Hou, Liujiao Cao, Rui Li, Meixuan Li, Ningning Mi, Peng Xie, Siqing Wu, Linmin Hu, Xiuxia Li, Zhongyang Song, Jing Ji, Zhiming Zhang, Kehu Yang |
| 116 |
[GO] |
2023―Jan―19 |
Huashi baidu granule in the treatment of pediatric patients with mild coronavirus disease 2019: A single-center, open-label, parallel-group randomized controlled clinical trial |
Jiande Chen, Qiuyu Tang, Baoqin Zhang, Shuhua Yuan, Jia Chen, Shiyu Shen, Dong Wang, Jilei Lin, Hongliang Dong, Yong Yin, Jian Gao |
| 117 |
[GO] |
2023―Jan―17 |
Remdesivir associated sinus bradycardia in patients with COVID-19: A prospective longitudinal study |
Maryam Hajimoradi, Babak Sharif Kashani, Farzaneh Dastan, Sina Aghdasi, Atefeh Abedini, Farah Naghashzadeh, Arezoo Mohamadifar, Mohammad Sadegh Keshmiri, Sima Noorali, Somayeh Lookzadeh, Niloufar Alizadeh, Mohammad Amin Siri, Mohammadali Tavasolpanahi, Yazdan Abdolmohammadi, Masoud Shafaghi, Zahra Sadat Rouhani, Shadi Shafaghi |
| 118 |
[GO] |
2023―Jan―16 |
Analysis of spontaneous reports of suspected adverse reactions after vaccination against COVID-19 in Slovakia |
Monika Lassanova, Stefan Lassan, Silvia Liskova, Tomas Tesar, Monika Cicova |
| 119 |
[GO] |
2023―Jan―13 |
Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial |
Francesco Di Pierro, Amjad Khan, Somia Iqtadar, Sami Ullah Mumtaz, Muhammad Nabeel Akbar Chaudhry, Alexander Bertuccioli, Giuseppe Derosa, Pamela Maffioli, Stefano Togni, Antonella Riva, Pietro Allegrini, Martino Recchia, Nicola Zerbinati |
| 120 |
[GO] |
2023―Jan―10 |
The pathological mechanism of the COVID-19 convalescence and its treatment with traditional Chinese medicine |
Linlin Jiang, Xuedong An, Yingying Duan, Fengmei Lian, De Jin, Yuehong Zhang, Cunqing Yang, Yuqing Zhang, Xiaomin Kang, Yuting Sun |
| 121 |
[GO] |
2023―Jan―05 |
Erratum: A Retrospective Study on the Use of Chinese Patent Medicine in 24 Medical Institutions for COVID-19 in China |
Frontiers Production Office |
| 122 |
[GO] |
2022―Dec―23 |
Dispensing of psychotropic drugs in the Brazilian capital city before and during the COVID-19 pandemic (2018-2020) |
Pamela Alejandra Escalante Saavedra, Dayani Galato, Calliandra Maria de Souza Silva, Izabel Cristina Rodrigues da Silva, Emília Vitoria da Silva |
| 123 |
[GO] |
2022―Dec―23 |
Attitudes and behaviors regarding online pharmacies in the aftermath of COVID-19 pandemic: At the tipping point towards the new normal |
András Fittler, Tünde Ambrus, Anna Serefko, Lenka Smejkalová, Anna Kijewska, Aleksandra Szopa, Mátyás Káplár |
| 124 |
[GO] |
2022―Dec―20 |
Combination of the parent analogue of remdesivir (GS-441524) and molnupiravir results in a markedly potent antiviral effect in SARS-CoV-2 infected Syrian hamsters |
Rana Abdelnabi, Piet Maes, Steven de Jonghe, Birgit Weynand, Johan Neyts |
| 125 |
[GO] |
2022―Dec―13 |
Cell cycle block by p53 activation reduces SARS-CoV-2 release in infected alveolar basal epithelial A549-hACE2 cells |
Giada Lodi, Valentina Gentili, Fabio Casciano, Arianna Romani, Giorgio Zauli, Paola Secchiero, Enrico Zauli, Carolina Simioni, Silvia Beltrami, Mercedes Fernandez, Roberta Rizzo, Rebecca Voltan |
| 126 |
[GO] |
2022―Dec―12 |
Emerging toolset of three-dimensional pulmonary cell culture models for simulating lung pathophysiology towards mechanistic elucidation and therapeutic treatment of SARS-COV-2 infection |
Kai Ni, Bo Che, Chongxin Yang, Youyuan Qin, Rong Gu, Chunhong Wang, Mingzhi Luo, Linhong Deng |
| 127 |
[GO] |
2022―Dec―12 |
A randomized, double-blind, placebo-controlled phase I trial of inhalation treatment of recombinant TFF2-IFN protein: A multifunctional candidate for the treatment of COVID-19 |
Yan Liu, Guanxing Zhai, Weihui Fu, Xiaoyan Zhang, Jianqing Xu |
| 128 |
[GO] |
2022―Dec―07 |
Beta-blockers in post-acute myocardial infarction patients: Drug prescription patterns from 2018 to Italy’s first wave of the COVID-19 pandemic |
Elena Olmastroni, Federica Galimberti, Alberico L. Catapano, Elena Tragni, Manuela Casula |
| 129 |
[GO] |
2022―Dec―01 |
Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex |
Yongmei Feng, Stefan Grotegut, Predrag Jovanovic, Valentina Gandin, Steven H. Olson, Rabi Murad, Anne Beall, Sharon Colayco, Paul De-Jesus, Sumit Chanda, Brian P. English, Robert H. Singer, Michael Jackson, Ivan Topisirovic, Ze’ev A. Ronai |
| 130 |
[GO] |
2022―Dec―01 |
Efficacy and safety profile of corticosteroids and non-steroidal anti-inflammatory drugs in COVID-19 management: A narrative review |
Seth Kwabena Amponsah, Benjamin Tagoe, Ismaila Adams, Kwasi Agyei Bugyei |
| 131 |
[GO] |
2022―Nov―30 |
Selective serotonin reuptake inhibitors: New hope in the fight against COVID-19 |
Mahsa Asadi Anar, Elaheh Foroughi, Elika Sohrabi, Samira Peiravi, Yasaman Tavakoli, Mozhgan Kameli Khouzani, Parisa Behshood, Melika Shamshiri, Arezoo Faridzadeh, Kimia Keylani, Seyedeh Faride Langari, Akram Ansari, Amirmohammad Khalaji, Setareh Garousi, Mehran Mottahedi, Sara Honari, Niloofar Deravi |
| 132 |
[GO] |
2022―Nov―30 |
Impact of fluvoxamine on outpatient treatment of COVID-19 in Honduras in a prospective observational real-world study |
Estela Pineda, Jarmanjeet Singh, Miguel Vargas Pineda, Jose Garay Umanzor, Fernando Baires, Luis G. Benitez, Cesar Burgos, Anupamjeet Kaur Sekhon, Nicole Crisp, Anita S. Lewis, Jana Radwanski, Marco Bermudez, Karen Sanchez Barjun, Oscar Diaz, Elsa Palou, Rossany E. Escalante, Carlos Isai Hernandez, Mark L. Stevens, Deke Eberhard, Manuel Sierra, Tito Alvarado, Omar Videa, Miguel Sierra-Hoffman, Fernando Valerio-Pascua |
| 133 |
[GO] |
2022―Nov―30 |
Hypertension related toxicity of chloroquine explains its failure against COVID-19: Based on rat model |
Junqi Wang, Xian Jing, Lizhong Hua, Yuling Zheng, Shiheng Hu, Jing Xiao, Dawei Guo, Wenda Wu, Hui Ji, Lin Peng, Shanxiang Jiang, Xiuge Gao |
| 134 |
[GO] |
2022―Nov―28 |
Drug-induced liver injury in COVID-19 treatment: Incidence, mechanisms and clinical management |
Xichuan Li, Wanting Wang, Suying Yan, Weipeng Zhao, Hui Xiong, Cuiping Bao, Jinqian Chen, Yuan Yue, Yanjun Su, Chunze Zhang |
| 135 |
[GO] |
2022―Nov―24 |
Challenges in evaluating treatments for COVID-19: The case of in-hospital anticoagulant use and the risk of adverse outcomes |
Ya-Hui Yu, In-Sun Oh, Han Eol Jeong, Robert W. Platt, Antonios Douros, Ju-Young Shin, Kristian B. Filion |
| 136 |
[GO] |
2022―Nov―24 |
Drug-related problems in patients admitted for SARS-CoV-2 infection during the COVID-19 pandemic |
J. Barceló-Vidal, D. Echeverría-Esnal, N. Carballo, M. De Antonio-Cuscó, X. Fernández-Sala, M. E. Navarrete-Rouco, E. Colominas-González, S. Luque, M. Fuster-Esteva, L. Domingo, M. Sala, X. Duran, S. Grau, O. Ferrández |
| 137 |
[GO] |
2022―Nov―24 |
Adverse drug events in the prevention and treatment of COVID-19: A data mining study on the FDA adverse event reporting system |
Qiang Guo, Shaojun Duan, Yaxi Liu, Yinxia Yuan |
| 138 |
[GO] |
2022―Nov―24 |
Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries |
Sophie H. Bots, Judit Riera-Arnau, Svetlana V. Belitser, Davide Messina, Maria Aragón, Ema Alsina, Ian J. Douglas, Carlos E. Durán, Patricia García-Poza, Rosa Gini, Ron M. C. Herings, Consuelo Huerta, Malede Mequanent Sisay, Mar Martín-Pérez, Ivonne Martin, Jetty A. Overbeek, Olga Paoletti, Meritxell Pallejà-Millán, Anna Schultze, Patrick Souverein, Karin M. A. Swart, Felipe Villalobos, Olaf H. Klungel, Miriam C. J. M. Sturkenboom |
| 139 |
[GO] |
2022―Nov―23 |
The role of IL-6 in coronavirus, especially in COVID-19 |
Xinyi Wang, Guozheng Tang, Yuchen Liu, Lizhi Zhang, Bangjie Chen, Yanxun Han, Ziyue Fu, Liuning Wang, Guangzhi Hu, Qing Ma, Shuyan Sheng, Jianpeng Wang, Xinyang Hu, Song Shao |
| 140 |
[GO] |
2022―Nov―23 |
Discovery of the key active compounds in Citri Reticulatae Pericarpium (Citrus reticulata “Chachi”) and their therapeutic potential for the treatment of COVID-19 based on comparative metabolomics and network pharmacology |
Fu Wang, Lin Chen, Hongping Chen, Zhuyun Yan, Youping Liu |
| 141 |
[GO] |
2022―Nov―18 |
Identification of highly effective inhibitors against SARS-CoV-2 main protease: From virtual screening to in vitro study |
Hu Wang, Jun Wen, Yang Yang, Hailin Liu, Song Wang, Xiaoli Ding, Chunqiao Zhou, Xuelin Zhang |
| 142 |
[GO] |
2022―Nov―17 |
Correlation between the severity of COVID-19 vaccine-related adverse events and the blood group of the vaccinees in Saudi Arabia: A web-based survey |
Ohoud S. Almalki, Amany S. Khalifa, Ozouf F. Alhemeidi, Ashraf A. Ewis, Abeer M. Shady, Sayed F. Abdelwahab |
| 143 |
[GO] |
2022―Nov―16 |
Immunopathogenesis in SARS-CoV-2 and Mycobacterium tuberculosis: The danger of overlapping crises |
Prakasini Satapathy, Radha Kanta Ratho, Sunil Sethi |
| 144 |
[GO] |
2022―Nov―14 |
Patterns of statin adherence in primary cardiovascular disease prevention during the pandemic |
Sara Malo, Lina Maldonado, María José Rabanaque, Antonio Gimeno-Miguel, Sara Castel-Feced, María Jesús Lallana, Isabel Aguilar-Palacio |
| 145 |
[GO] |
2022―Nov―11 |
Fusion assays for screening of fusion inhibitors targeting SARS-CoV-2 entry and syncytia formation |
Shiu-Wan Chan |
| 146 |
[GO] |
2022―Nov―11 |
Review of preclinical data of PF-07304814 and its active metabolite derivatives against SARS-CoV-2 infection |
Wujun Chen, Yingchun Shao, Xiaojin Peng, Bing Liang, Jiazhen Xu, Dongming Xing |
| 147 |
[GO] |
2022―Nov―11 |
Design of novel disturbing peptides against ACE2 SARS-CoV-2 spike-binding region by computational approaches |
Sara Zareei, Saeed Pourmand, Massoud Amanlou |
| 148 |
[GO] |
2022―Nov―09 |
Multicenter, randomized controlled trial of traditional Japanese medicine, kakkonto with shosaikotokakikyosekko, for mild and moderate coronavirus disease patients |
Shin Takayama, Takao Namiki, Ryutaro Arita, Rie Ono, Akiko Kikuchi, Minoru Ohsawa, Natsumi Saito, Satoko Suzuki, Hajime Nakae, Seiichi Kobayashi, Tetsuhiro Yoshino, Tomoaki Ishigami, Koichiro Tanaka, Kotaro Nochioka, Airi Takagi, Masaru Mimura, Takuhiro Yamaguchi, Tadashi Ishii, Akito Hisanaga, Kazuo Mitani, Takashi Ito |
| 149 |
[GO] |
2022―Nov―08 |
Emerging pneumonia-like illness “legionellosis” in Argentina in the COVID-19 era: Cause to panic? |
Ranjan K. Mohapatra, Ahmed Mahal, Venkataramana Kandi, L. V. Simhachalam Kutikuppala, Ashish K. Sarangi, Snehasish Mishra |
| 150 |
[GO] |
2022―Nov―08 |
The effect of Nigella sativa and vitamin D3 supplementation on the clinical outcome in COVID-19 patients: A randomized controlled clinical trial |
Shimaa A. Said, Alsayyed Abdulbaset, Amal A. El-Kholy, Osama Besckales, Nagwa A. Sabri |
| 151 |
[GO] |
2022―Nov―08 |
Combined effect of traditional Chinese herbal-based formulations Jing Si herbal tea and Jing Si nasal drop inhibits adhesion and transmission of SARS-CoV2 in diabetic SKH-1 mice |
Chien-Yi Chiang, Wei-Wen Kuo, Yu-Jung Lin, Chia-Hua Kuo, Cheng-Yen Shih, Pi-Yu Lin, Shinn-Zong Lin, Tsung-Jung Ho, Chih-Yang Huang, Marthandam Asokan Shibu |
| 152 |
[GO] |
2022―Nov―07 |
Serious adverse reaction associated with the COVID-19 vaccines of BNT162b2, Ad26.COV2.S, and mRNA-1273: Gaining insight through the VAERS |
Ming-Ming Yan, Hui Zhao, Zi-Ran Li, Jun-Wei Chow, Qian Zhang, Yu-Peng Qi, Shu-Shan Wu, Ming-Kang Zhong, Xiao-Yan Qiu |
| 153 |
[GO] |
2022―Nov―03 |
Efficacy and safety of glycyrrhizic acid preparation treating comorbid liver injury in COVID-19: A systematic review |
Xu Liu, Xia Tian, Zhipeng Ma, Jiali Chen, Qingsong Huang, Peiyang Gao, Chuantao Zhang |
| 154 |
[GO] |
2022―Oct―26 |
Herbo-mineral formulation, Divya-Swasari-Vati averts SARS-CoV-2 pseudovirus entry into human alveolar epithelial cells by interfering with spike protein-ACE 2 interaction and IL-6/TNF-α /NF-κB signaling |
Acharya Balkrishna, Sudeep Goswami, Hoshiyar Singh, Vivek Gohel, Rishabh Dev, Swati Haldar, Anurag Varshney |
| 155 |
[GO] |
2022―Oct―20 |
Plant polysaccharides with anti-lung injury effects as a potential therapeutic strategy for COVID-19 |
Peng Huang, Jiahui Zhang, Wenqian Duan, Juying Jiao, Aijing Leng, Jialin Qu |
| 156 |
[GO] |
2022―Oct―19 |
Prevention and treatment of ventilator-associated pneumonia in COVID-19 |
Jiayi Deng, Fanglin Li, Ningjie Zhang, Yanjun Zhong |
| 157 |
[GO] |
2022―Oct―19 |
Biofunctional roles of estrogen in coronavirus disease 2019: Beyond a steroid hormone |
Zhong-Ping Wang, Mao Hua, Tai Jiu, Ri-Li Ge, Zhenzhong Bai |
| 158 |
[GO] |
2022―Oct―19 |
Dual-targeting cyclic peptides of receptor-binding domain (RBD) and main protease (Mpro) as potential drug leads for the treatment of SARS-CoV-2 infection |
Zhen Xu, Yunting Zou, Xi Gao, Miao-Miao Niu, Jindong Li, Lu Xue, Su Jiang |
| 159 |
[GO] |
2022―Oct―14 |
Efficacy and safety of baricitinib and tocilizumab in hospitalized patients with COVID-19: A comparison using systematic review and meta-analysis |
Jerin Jose Cherian, Madhavi Eerike, Bhavani Shankara Bagepally, Saibal Das, Samiran Panda |
| 160 |
[GO] |
2022―Oct―12 |
In vitro effect of Withania somnifera, AYUSH-64, and remdesivir on the activity of CYP-450 enzymes: Implications for possible herb-drug interactions in the management of COVID-19 |
Siva Swapna Kasarla, Swapnil P. Borse, Yashwant Kumar, Neha Sharma, Madhu Dikshit |
| 161 |
[GO] |
2022―Oct―10 |
The potential for traditional Chinese therapy in treating sleep disorders caused by COVID-19 through the cholinergic anti-inflammatory pathway |
Xiaoxia Xie, Nana Zhang, Jingya Fu, Zhenzhi Wang, Zirun Ye, Zhijun Liu |
| 162 |
[GO] |
2022―Oct―10 |
Drugs for the prevention and treatment of COVID-19 and its complications: An update on what we learned in the past 2 years |
Giuseppe Remuzzi, Stefano Schiaffino, Maria Gabriella Santoro, Garret A. FitzGerald, Gennaro Melino, Carlo Patrono |
| 163 |
[GO] |
2022―Oct―07 |
A retrospective study of Pupingqinghua prescription versus Lianhuaqingwen in Chinese participants infected with SARS-CoV-2 Omicron variants |
Yidan Dong, Wei Zhai, Bangjiang Fang, Chenyang Liu, Suyun Yuan, Youhua Wang, Qixiang Song, Hai Li, Bin Chen, Dan Cui, Jun Wang, Qiong Wu, Chang Zhou, Maolin Zhou, Shuchun Li, Xu Zhuang, Qingrong Xu, Yu Zheng, Yingen Wu, Junhua Zheng, Min Cao |
| 164 |
[GO] |
2022―Oct―05 |
Chinese herbal prescriptions for COVID-19 management: Special reference to Taiwan Chingguan Yihau (NRICM101) |
Yi-Chang Su, Guan-Jhong Huang, Jaung-Geng Lin |
| 165 |
[GO] |
2022―Oct―05 |
Associations between the use of aspirin or other antiplatelet drugs and all-cause mortality among patients with COVID-19: A meta-analysis |
Wanting Su, He Miao, Zhaotian Guo, Qianhui Chen, Tao Huang, Renyu Ding |
| 166 |
[GO] |
2022―Oct―05 |
Screening of potential inhibitors targeting the main protease structure of SARS-CoV-2 via molecular docking |
Xinbo Yang, Xianrong Xing, Yirui Liu, Yuanjie Zheng |
| 167 |
[GO] |
2022―Oct―03 |
Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic |
José Diogo S. Souza, Antonio W. Zuardi, Francisco S. Guimarães, Flávia de Lima Osório, Sonia Regina Loureiro, Alline Cristina Campos, Jaime E. C. Hallak, Rafael G. Dos Santos, Isabella Lara Machado Silveira, Karina Pereira-Lima, Julia Cozar Pacheco, Juliana Mayumi Ushirohira, Rafael Rinaldi Ferreira, Karla Cristinne Mancini Costa, Davi Silveira Scomparin, Franciele Franco Scarante, Isabela Pires-Dos-Santos, Raphael Mechoulam, Flávio Kapczinski, Benedito A. L. Fonseca, Danillo L. A. Esposito, Maristela Haddad Andraus, José Alexandre S. Crippa |
| 168 |
[GO] |
2022―Oct―03 |
Theoretical exploration on structures, bonding aspects and molecular docking of α-aminophosphonate ligated copper complexes against SARS-CoV-2 proteases |
Oval Yadav, Manjeet Kumar, Himanshi Mittal, Kiran Yadav, Veronique Seidel, Azaj Ansari |
| 169 |
[GO] |
2022―Sep―30 |
Atovaquone for treatment of COVID-19: A prospective randomized, double-blind, placebo-controlled clinical trial |
Mamta K. Jain, James A. De Lemos, Darren K. McGuire, Colby. Ayers, Jennifer L. Eitson, Claudia L. Sanchez, Dena Kamel, Jessica A. Meisner, Emilia V. Thomas, Anita A. Hegde, Satish Mocherla, Joslyn K. Strebe, Xilong Li, Noelle S. Williams, Chao Xing, Mahmoud S. Ahmed, Ping Wang, Hesham A. Sadek, John W. Schoggins |
| 170 |
[GO] |
2022―Sep―29 |
Potential therapeutic strategies for quercetin targeting critical pathological mechanisms associated with colon adenocarcinoma and COVID-19 |
Xiushen Li, Weizheng Liang, Chengwei Yu, Qingxue Meng, Weiwen Zhang, Xueliang Wu, Jun Xue, Shoulong Deng, Hao Wang |
| 171 |
[GO] |
2022―Sep―27 |
Hydroxychloroquine, azithromycin and methylprednisolone and in hospital survival in severe COVID-19 pneumonia |
Ronaldo C. Go, Themba Nyirenda |
| 172 |
[GO] |
2022―Sep―26 |
Warfarin anticoagulation management during the COVID-19 pandemic: The role of internet clinic and machine learning |
Meng-Fei Dai, Shu-Yue Li, Ji-Fan Zhang, Bao-Yan Wang, Lin Zhou, Feng Yu, Hang Xu, Wei-Hong Ge |
| 173 |
[GO] |
2022―Sep―26 |
Apolipoprotein-A-I for severe COVID-19-induced hyperinflammatory states: A prospective case study |
Stanislas Faguer, Arnaud Del Bello, Chloé Danet, Yves Renaudineau, Jacques Izopet, Nassim Kamar |
| 174 |
[GO] |
2022―Sep―23 |
Network pharmacology and computer-aided drug design to explored potential targets of Lianhua Qingwen and Qingfei Paidu decoction for COVID-19 |
Liyuan Li, Xiaoying Wang, Xiao Guo, Yikun Li, Qiuhang Song, Aiying Li |
| 175 |
[GO] |
2022―Sep―20 |
Willingness to pay for and willingness to vaccinate with the COVID-19 vaccine booster dose in China |
Hui Jun Zhou, Lei Pan, Hui Shi, Ji Wei Luo, Pei Wang, Hannah K. Porter, Ye Bi, Minghui Li |
| 176 |
[GO] |
2022―Sep―16 |
Erratum: Remdesivir strongly binds to RNA-dependent RNA polymerase, membrane protein, and main protease of SARS-CoV-2: Indication from molecular modeling and simulations |
Frontiers Production Office |
| 177 |
[GO] |
2022―Sep―14 |
International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patients |
Akihiko Nishimura, Junqing Xie, Kristin Kostka, Talita Duarte-Salles, Sergio Fernández Bertolín, María Aragón, Clair Blacketer, Azza Shoaibi, Scott L. DuVall, Kristine Lynch, Michael E. Matheny, Thomas Falconer, Daniel R. Morales, Mitchell M. Conover, Seng Chan You, Nicole Pratt, James Weaver, Anthony G. Sena, Martijn J. Schuemie, Jenna Reps, Christian Reich, Peter R. Rijnbeek, Patrick B. Ryan, George Hripcsak, Daniel Prieto-Alhambra, Marc A. Suchard |
| 178 |
[GO] |
2022―Sep―13 |
Single-cell sequencing of brain tissues reveal the central nervous system’s susceptibility to SARS-CoV-2 and the drug |
Zhichao Lu, Ziheng Wang, Zhuhuan Song, Chen Chen, He Ma, Peipei Gong, Yunzhao Xu |
| 179 |
[GO] |
2022―Sep―09 |
Psychotropic drugs interaction with the lipid nanoparticle of COVID-19 mRNA therapeutics |
Adonis Sfera, Sabine Hazan, Jonathan J. Anton, Dan O. Sfera, Christina V. Andronescu, Sarvin Sasannia, Leah Rahman, Zisis Kozlakidis |
| 180 |
[GO] |
2022―Sep―09 |
Efficacy and safety of chinese herbal medicine for treating mild or moderate COVID-19: A systematic review and meta-analysis of randomized controlled trials and observational studies |
Hongfei Zhu, Mengting Li, Chen Tian, Honghao Lai, Yuqing Zhang, Jiaheng Shi, Nannan Shi, Hui Zhao, Kehu Yang, Hongcai Shang, Xin Sun, Jie Liu, Long Ge, Luqi Huang |
| 181 |
[GO] |
2022―Sep―08 |
Remdesivir in treating hospitalized patients with COVID-19: A renewed review of clinical trials |
Zhenchao Wu, Zhifei Han, Beibei Liu, Ning Shen |
| 182 |
[GO] |
2022―Sep―07 |
Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments |
Zhi-Mei Liu, Ming-Hui Yang, Kun Yu, Zheng-Xing Lian, Shou-Long Deng |
| 183 |
[GO] |
2022―Sep―06 |
Corrigendum: Impact of the COVID-19 pandemic on the diagnosis of tuberculosis in Brazil: Is the WHO end TB strategy at risk? |
Mariana do Rosário Souza, Wandklebson Silva da Paz, Vinícius Barbosa dos Santos Sales, Gleidson Felipe Hilario de Jesus, Débora dos Santos Tavares, Shirley V. M. Almeida Lima, Álvaro Francisco Lopes Sousa, Enaldo Vieira de Melo, Rodrigo Feliciano do Carmo, Carlos Dornels Freire de Souza, Márcio Bezerra-Santos |
| 184 |
[GO] |
2022―Sep―06 |
A novel gene signature based on the hub genes of COVID-19 predicts the prognosis of idiopathic pulmonary fibrosis |
Run Guo, Yuefei Zhou, Fang Lin, Mengxing Li, Chunting Tan, Bo Xu |
| 185 |
[GO] |
2022―Sep―06 |
Randomized, placebo-controlled, single-blind phase 1 studies of the safety, tolerability, and pharmacokinetics of BRII-196 and BRII-198, SARS-CoV-2 spike-targeting monoclonal antibodies with an extended half-life in healthy adults |
Xiaohua Hao, Zheng Zhang, Ji Ma, Lin Cheng, Yun Ji, Yang Liu, Dong Zhao, Wen Zhang, Chunming Li, Li Yan, David Margolis, Qing Zhu, Yao Zhang, Fujie Zhang |
| 186 |
[GO] |
2022―Sep―02 |
Exploring the mechanism of action of licorice in the treatment of COVID-19 through bioinformatics analysis and molecular dynamics simulation |
Jun-Feng Cao, Yunli Gong, Mei Wu, Xingyu Yang, Li Xiong, Shengyan Chen, Zixuan Xiao, Yang Li, Lixin Zhang, Wang Zan, Xiao Zhang |
| 187 |
[GO] |
2022―Sep―01 |
Therapeutic effects of herbal-medicine combined therapy for COVID-19: A systematic review and meta-analysis of randomized controlled trials |
Tsai-Ju Chien, Chia-Yu Liu, Yuan-I Chang, Ching-Ju Fang, Juo-Hsiang Pai, Yu-Xuan Wu, Shuoh-Wen Chen |
| 188 |
[GO] |
2022―Aug―26 |
Immune-related adverse events of biological immunotherapies used in COVID-19 |
Daniela Baracaldo-Santamaría, Giovanna María Barros-Arias, Felipe Hernández-Guerrero, Alejandra De-La-Torre, Carlos-Alberto Calderon-Ospina |
| 189 |
[GO] |
2022―Aug―25 |
Optimal COVID-19 therapeutic candidate discovery using the CANDO platform |
William Mangione, Zackary Falls, Ram Samudrala |
| 190 |
[GO] |
2022―Aug―25 |
Discovery of genistein derivatives as potential SARS-CoV-2 main protease inhibitors by virtual screening, molecular dynamics simulations and ADMET analysis |
Jiawei Liu, Ling Zhang, Jian Gao, Baochen Zhang, Xiaoli Liu, Ninghui Yang, Xiaotong Liu, Xifu Liu, Yu Cheng |
| 191 |
[GO] |
2022―Aug―24 |
Using an untargeted metabolomics approach to analyze serum metabolites in COVID-19 patients with nucleic acid turning negative |
Wenyu Chen, Ming Yao, Miaomiao Chen, Zhao Ou, Qi Yang, Yanbin He, Ning Zhang, Min Deng, Yuqi Wu, Rongchang Chen, Xiaoli Tan, Ziqing Kong |
| 192 |
[GO] |
2022―Aug―19 |
Bioactive natural products in COVID-19 therapy |
Zhonglei Wang, Ning Wang, Liyan Yang, Xian-qing Song |
| 193 |
[GO] |
2022―Aug―19 |
A comprehensive review on disposition kinetics and dosage of oral administration of Andrographis paniculata, an alternative herbal medicine, in co-treatment of coronavirus disease |
Phanit Songvut, Tawit Suriyo, Duangchit Panomvana, Nuchanart Rangkadilok, Jutamaad Satayavivad |
| 194 |
[GO] |
2022―Aug―17 |
Investigation into the in vivo mechanism of diosmetin in patients with breast cancer and COVID-19 using bioinformatics |
Jin Wang, Shanbo Ma, Long Li, Yuhan Chen, Qian Yang, Feiyan Wang, Meiling Zheng, Shan Miao, Xiaopeng Shi |
| 195 |
[GO] |
2022―Aug―16 |
Network pharmacology reveals multitarget mechanism of action of drugs to be repurposed for COVID-19 |
Melissa Alegría-Arcos, Tábata Barbosa, Felipe Sepúlveda, German Combariza, Janneth González, Carmen Gil, Ana Martínez, David Ramírez |
| 196 |
[GO] |
2022―Aug―16 |
Preclinical Pharmacokinetics and In Vitro Properties of GS-441524, a Potential Oral Drug Candidate for COVID-19 Treatment |
Amy Q. Wang, Natalie R. Hagen, Elias C. Padilha, Mengbi Yang, Pranav Shah, Catherine Z. Chen, Wenwei Huang, Pramod Terse, Philip Sanderson, Wei Zheng, Xin Xu |
| 197 |
[GO] |
2022―Aug―16 |
Effectiveness and safety analysis of SanHanHuaShi granules for the treatment of coronavirus disease 2019: Study protocol and statistical analysis plan for a randomized, parallel-controlled, open-label clinical trial |
Yangyang Liu, Xi Chen, Hongan Wang, Chensi Yao, Xiaowen Gou, Zezheng Gao, Linlin Sun, Dan Liu, Cheng Tang, Yu Wei, Qiyou Ding, Haoyu Yang, Jiaran Lin, Keyu Chen, Jia Chen, Linhua Zhao, Min Li, Lin Han, Jian Wang, Jixiang Ren, Ying Zhang |
| 198 |
[GO] |
2022―Aug―16 |
Real-world effectiveness of Yindan Jiedu granules-based treatment on patients infected with the SARS-CoV-2 Omicron variants BA.2 combined with high-risk factors: A cohort study |
Ying Feng, Yao Liu, Long Liu, Yao Liu, Yuyong Jiang, Yixin Hou, Yang Zhou, Rui Song, Xiaoyou Chen, Xianbo Wang |
| 199 |
[GO] |
2022―Aug―15 |
Authorization of COVID-19 clinical trials: lessons from 2 years of experience of a national competent authority |
Stéphane Vignot, Alban Dhanani, Isabelle Sainte-Marie, Laure de Ligniville Lajavardi, Gwennaelle Even, Muriel Echemann, Nina Hulin, Claire Ménoret, Patrick Maison, Christelle Ratignier-Carbonneil |
| 200 |
[GO] |
2022―Aug―15 |
Smart therapies against global pandemics: A potential of short peptides |
Vasso Apostolopoulos, Joanna Bojarska, Jack Feehan, John Matsoukas, Wojciech Wolf |
| 201 |
[GO] |
2022―Aug―11 |
Potential protective benefits of Schisandrin B against severe acute hepatitis in children during the COVID-19 pandemic based on a network pharmacology analysis |
Yanhua Fang, Lingling Zhang, Zhe Wang, Ruoyu Wang, Shanshan Liang |
| 202 |
[GO] |
2022―Aug―09 |
In silico analysis and preclinical findings uncover potential targets of anti-cervical carcinoma and COVID-19 in laminarin, a promising nutraceutical |
Jiaqi Liu, Yudong Chen, Litao Nie, Xiao Liang, Wenjun Huang, Rong Li |
| 203 |
[GO] |
2022―Aug―09 |
Editorial: Cytokine Release Syndrome in COVID-19: Mechanisms and Management |
Tao Hu |
| 204 |
[GO] |
2022―Aug―09 |
Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development |
Xiao-Huan Liu, Ting Cheng, Bao-Yu Liu, Jia Chi, Ting Shu, Tao Wang |
| 205 |
[GO] |
2022―Aug―08 |
Role of tannic acid against SARS-cov-2 cell entry by targeting the interface region between S-protein-RBD and human ACE2 |
Xi Chen, Ziyuan Wang, Jing Wang, Yifan Yao, Qian Wang, Jiahao Huang, Xianping Xiang, Yifan Zhou, Yintong Xue, Yan Li, Xiang Gao, Lijun Wang, Ming Chu, Yuedan Wang |
| 206 |
[GO] |
2022―Aug―04 |
Application of network pharmacology in the study of the mechanism of action of traditional chinese medicine in the treatment of COVID-19 |
Shihao Zheng, Tianyu Xue, Bin Wang, Haolin Guo, Qiquan Liu |
| 207 |
[GO] |
2022―Aug―01 |
Identifying Drug-Induced Liver Injury Associated With Inflammation-Drug and Drug-Drug Interactions in Pharmacologic Treatments for COVID-19 by Bioinformatics and System Biology Analyses: The Role of Pregnane X Receptor |
Jingjing Huang, Zhaokang Zhang, Chenxia Hao, Yuzhen Qiu, Ruoming Tan, Jialin Liu, Xiaoli Wang, Wanhua Yang, Hongping Qu |
| 208 |
[GO] |
2022―Jul―22 |
The common regulatory pathway of COVID-19 and multiple inflammatory diseases and the molecular mechanism of cepharanthine in the treatment of COVID-19 |
Ping Jiang, Jingyao Ye, Menglong Jia, Xiaopeng Li, Shujun Wei, Nianhu Li |
| 209 |
[GO] |
2022―Jul―22 |
Detecting drug-drug interactions between therapies for COVID-19 and concomitant medications through the FDA adverse event reporting system |
Eugene Jeong, Scott D. Nelson, Yu Su, Bradley Malin, Lang Li, You Chen |
| 210 |
[GO] |
2022―Jul―22 |
Treatment of COVID-19 Pneumonia and Acute Respiratory Distress With Ramatroban, a Thromboxane A2 and Prostaglandin D2 Receptor Antagonist: A Four-Patient Case Series Report |
Martin L. Ogletree, Kate Chander Chiang, Rashmi Kulshrestha, Aditya Agarwal, Ashutosh Agarwal, Ajay Gupta |
| 211 |
[GO] |
2022―Jul―22 |
Camostat Mesylate Versus Lopinavir/Ritonavir in Hospitalized Patients With COVID-19-Results From a Randomized, Controlled, Open Label, Platform Trial (ACOVACT) |
M. Karolyi, E. Pawelka, S. Omid, F. Koenig, V. Kauer, B. Rumpf, W. Hoepler, A. Kuran, H. Laferl, T. Seitz, M. Traugott, V. Rathkolb, M. Mueller, A. Abrahamowicz, C. Schoergenhofer, M. Hecking, A. Assinger, C. Wenisch, M. Zeitlinger, B. Jilma, A. Zoufaly |
| 212 |
[GO] |
2022―Jul―15 |
Role of Traditional Chinese Medicine in Treating Severe or Critical COVID-19: A Systematic Review of Randomized Controlled Trials and Observational Studies |
Mengting Li, Hongfei Zhu, Yafei Liu, Yao Lu, Minyao Sun, Yuqing Zhang, Jiaheng Shi, Nannan Shi, Ling Li, Kehu Yang, Xin Sun, Jie Liu, Long Ge, Luqi Huang |
| 213 |
[GO] |
2022―Jul―14 |
Use of Tox21 Screening Data to Evaluate the COVID-19 Drug Candidates for Their Potential Toxic Effects and Related Pathways |
Srilatha Sakamuru, Ruili Huang, Menghang Xia |
| 214 |
[GO] |
2022―Jul―13 |
Treatment Effect of Qingfei Paidu Decoction Combined With Conventional Treatment on COVID-19 Patients and Other Respiratory Diseases: A Multi-Center Retrospective Case Series |
Xingyu Zong, Ning Liang, Jingya Wang, Huizhen Li, Dingyi Wang, Yaxin Chen, Haili Zhang, Liwen Jiao, An Li, Guihui Wu, Jike Li, Mingxuan Wang, Hongde Liu, Zhang Liu, Shusen Zhao, Jin Huang, Qiuhua Huang, Xiaoyan Wang, Jin Qin, Yan Ma, Yanping Wang, Nannan Shi |
| 215 |
[GO] |
2022―Jul―13 |
A Case-Based Monitoring Approach to Evaluate Safety of COVID-19 Vaccines in a Partially Integrated Health Information System: A Study Protocol |
Norazida Ab Rahman, Ming Tsuey Lim, Fei Yee Lee, Su Miin Ong, Kalaiarasu M. Peariasamy, Sheamini Sivasampu |
| 216 |
[GO] |
2022―Jul―08 |
Editorial: Medication Safety in COVID-19 Management |
Saibal Das |
| 217 |
[GO] |
2022―Jul―08 |
Pre-Clinical Development of a Potent Neutralizing Antibody MW3321 With Extensive SARS-CoV-2 Variants Coverage |
Wen Jiang, Zherui Zhang, Yuhe Zhu, Ben Chen, Chunying Gu, Zhiyan Liu, Xukai Zhang, Hualong Xiong, Yanan Zhang, Bin Zheng, Rongjuan Wang, Shasha Jiao, An Wang, Tianying Zhang, Jinchao Zhang, Shuang Wang, Bo Zhang, Gang Li, Xun Gui |
| 218 |
[GO] |
2022―Jul―07 |
Chronic Administration of COVID-19 Drugs Fluvoxamine and Lopinavir Shortens Action Potential Duration by Inhibiting the Human Ether-à-go-go-Related Gene and Cav1.2 |
Zequn Zheng, Dihui Cai, Yin Fu, Ying Wang, Yongfei Song, Jiangfang Lian |
| 219 |
[GO] |
2022―Jul―05 |
The Effect of Statins on Clinical Outcome Among Hospitalized Patients With COVID-19: A Multi-Centric Cohort Study |
Srikanth Umakanthan, Sanjum Senthil, Stanley John, Mahesh K. Madhavan, Jessica Das, Sonal Patil, Raghunath Rameshwaram, Ananya Cintham, Venkatesh Subramaniam, Madhusudan Yogi, Abhishek Bansal, Sumesh Achutham, Chandini Shekar, Vijay Murthy, Robbin Selvaraj |
| 220 |
[GO] |
2022―Jul―04 |
Beneficial Effect of Short-Term Supplementation of High Dose of Vitamin D3 in Hospitalized Patients With COVID-19: A Multicenter, Single-Blinded, Prospective Randomized Pilot Clinical Trial |
Miguel Cervero, Daniel López-Wolf, Guiomar Casado, Maria Novella-Mena, Pablo Ryan-Murua, María Luisa Taboada-Martínez, Sara Rodríguez-Mora, Lorena Vigón, Mayte Coiras, Montserrat Torres |
| 221 |
[GO] |
2022―Jul―04 |
Virofree, an Herbal Medicine-Based Formula, Interrupts the Viral Infection of Delta and Omicron Variants of SARS-CoV-2 |
Ly Hien Doan, Li-Wei Chu, Zi-Yi Huang, Anh Thuc Nguyen, Chia-Yin Lee, Chien-Ling Huang, Yu-Fen Chang, Wen-Yu Hsieh, Trang Thi Huyen Nguyen, Chao-Hsiung Lin, Chun-Li Su, Tsung-Hsien Chuang, Jin-Mei Lai, Feng-Sheng Wang, Chia-Jui Yang, Hui-Kang Liu, Yueh-Hsin Ping, Chi-Ying F. Huang |
| 222 |
[GO] |
2022―Jun―30 |
The Anti-Histamine Azelastine, Identified by Computational Drug Repurposing, Inhibits Infection by Major Variants of SARS-CoV-2 in Cell Cultures and Reconstituted Human Nasal Tissue |
Robert Konrat, Henrietta Papp, Janine Kimpel, Annika Rössler, Valéria Szijártó, Gábor Nagy, Mónika Madai, Safia Zeghbib, Anett Kuczmog, Zsófia Lanszki, Tanja Gesell, Zsuzsanna Helyes, Gábor Kemenesi, Ferenc Jakab, Eszter Nagy |
| 223 |
[GO] |
2022―Jun―30 |
Therapeutic Targeting of Innate Immune Receptors Against SARS-CoV-2 Infection |
Mariya Farooq, Abdul Waheed Khan, Bilal Ahmad, Moon Suk Kim, Sangdun Choi |
| 224 |
[GO] |
2022―Jun―29 |
Impact of the COVID-19 Pandemic on the Diagnosis of Tuberculosis in Brazil: Is the WHO End TB Strategy at Risk? |
Mariana do Rosário Souza, Wandklebson Silva da Paz, Vinícius Barbosa dos Santos Sales, Gleidson Felipe Hilario de Jesus, Débora dos Santos Tavares, Shirley V. M. Almeida Lima, Álvaro Francisco Lopes Sousa, Enaldo Vieira de Melo, Rodrigo Feliciano do Carmo, Carlos Dornels Freire de Souza, Márcio Bezerra-Santos |
| 225 |
[GO] |
2022―Jun―24 |
Profiling COVID-19 Vaccine Adverse Events by Statistical and Ontological Analysis of VAERS Case Reports |
Wenxin Guo, Jessica Deguise, Yujia Tian, Philip Chi-En Huang, Rohit Goru, Qiuyue Yang, Suyuan Peng, Luxia Zhang, Lili Zhao, Jiangan Xie, Yongqun He |
| 226 |
[GO] |
2022―Jun―21 |
Is Ivermectin Effective in Treating COVID-19? |
Shuangshuang Yang, Shan Shen, Ning Hou |
| 227 |
[GO] |
2022―Jun―20 |
Herbal Medicine Intervention for the Treatment of COVID-19: A Living Systematic Review and Cumulative Meta-Analysis |
Lin Ang, Eunhye Song, Xiao-Yang Hu, Hye Won Lee, Yaolong Chen, Myeong Soo Lee |
| 228 |
[GO] |
2022―Jun―17 |
Target Specific Inhibition of Protein Tyrosine Kinase in Conjunction With Cancer and SARS-COV-2 by Olive Nutraceuticals |
Arabinda Ghosh, Nobendu Mukerjee, Bhavdeep Sharma, Anushree Pant, Yugal Kishore Mohanta, Rahul D. Jawarkar, Ravindrakumar L. Bakal, Ermias Mergia Terefe, Gaber El-Saber Batiha, Gomaa Mostafa-Hedeab, Nisreen Khalid Aref Albezrah, Abhijit Dey, Debabrat Baishya |
| 229 |
[GO] |
2022―Jun―15 |
Editorial: Pharmacological and Biochemical Perspectives of Kinase Inhibitors in Cancer and COVID-19 Therapeutics, Volume I |
Balakumar Chandrasekaran, Muthupandian Saravanan |
| 230 |
[GO] |
2022―Jun―08 |
Modeling Kaempferol as a Potential Pharmacological Agent for COVID-19/PF Co-Occurrence Based on Bioinformatics and System Pharmacological Tools |
Yong Jiang, Yi-Zi Xie, Chen-Wen Peng, Kai-Nan Yao, Xue-Ying Lin, Shao-Feng Zhan, Hong-Fa Zhuang, Hui-Ting Huang, Xiao-Hong Liu, Xiu-Fang Huang, Hang Li |
| 231 |
[GO] |
2022―Jun―07 |
Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19-Results From a Pilot Open-Label, Randomized Controlled Trial |
Amjad Khan, Somia Iqtadar, Sami Ullah Mumtaz, Michael Heinrich, Domingo A. Pascual-Figal, Shona Livingstone, Sajid Abaidullah |
| 232 |
[GO] |
2022―Jun―03 |
Efficacy and Safety of Chinese Medicine Lianhua Qingwen for Treating COVID-19: An Updated meta-Analysis |
Yapeng Li, Peng Xiao, Nanyang Liu, Zhijie Zhang |
| 233 |
[GO] |
2022―Jun―02 |
Bioinformatics and System Biology Approach to Reveal the Interaction Network and the Therapeutic Implications for Non-Small Cell Lung Cancer Patients With COVID-19 |
Zhenjie Zhuang, Xiaoying Zhong, Qianying Chen, Huiqi Chen, Zhanhua Liu |
| 234 |
[GO] |
2022―Jun―02 |
Chemical Constituents of Essential Oils Used in Olfactory Training: Focus on COVID-19 Induced Olfactory Dysfunction |
Sachiko Koyama, Thomas Heinbockel |
| 235 |
[GO] |
2022―Jun―02 |
Key Considerations for Phase 2 or 3 Clinical Study Design of Anti-Inflammatory Agent for COVID-19 Treatment |
Yewon Park, Joo Young Na, Joo-Youn Cho, Jaeseong Oh, Su-jin Rhee |
| 236 |
[GO] |
2022―Jun―01 |
Mechanism of Multi-Organ Injury in Experimental COVID-19 and Its Inhibition by a Small Molecule Peptide |
Michael J. Paidas, Natarajan Sampath, Emma A. Schindler, Daniela S. Cosio, Chima Obianuju Ndubizu, Nagarajarao Shamaladevi, Jaclyn Kwal, Suset Rodriguez, Anis Ahmad, Norma Sue Kenyon, Arumugam R. Jayakumar |
| 237 |
[GO] |
2022―Jun―01 |
p53/NF-kB Balance in SARS-CoV-2 Infection: From OMICs, Genomics and Pharmacogenomics Insights to Tailored Therapeutic Perspectives (COVIDomics) |
Daniela Milani, Lorenzo Caruso, Enrico Zauli, Adi Mohammed Al Owaifeer, Paola Secchiero, Giorgio Zauli, Donato Gemmati, Veronica Tisato |
| 238 |
[GO] |
2022―May―30 |
Initiation of Tocilizumab or Baricitinib Were Associated With Comparable Clinical Outcomes Among Patients Hospitalized With COVID-19 and Treated With Dexamethasone |
Carlos K. H. Wong, Kristy T. K. Lau, Ivan C. H. Au, Xi Xiong, Matthew S. H. Chung, Belle Y. C. Leung, Eric H. Y. Lau, Benjamin J. Cowling |
| 239 |
[GO] |
2022―May―23 |
Puerarin: A Potential Therapeutic for Colon Adenocarcinoma (COAD) Patients Suffering From SARS-CoV-2 Infection |
Weizheng Liang, Xiushen Li, Yue Yao, Qingxue Meng, Xueliang Wu, Hao Wang, Jun Xue |
| 240 |
[GO] |
2022―May―20 |
Exploiting Extracellular Vesicles Strategies to Modulate Cell Death and Inflammation in COVID-19 |
Barbara Bortot, Arianna Romani, Giuseppe Ricci, Stefania Biffi |
| 241 |
[GO] |
2022―May―20 |
COVID-19 Vaccine-Associated Transient Global Amnesia: A Disproportionality Analysis of the WHO Safety Database |
Diane Merino, Alexandre O. Gérard, Elise K. Van Obberghen, Nouha Ben Othman, Eric Ettore, Bruno Giordana, Delphine Viard, Fanny Rocher, Alexandre Destere, Michel Benoit, Milou-Daniel Drici |
| 242 |
[GO] |
2022―May―11 |
Long-Term Cardiovascular and Cerebrovascular Challenges Posed by COVID-19 in Patients With Familial Hypercholesterolemia |
Alpo Vuorio, Frederick Raal, Petra Ijäs, Markku Kaste, Petri T. Kovanen |
| 243 |
[GO] |
2022―May―02 |
Antiviral Activity of Selected Lamiaceae Essential Oils and Their Monoterpenes Against SARS-Cov-2 |
Sanja Ćavar Zeljković, Ermin Schadich, Petr Džubák, Marián Hajdúch, Petr Tarkowski |
| 244 |
[GO] |
2022―Apr―29 |
Oxidative Stress and Hyper-Inflammation as Major Drivers of Severe COVID-19 and Long COVID: Implications for the Benefit of High-Dose Intravenous Vitamin C |
Claudia Vollbracht, Karin Kraft |
| 245 |
[GO] |
2022―Apr―28 |
Network Pharmacology and Bioinformatics Analyses Identify Intersection Genes of Vitamin D3 and COVID-19 as Potential Therapeutic Targets |
Shanglin Wang, Huayu Gao, Xiaoru Wang, Xiaoli Ma, Lulu Zhang, Yuanxin Xing, Yanfei Jia, Yunshan Wang |
| 246 |
[GO] |
2022―Apr―27 |
Psychotropic Medication Use Before and During COVID-19: A Population-Wide Study |
Christine Leong, Kaarina Kowalec, Sherif Eltonsy, James M. Bolton, Murray W. Enns, Qier Tan, Marina Yogendran, Dan Chateau, Joseph A. Delaney, Jitender Sareen, Jamison Falk, Rae Spiwak, Sarvesh Logsetty, Silvia Alessi-Severini |
| 247 |
[GO] |
2022―Apr―26 |
Echinacea Purpurea For the Long-Term Prevention of Viral Respiratory Tract Infections During Covid-19 Pandemic: A Randomized, Open, Controlled, Exploratory Clinical Study |
Emil Kolev, Lilyana Mircheva, Michael R. Edwards, Sebastian L. Johnston, Krassimir Kalinov, Rainer Stange, Giuseppe Gancitano, Wim Vanden Berghe, Samo Kreft |
| 248 |
[GO] |
2022―Apr―26 |
Selinexor and COVID-19: The Neglected Warden |
Gomaa Mostafa-Hedeab, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Nermeen N. Welson, Gaber El-Saber Batiha, Carlos Adam Conte-Junior |
| 249 |
[GO] |
2022―Apr―25 |
Effective Regulation of Gut Microbiota With Probiotics and Prebiotics May Prevent or Alleviate COVID-19 Through the Gut-Lung Axis |
Lei Xu, Chung S. Yang, Yanan Liu, Xin Zhang |
| 250 |
[GO] |
2022―Apr―25 |
Histamine Potentiates SARS-CoV-2 Spike Protein Entry Into Endothelial Cells |
Somasundaram Raghavan, M. Dennis Leo |
| 251 |
[GO] |
2022―Apr―14 |
Appropriateness of Antibiotic Prescriptions in Chinese Primary Health Care and the Impact of the COVID-19 Pandemic: A Typically Descriptive and Longitudinal Database Study in Yinchuan City |
Houyu Zhao, Shengfeng Wang, Ruogu Meng, Guozhen Liu, Jing Hu, Huina Zhang, Shaohua Yan, Siyan Zhan |
| 252 |
[GO] |
2022―Apr―14 |
Pharmaceutical Prospects of Curcuminoids for the Remedy of COVID-19: Truth or Myth |
Yaw-Syan Fu, Wan-Yi Ho, Ning Kang, May-Jywan Tsai, Jingyi Wu, Liyue Huang, Ching-Feng Weng |
| 253 |
[GO] |
2022―Apr―14 |
Efficacy and Safety of Lithium Treatment in SARS-CoV-2 Infected Patients |
Carlos Spuch, Marta López-García, Tania Rivera-Baltanás, J. J Cabrera-Alvargonzález, Sudhir Gadh, Daniela Rodrigues-Amorim, Tania Álvarez-Estévez, Almudena Mora, Marta Iglesias-Martínez-Almeida, Luis Freiría-Martínez, Maite Pérez-Rodríguez, Alexandre Pérez-González, Ana López-Domínguez, María Rebeca Longueira-Suarez, Adrián Sousa-Domínguez, Alejandro Araújo-Ameijeiras, David Mosquera-Rodríguez, Manuel Crespo, Dolores Vila-Fernández, Benito Regueiro, Jose Manuel Olivares |
| 254 |
[GO] |
2022―Apr―12 |
2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An Update |
Zoufang Huang, Vivek P. Chavda, Lalitkumar K. Vora, Normi Gajjar, Vasso Apostolopoulos, Nirav Shah, Zhe-Sheng Chen |
| 255 |
[GO] |
2022―Apr―07 |
Plant Source Derived Compound Exhibited In Silico Inhibition of Membrane Glycoprotein In SARS-CoV-2: Paving the Way to Discover a New Class of Compound For Treatment of COVID-19 |
Saurov Mahanta, Tufan Naiya, Kunal Biswas, Liza Changkakoti, Yugal Kishore Mohanta, Bhaben Tanti, Awdhesh Kumar Mishra, Tapan Kumar Mohanta, Nanaocha Sharma |
| 256 |
[GO] |
2022―Apr―07 |
Thymoquinone’s Antiviral Effects: It is Time to be Proven in the Covid-19 Pandemic Era and its Omicron Variant Surge |
Maen Abdelrahim, Abdullah Esmail, Noor Al Saadi, Eva Zsigmond, Ebtesam Al Najjar, Doaa Bugazia, Hadeel Al-Rawi, Ayat Alsaadi, Ahmed O. Kaseb |
| 257 |
[GO] |
2022―Apr―05 |
Efficacy and Outcome of Remdesivir and Tocilizumab Combination Against Dexamethasone for the Treatment of Severe COVID-19: A Randomized Controlled Trial |
Abu Taiub Mohammed Mohiuddin Chowdhury, Aktar Kamal, Kafil Uddin Abbas, Shubhashis Talukder, Md Rezaul Karim, Md. Ahsan Ali, Md. Nuruzzaman, Yarui Li, Shuixiang He |
| 258 |
[GO] |
2022―Apr―04 |
Kinase Inhibitors as Potential Therapeutic Agents in the Treatment of COVID-19 |
Rajashri R. Naik, Ashok K. Shakya, Safwan M. Aladwan, Mohamed El-Tanani |
| 259 |
[GO] |
2022―Mar―31 |
The Use of Oral Anticoagulation Is Not Associated With a Reduced Risk of Mortality in Patients With COVID-19: A Systematic Review and Meta-Analysis of Cohort Studies |
Meng-Fei Dai, Si-Tong Guo, Yi-Jun Ke, Bao-Yan Wang, Feng Yu, Hang Xu, Zhi-Chun Gu, Wei-Hong Ge |
| 260 |
[GO] |
2022―Mar―30 |
Pulmonary Inflammatory Response in Lethal COVID-19 Reveals Potential Therapeutic Targets and Drugs in Phases III/IV Clinical Trials |
Andrés López-Cortés, Santiago Guerrero, Esteban Ortiz-Prado, Verónica Yumiceba, Antonella Vera-Guapi, Ángela León Cáceres, Katherine Simbaña-Rivera, Ana María Gómez-Jaramillo, Gabriela Echeverría-Garcés, Jennyfer M. García-Cárdenas, Patricia Guevara-Ramírez, Alejandro Cabrera-Andrade, Lourdes Puig San Andrés, Doménica Cevallos-Robalino, Jhommara Bautista, Isaac Armendáriz-Castillo, Andy Pérez-Villa, Andrea Abad-Sojos, María José Ramos-Medina, Ariana León-Sosa, Estefanía Abarca, Álvaro A. Pérez-Meza, Karol Nieto-Jaramillo, Andrea V. Jácome, Andrea Morillo, Fernanda Arias-Erazo, Luis Fuenmayor-González, Luis Abel Quiñones, Nikolaos C. Kyriakidis |
| 261 |
[GO] |
2022―Mar―30 |
Kampo Medicine Promotes Early Recovery From Coronavirus Disease 2019-Related Olfactory Dysfunction: A Retrospective Observational Study |
Rie Ono, Ryutaro Arita, Shin Takayama, Akiko Kikuchi, Minoru Ohsawa, Natsumi Saito, Satoko Suzuki, Tadashi Ishii |
| 262 |
[GO] |
2022―Mar―30 |
In vitro Suppression of SARS-CoV-2 Infection by Existing Kampo Formulas and Crude Constituent Drugs Used for Treatment of Common Cold Respiratory Symptoms |
Masaki Kakimoto, Toshihito Nomura, Tanuza Nazmul, Hiroki Kitagawa, Keishi Kanno, Keiko Ogawa-Ochiai, Hiroki Ohge, Masanori Ito, Takemasa Sakaguchi |
| 263 |
[GO] |
2022―Mar―29 |
Treatment of COVID-19 in Hemodialysis Patients Using Traditional Chinese Medicine: A Single-Center, Retrospective Study |
Wei Huang, Bo Jiang, Jinli Luo, Meng Luo, Xiaoming Ding, Qian Yang, Lin-Hua Zhao, Qin-Guo Sun, Xiao-Lin Tong |
| 264 |
[GO] |
2022―Mar―29 |
Acute Kidney Injury Associated With Remdesivir: A Comprehensive Pharmacovigilance Analysis of COVID-19 Reports in FAERS |
Bin Wu, Min Luo, Fengbo Wu, Zhiyao He, Yuwen Li, Ting Xu |
| 265 |
[GO] |
2022―Mar―29 |
Optimization of SARS-CoV-2 Pseudovirion Production in Lentivirus Backbone With a Novel Liposomal System |
Gokulnath Mahalingam, Hari Krishnareddy Rachamalla, Porkizhi Arjunan, Yogapriya Periyasami, Salma M, Saravanabhavan Thangavel, Kumarasamypet M. Mohankumar, Mahesh Moorthy, Shaji R. Velayudhan, Alok Srivastava, Srujan Marepally |
| 266 |
[GO] |
2022―Mar―29 |
Drug Prescriptions in the Outpatient Management of COVID-19: Evidence-Based Recommendations Versus Real Practice |
Valeria Belleudi, Marco Finocchietti, Filomena Fortinguerra, Aurora Di Filippo, Francesco Trotta, Marina Davoli, Antonio Addis |
| 267 |
[GO] |
2022―Mar―29 |
Case Report: Recanalization of Branch Retinal Artery Occlusion Due to Microthrombi Following the First Dose of SARS-CoV-2 mRNA Vaccination |
Min Seung Kang, Sang Yoon Kim, Han Jo Kwon |
| 268 |
[GO] |
2022―Mar―29 |
Honeysuckle (Lonicera japonica) and Huangqi (Astragalus membranaceus) Suppress SARS-CoV-2 Entry and COVID-19 Related Cytokine Storm in Vitro |
Yuan-Chieh Yeh, Ly Hien Doan, Zi-Yi Huang, Li-Wei Chu, Tzu-Hau Shi, Ying-Ray Lee, Cheng-Tao Wu, Chao-Hsiung Lin, Shu-Tuan Chiang, Hui-Kang Liu, Tsung-Hsien Chuang, Yueh-Hsin Ping, Hsiao-Sheng Liu, Chi-Ying F. Huang |
| 269 |
[GO] |
2022―Mar―24 |
Consumption Trends of Antibiotics in Brazil During the COVID-19 Pandemic |
Fernando de Sá Del Fiol, Cristiane de Cássia Bergamaschi, Isaltino Pereira De Andrade, Luciane Cruz Lopes, Marcus Tolentino Silva, Silvio Barberato-Filho |
| 270 |
[GO] |
2022―Mar―23 |
The Traditional Chinese Medicine Formula Jing Guan Fang for Preventing SARS-CoV-2 Infection: From Clinical Observation to Basic Research |
Yueh-Hsin Ping, Hsin Yeh, Li-Wei Chu, Zhi-Hu Lin, Yin-Chieh Hsu, Lie-Chwen Lin, Chung-Hua Hsu, Shu-Ling Fu, Tung-Yi Lin |
| 271 |
[GO] |
2022―Mar―22 |
Association Between Drug Treatments and the Incidence of Liver Injury in Hospitalized Patients With COVID-19 |
Suyu Gao, Qingqing Yang, Xuanxuan Wang, Wen Hu, Yun Lu, Kun Yang, Qiaoli Jiang, Wenjing Li, Haibo Song, Feng Sun, Hong Cheng |
| 272 |
[GO] |
2022―Mar―17 |
Acute Kidney Injury and Drugs Prescribed for COVID-19 in Diabetes Patients: A Real-World Disproportionality Analysis |
Yu Zhou, Jianbin Li, Linyao Wang, Xinyan Zhu, Meilian Zhang, Jiaping Zheng |
| 273 |
[GO] |
2022―Mar―15 |
Editorial: Vitamin D and COVID-19: New Mechanistic and Therapeutic Insights |
Ewa Marcinkowska, Geoffrey Brown |
| 274 |
[GO] |
2022―Mar―14 |
Editorial: Novel Therapeutic Interventions Against Infectious Diseases: COVID-19 |
Sugunadevi Sakkiah, Brijesh Kumar Singh, Keun Woo Lee, Chandrabose Selvaraj |
| 275 |
[GO] |
2022―Mar―10 |
Riboflavin for COVID-19 Adjuvant Treatment in Patients With Mental Health Disorders: Observational Study |
R. A. Akasov, E. V. Khaydukov, D. S. Andreyuk, N. V. Sholina, A. N. Sheremeta, D. V. Romanov, G. P. Kostyuk, V. Ya. Panchenko, M. V. Kovalchuk |
| 276 |
[GO] |
2022―Mar―10 |
Aspirin in COVID-19: Pros and Cons |
Rana Zareef, Marwa Diab, Tala Al Saleh, Adham Makarem, Nour K. Younis, Fadi Bitar, Mariam Arabi |
| 277 |
[GO] |
2022―Mar―10 |
Oral Lisinopril Raises Tissue Levels of ACE2, the SARS-CoV-2 Receptor, in Healthy Male and Female Mice |
Steven D. Brooks, Rachel L. Smith, Aline S. Moreira, Hans C. Ackerman |
| 278 |
[GO] |
2022―Mar―09 |
Diabetes, Metformin and the Clinical Course of Covid-19: Outcomes, Mechanisms and Suggestions on the Therapeutic Use of Metformin |
Clifford J. Bailey, Mike Gwilt |
| 279 |
[GO] |
2022―Mar―08 |
Inspiration for COVID-19 Treatment: Network Analysis and Experimental Validation of Baicalin for Cytokine Storm |
Jia You, Huawei Li, Peng Fan, Xi Yang, Yuanfeng Wei, Lingnan Zheng, Zhaojun Li, Cheng Yi |
| 280 |
[GO] |
2022―Mar―04 |
Title: Understanding a Low Vitamin D State in the Context of COVID-19 |
James Bernard Walsh, Daniel M. McCartney, Éamon Laird, Kevin McCarroll, Declan G. Byrne, Martin Healy, Paula M. O’Shea, Rose Anne Kenny, John L. Faul |
| 281 |
[GO] |
2022―Mar―03 |
Difficulty in Repurposing Selective Serotonin Reuptake Inhibitors and Other Antidepressants with Functional Inhibition of Acid Sphingomyelinase in COVID-19 Infection |
Pascal Le Corre, Gwenolé Loas |
| 282 |
[GO] |
2022―Feb―28 |
Case Report: Tackling Complement Hyperactivation With Eculizumab in Atypical Hemolytic Uremic Syndrome Triggered by COVID-19 |
Valentina Fanny Leone, Amantia Imeraj, Sara Gastoldi, Caterina Mele, Lucia Liguori, Carmelita Condemi, Piero Ruggenenti, Giuseppe Remuzzi, Camillo Carrara |
| 283 |
[GO] |
2022―Feb―25 |
Mechanism of Action of Small-Molecule Agents in Ongoing Clinical Trials for SARS-CoV-2: A Review |
Lei Zhao, Song Li, Wu Zhong |
| 284 |
[GO] |
2022―Feb―21 |
The Role of Vitamin D in COVID-19 and the Impact of Pandemic Restrictions on Vitamin D Blood Content |
Agata Tomaszewska, Agnieszka Rustecka, Agnieszka Lipińska-Opałka, Rafal P. Piprek, Małgorzata Kloc, Bolesław Kalicki, Jacek Z. Kubiak |
| 285 |
[GO] |
2022―Feb―21 |
A Novel COVID-19-Related Drug Discovery Approach Based on Non-Equidimensional Data Clustering |
Bolin Chen, Yourui Han, Xuequn Shang, Shenggui Zhang |
| 286 |
[GO] |
2022―Feb―18 |
Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies |
Mohitosh Biswas, Nares Sawajan, Thanyada Rungrotmongkol, Kamonpan Sanachai, Maliheh Ershadian, Chonlaphat Sukasem |
| 287 |
[GO] |
2022―Feb―18 |
Tocilizumab and COVID-19: Timing of Administration and Efficacy |
Emna Abidi, Wasim S. El Nekidy, Eman Alefishat, Nadeem Rahman, Georg A. Petroianu, Rania El-Lababidi, Jihad Mallat |
| 288 |
[GO] |
2022―Feb―14 |
Antibiotic Use in China’s Public Healthcare Institutions During the COVID-19 Pandemic: An Analysis of Nationwide Procurement Data, 2018-2020 |
Ying Yang, Xin Geng, Xiaojun Liu, Xiaotong Wen, Ruonan Wu, Dan Cui, Zongfu Mao |
| 289 |
[GO] |
2022―Feb―14 |
Increased Circulating Cytokines Have a Role in COVID-19 Severity and Death With a More Pronounced Effect in Males: A Systematic Review and Meta-Analysis |
Huating Hu, Hudan Pan, Runze Li, Kancheng He, Han Zhang, Liang Liu |
| 290 |
[GO] |
2022―Feb―09 |
Effectiveness of Antiviral Therapy in Highly-Transmissible Variants of SARS-CoV-2: A Modeling and Simulation Study |
Verena Schöning, Charlotte Kern, Carlos Chaccour, Felix Hammann |
| 291 |
[GO] |
2022―Feb―08 |
Montelukast Inhibits Platelet Activation Induced by Plasma From COVID-19 Patients |
Marina Camera, Paola Canzano, Marta Brambilla, G. Enrico Rovati |
| 292 |
[GO] |
2022―Feb―07 |
Evidence Mapping of 23 Systematic Reviews of Traditional Chinese Medicine Combined With Western Medicine Approaches for COVID-19 |
Ting Zhang, Xuechao Li, Yamin Chen, Liang Zhao, Jinhui Tian, Junhua Zhang |
| 293 |
[GO] |
2022―Feb―04 |
Continuous Renal Replacement Therapy With oXiris Filter May Not be an Effective Resolution to Alleviate Cytokine Release Syndrome in Non-AKI Patients With Severe and Critical COVID-19 |
Kai Kang, Yunpeng Luo, Yang Gao, Jiannan Zhang, Changsong Wang, Dongsheng Fei, Wei Yang, Xianglin Meng, Ming Ye, Yan Gao, Haitao Liu, Xue Du, Yuanyuan Ji, Jieling Wei, Wanqiu Xie, Jun Wang, Mingyan Zhao, Kaijiang Yu |
| 294 |
[GO] |
2022―Feb―04 |
The Association Between Proton Pump Inhibitors and COVID-19 is Confounded by Hyperglycemia in a Population-Based Study |
Asher Shafrir, Ariel A. Benson, Lior H. Katz, Tiberiu Hershcovici, Menachem Bitan, Ora Paltiel, Ronit Calderon-Margalit, Rifaat Safadi, Michal Shauly-Aharonov |
| 295 |
[GO] |
2022―Feb―04 |
Composition, Clinical Efficiency, and Mechanism of NHC-Approved “Three Chinese Medicines and Three Chinese Recipes” for COVID-19 Treatment |
Ke-Yao Xia, Zeyuan Zhao, Taif Shah, Jing-Yi Wang, Zulqarnain Baloch |
| 296 |
[GO] |
2022―Feb―02 |
The Role of Cytochrome P450 Enzymes in COVID-19 Pathogenesis and Therapy |
Guyi Wang, Bing Xiao, Jiayi Deng, Linmei Gong, Yi Li, Jinxiu Li, Yanjun Zhong |
| 297 |
[GO] |
2022―Jan―28 |
PBPK Modelling of Dexamethasone in Patients With COVID-19 and Liver Disease |
Maiara Camotti Montanha, Nicolas Cottura, Michael Booth, Daryl Hodge, Fazila Bunglawala, Hannah Kinvig, Sandra Grañana-Castillo, Andrew Lloyd, Saye Khoo, Marco Siccardi |
| 298 |
[GO] |
2022―Jan―28 |
Barriers and Enablers for Adherence to Antiretroviral Therapy Among People Living With HIV/AIDS in the Era of COVID-19: A Qualitative Study From Pakistan |
Ali Ahmed, Juman Abdulelah Dujaili, Musarat Jabeen, Malik Muhammad Umair, Lay-Hong Chuah, Furqan Khurshid Hashmi, Ahmed Awaisu, Nathorn Chaiyakunapruk |
| 299 |
[GO] |
2022―Jan―28 |
Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells |
Fedor Simko, Tomas Baka |
| 300 |
[GO] |
2022―Jan―25 |
Construction of the Enterococcal Strain Expressing Immunogenic Fragment of SARS-Cov-2 Virus |
Alexander Suvorov, Tatiana Gupalova, Yulia Desheva, Tatiana Kramskaya, Elena Bormotova, Irina Koroleva, Olga Kopteva, Galina Leontieva |
| 301 |
[GO] |
2022―Jan―21 |
Specific Interleukin-1 Inhibitors, Specific Interleukin-6 Inhibitors, and GM-CSF Blockades for COVID-19 (at the Edge of Sepsis): A Systematic Review |
Ying Wang, Kun Zhu, Rulin Dai, Rui Li, Miao Li, Xin Lv, Qian Yu |
| 302 |
[GO] |
2022―Jan―20 |
Bulbus Fritillariae Cirrhosae as a Respiratory Medicine: Is There a Potential Drug in the Treatment of COVID-19? |
Yunyun Quan, Li Li, Zhujun Yin, Shilong Chen, Jing Yi, Jirui Lang, Lu Zhang, Qianhua Yue, Junning Zhao |
| 303 |
[GO] |
2022―Jan―19 |
Antidepressant and Antipsychotic Drugs Reduce Viral Infection by SARS-CoV-2 and Fluoxetine Shows Antiviral Activity Against the Novel Variants in vitro |
Senem Merve Fred, Suvi Kuivanen, Hasan Ugurlu, Plinio Cabrera Casarotto, Lev Levanov, Kalle Saksela, Olli Vapalahti, Eero Castrén |
| 304 |
[GO] |
2022―Jan―13 |
COVID-19 and Periodontitis: A Dangerous Association? |
Francisco Javier Silvestre, Cecilia Fabiana Márquez-Arrico |
| 305 |
[GO] |
2022―Jan―12 |
Editorial: Biomolecules Against Coronaviruses: Molecular Aspects, Multi-Omics and Systems Pharmacology |
Christophe Hano, Ilaria Peluso, Jen-Tsung Chen |
| 306 |
[GO] |
2022―Jan―12 |
The Role of Interleukin-8 in Lung Inflammation and Injury: Implications for the Management of COVID-19 and Hyperinflammatory Acute Respiratory Distress Syndrome |
Maria Candida Cesta, Mara Zippoli, Carolina Marsiglia, Elizabeth Marie Gavioli, Flavio Mantelli, Marcello Allegretti, Robert A. Balk |
| 307 |
[GO] |
2022―Jan―12 |
Angiotensin-Converting Enzyme Genotype-Specific Immune Response Contributes to the Susceptibility of COVID-19: A Nested Case-Control Study |
Pengyun Gong, Fanghua Mei, Ruili Li, Yuchen Wang, Weizheng Li, Kai Pan, Junqiang Xu, Chao Liu, Hongjun Li, Kun Cai, Wei Shi |
| 308 |
[GO] |
2022―Jan―06 |
Opioids in COVID-19: Two Sides of a Coin |
Camila Vantini Capasso Palamim, Matheus Negri Boschiero, Aléthea Guimarães Faria, Felipe Eduardo Valencise, Fernando Augusto Lima Marson |
| 309 |
[GO] |
2022―Jan―05 |
The Interaction Between Pulmonary Fibrosis and COVID-19 and the Application of Related Anti-Fibrotic Drugs |
Hao Shen, Nu Zhang, Yuqing Liu, Xuerong Yang, Yuanyuan He, Qi Li, Xiaoyan Shen, Yulian Zhu, Yong Yang |
| 310 |
[GO] |
2022―Jan―05 |
Construction of the Enterococcal Strain Expressing Immunogenic Fragment of SARS-Cov-2 Virus |
Alexander Suvorov, Tatiana Gupalova, Yulia Desheva, Tatiana Kramskaya, Elena Bormotova, Irina Koroleva, Olga Kopteva, Galina Leontieva |
| 311 |
[GO] |
2022―Jan―04 |
Perception, Attitude, and Confidence of Physicians About Antimicrobial Resistance and Antimicrobial Prescribing Among COVID-19 Patients: A Cross-Sectional Study From Punjab, Pakistan |
Khezar Hayat, Zia Ul Mustafa, Muhammad Nabeel Ikram, Muhammad Ijaz-Ul-Haq, Irum Noor, Muhammad Fawad Rasool, Hafiz Muhammad Ishaq, Anees Ur Rehman, Syed Shahzad Hasan, Yu Fang |
| 312 |
[GO] |
2021―Dec―24 |
Signaling Potential Therapeutic Herbal Medicine Prescription for Treating COVID-19 by Collaborative Filtering |
Fan Yang, Qi Zhang, Zhongshang Yuan, Saisai Teng, Lizhen Cui, Fuzhong Xue, Leyi Wei |
| 313 |
[GO] |
2021―Dec―23 |
Host Factor Interaction Networks Identified by Integrative Bioinformatics Analysis Reveals Therapeutic Implications in COPD Patients With COVID-19 |
Wenjiang Zheng, Ting Wang, Peng Wu, Qian Yan, Chengxin Liu, Hui Wu, Shaofeng Zhan, Xiaohong Liu, Yong Jiang, Hongfa Zhuang |
| 314 |
[GO] |
2021―Dec―23 |
Molecular and Clinical Aspects of COVID-19 Vaccines and Other Therapeutic Interventions Apropos Emerging Variants of Concern |
Khursheed Ul Islam, Thoraya Mohamed Elhassan A-Elgadir, Sarah Afaq, Tanveer Ahmad, Jawed Iqbal |
| 315 |
[GO] |
2021―Dec―22 |
Household Drug Stockpiling and Panic Buying of Drugs During the COVID-19 Pandemic: A Study From Jordan |
Sura Al Zoubi, Lobna Gharaibeh, Hatim M. Jaber, Zaha Al-Zoubi |
| 316 |
[GO] |
2021―Dec―17 |
Corrigendum: Antiviral and Immunomodulatory Effects of Pelargonium sidoides DC. Root Extract EPs® 7630 in SARS-CoV-2-Infected Human Lung Cells |
Jan Papies, Jackson Emanuel, Nicolas Heinemann, Žarko Kulić, Simon Schroeder, Beate Tenner, Martin D. Lehner, Georg Seifert, Marcel A. Müller |
| 317 |
[GO] |
2021―Dec―16 |
Low-Dose Fluvoxamine Modulates Endocytic Trafficking of SARS-CoV-2 Spike Protein: A Potential Mechanism for Anti-COVID-19 Protection by Antidepressants |
Oleg O. Glebov |
| 318 |
[GO] |
2021―Dec―10 |
Increased Use of Antibiotics in the Intensive Care Unit During Coronavirus Disease (COVID-19) Pandemic in a Brazilian Hospital |
Alice Ramos Oliveira Silva, Diamantino Ribeiro Salgado, Luis Phillipe Nagem Lopes, Débora Castanheira, Isabel Cristina Martins Emmerick, Elisangela Costa Lima |
| 319 |
[GO] |
2021―Dec―08 |
Development of a Network-Based Signal Detection Tool: The COVID-19 Adversome in the FDA Adverse Event Reporting System |
Michele Fusaroli, Emanuel Raschi, Milo Gatti, Fabrizio De Ponti, Elisabetta Poluzzi |
| 320 |
[GO] |
2021―Dec―06 |
Pre-Steady-State Kinetics of the SARS-CoV-2 Main Protease as a Powerful Tool for Antiviral Drug Discovery |
Maria Yu. Zakharova, Alexandra A. Kuznetsova, Victoria I. Uvarova, Anastasiia D. Fomina, Liubov I. Kozlovskaya, Elena N. Kaliberda, Inna N. Kurbatskaia, Ivan V. Smirnov, Anatoly A. Bulygin, Vera D. Knorre, Olga S. Fedorova, Alexandre Varnek, Dmitry I. Osolodkin, Aydar A. Ishmukhametov, Alexey M. Egorov, Alexander G. Gabibov, Nikita A. Kuznetsov |
| 321 |
[GO] |
2021―Dec―03 |
Editorial: Ethnopharmacological Responses to the Coronavirus Disease 2019 Pandemic |
Jia-bo Wang, Adolfo Andrade-Cetto, Javier Echeverria, Jon Wardle, Hung-Rong Yen, Michael Heinrich |
| 322 |
[GO] |
2021―Dec―01 |
Natural Products for the Prevention and Control of the COVID-19 Pandemic: Sustainable Bioresources |
Rajeev K. Singla, Xuefei He, Hitesh Chopra, Christos Tsagkaris, Li Shen, Mohammad Amjad Kamal, Bairong Shen |
| 323 |
[GO] |
2021―Dec―01 |
Traditional Uses, Pharmacological Effects, and Molecular Mechanisms of Licorice in Potential Therapy of COVID-19 |
Qian-hui Zhang, Hao-zhou Huang, Min Qiu, Zhen-feng Wu, Zhan-chang Xin, Xin-fu Cai, Qiang Shang, Jun-zhi Lin, Ding-kun Zhang, Li Han |
| 324 |
[GO] |
2021―Nov―22 |
Recent Updates in Experimental Research and Clinical Evaluation on Drugs for COVID-19 Treatment |
Houwen Zou, Yuqi Yang, Huiqiang Dai, Yunchuang Xiong, Jing-Quan Wang, Lusheng Lin, Zhe-Sheng Chen |
| 325 |
[GO] |
2021―Nov―19 |
Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells |
Oghenemega Okoloko, Elizabeth R. Vanderwall, Lucille M. Rich, Maria P. White, Stephen R. Reeves, Whitney E. Harrington, Kaitlyn A. Barrow, Jason S. Debley |
| 326 |
[GO] |
2021―Nov―18 |
The Drug Repurposing for COVID-19 Clinical Trials Provide Very Effective Therapeutic Combinations: Lessons Learned From Major Clinical Studies |
Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, Govindasamy Agoramoorthy, Sang-Soo Lee |
| 327 |
[GO] |
2021―Nov―18 |
Immunological and Preventive Effects of Hochuekkito and Kakkonto Against Coronavirus Disease in Healthcare Workers: A Retrospective Observational Study |
Keiko Ogawa-Ochiai, Hideki Ishikawa, Hongyang Li, Lam Vu Quang, Izumi Kimoto, Mitsuyuki Takamura, Tetsuya Hongawa, Yasuyuki Hane, Susumu Suzuki, Masaki Okajima, Keita Mori, Masanori Ito, Akiyoshi Takami |
| 328 |
[GO] |
2021―Nov―11 |
Herb-Drug Interaction Between Xiyanping Injection and Lopinavir/Ritonavir, Two Agents Used in COVID-19 Pharmacotherapy |
Linhu Ye, Lei Cheng, Yan Deng, Hong Liu, Xinyu Wu, Tingting Wang, Qi Chang, Yan Zhang, Dan Wang, Zongze Li, Xixiao Yang |
| 329 |
[GO] |
2021―Nov―11 |
Screening of a Small Molecule Compound Library Identifies Toosendanin as an Inhibitor Against Bunyavirus and SARS-CoV-2 |
Shufen Li, Meidi Ye, Yuanqiao Chen, Yulan Zhang, Jiachen Li, Wei Liu, Hao Li, Ke Peng |
| 330 |
[GO] |
2021―Nov―08 |
A Review of Medicinal Plants with Antiviral Activity Available in Bangladesh and Mechanistic Insight Into Their Bioactive Metabolites on SARS-CoV-2, HIV and HBV |
Sitesh C. Bachar, Kishor Mazumder, Ritesh Bachar, Asma Aktar, Mamun Al Mahtab |
| 331 |
[GO] |
2021―Nov―08 |
Breaking Barriers Amid the Pandemic: The Status of Telehealth in Southeast Asia and its Potential as a Mode of Healthcare Delivery in the Philippines |
Aitana Dy Macariola, Theara Mae Capacion Santarin, Ferianne Joy Manday Villaflor, Leofe Marie Guintos Villaluna, Rea Shane Leonora Yonzon, Jamie Ledesma Fermin, Shaira Limson Kee, Nouar AlDahoul, Hezerul Abdul Karim, Myles Joshua Toledo Tan |
| 332 |
[GO] |
2021―Nov―04 |
Phillyrin for COVID-19 and Influenza Co-infection: A Potential Therapeutic Strategy Targeting Host Based on Bioinformatics Analysis |
Yanni Lai, Tiantian Han, Zizhao Lao, Geng Li, Jianyong Xiao, Xiaohong Liu |
| 333 |
[GO] |
2021―Nov―02 |
Commentary: Potential Mechanism Prediction of Herbal Medicine for Pulmonary Fibrosis Associated With SARS-CoV-2 Infection Based on Network Analysis and Molecular Docking |
Congchao Jia, Xinya Peng, Hao Chi, Gang Tian |
| 334 |
[GO] |
2021―Oct―26 |
Traditional Chinese Medicine, Qingfei Paidu Decoction and Xuanfei Baidu Decoction, Inhibited Cytokine Production via NF-κB Signaling Pathway in Macrophages: Implications for Coronavirus Disease 2019 (COVID-19) Therapy |
Yujia Li, Bin Li, Pan Wang, Qinghua Wang |
| 335 |
[GO] |
2021―Oct―25 |
Clinical Characteristics and Inflammatory Immune Responses in COVID-19 Patients With Hypertension: A Retrospective Study |
Chaoran Wu, Guangbo Qu, Lei Wang, Shiyu Cao, Dandan Xia, Baolong Wang, Xiaoyun Fan, Changhui Wang |
| 336 |
[GO] |
2021―Oct―25 |
Enteric Coronavirus Infection and Treatment Modeled With an Immunocompetent Human Intestine-On-A-Chip |
Amir Bein, Seongmin Kim, Girija Goyal, Wuji Cao, Cicely Fadel, Arash Naziripour, Sanjay Sharma, Ben Swenor, Nina LoGrande, Atiq Nurani, Vincent N. Miao, Andrew W. Navia, Carly G. K. Ziegler, José Ordovas Montañes, Pranav Prabhala, Min Sun Kim, Rachelle Prantil-Baun, Melissa Rodas, Amanda Jiang, Lucy O’Sullivan, Gladness Tillya, Alex K. Shalek, Donald E. Ingber |
| 337 |
[GO] |
2021―Oct―25 |
Corrigendum: Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review |
Zhi-Hua Yang, Bin Wang, Qian Ma, Lin Wang, Ya-Xin Lin, Hai-Feng Yan, Zi-Xuan Fan, Hao-Jia Chen, Zhao Ge, Feng Zhu, Hui-Jie Wang, Bao-Nan Zhang, Hai-Dong Sun, Li-Min Feng |
| 338 |
[GO] |
2021―Oct―25 |
Antiviral and Immunomodulatory Effects of Pelargonium sidoides DC. Root Extract EPs® 7630 in SARS-CoV-2-Infected Human Lung Cells |
Jan Papies, Jackson Emanuel, Nicolas Heinemann, Žarko Kulić, Simon Schroeder, Beate Tenner, Martin D. Lehner, Georg Seifert, Marcel A. Müller |
| 339 |
[GO] |
2021―Oct―18 |
The Standard of Care Definitions on COVID-19 Pharmacological Clinical Trials: A Systematic Review |
Antonio Addis, Laura Amato, Fabio Cruciani, Rosella Saulle, Franco De Crescenzo, Zuzana Mitrova, Simona Vecchi, Francesco Perrone, Marina Davoli |
| 340 |
[GO] |
2021―Oct―14 |
Effect of Prophylactic Use of Intranasal Oil Formulations in the Hamster Model of COVID-19 |
Zaigham Abbas Rizvi, Manas Ranjan Tripathy, Nishant Sharma, Sandeep Goswami, N Srikanth, J. L. N. Sastry, Shailendra Mani, Milan Surjit, Amit Awasthi, Madhu Dikshit |
| 341 |
[GO] |
2021―Oct―01 |
The Establishment and Practice of Pharmacy Care Service Based on Internet Social Media: Telemedicine in Response to the COVID-19 Pandemic |
Huibo Li, Siqian Zheng, Da Li, Dechun Jiang, Fang Liu, Wei Guo, Zhenying Zhao, Yanfei Zhou, Jingting Liu, Rongsheng Zhao |
| 342 |
[GO] |
2021―Sep―17 |
Immunotherapy Summary for Cytokine Storm in COVID-19 |
Yaqun Li, Wenjie Zhao, Jinhua Liu, Zichao Chen, Qingtao Lv, Zhen Zhang |
| 343 |
[GO] |
2021―Sep―15 |
Add-On Effect of Honeysuckle in the Treatment of Coronavirus Disease 2019: A Systematic Review and Meta-Analysis |
Xu-Qin Du, Li-Peng Shi, Wen-Fu Cao, Zhi-Wei Chen, Biao Zuo, Jin-Yuan Hu |
| 344 |
[GO] |
2021―Sep―09 |
Therapeutic Potential of Annexins in Sepsis and COVID-19 |
Louise Mui, Claudio M. Martin, Brent J. Tschirhart, Qingping Feng |
| 345 |
[GO] |
2021―Sep―09 |
Tele-pharmacy Anticoagulation Clinic During COVID-19 Pandemic: Patient Outcomes |
Maha Al Ammari, Khalefa AlThiab, Manal AlJohani, Khizra Sultana, Nada Maklhafi, Hayel AlOnazi, Aswaq Maringa |
| 346 |
[GO] |
2021―Sep―06 |
Yisaipu® Provide AS Patients With an Economical Therapeutic Option While Original Biologicals are More Advantageous in the COVID-19 Epidemic Situation |
Hongjuan Lu, Yuanqiong Wang, Xiuwen Wang, Xin Wu, Ling Zhou, Li Lin, Rong Sheng, Haoran Tian, Ting Li, Huji Xu |
| 347 |
[GO] |
2021―Sep―06 |
Designing Short Peptides to Block the Interaction of SARS-CoV-2 and Human ACE2 for COVID-19 Therapeutics |
Abdul Basit, Asad Mustafa Karim, Muhammad Asif, Tanveer Ali, Jung Hun Lee, Jeong Ho Jeon, Shafiq ur Rehman, Sang Hee Lee |
| 348 |
[GO] |
2021―Sep―04 |
A Systematic Review and a Meta-Analysis Comparing Prophylactic and Therapeutic Low Molecular Weight Heparins for Mortality Reduction in 32,688 COVID-19 Patients |
Riccardo Giossi, Danilo Menichelli, Arianna Pani, Elena Tratta, Alessandra Romandini, Rossana Roncato, Alessandro Nani, Paolo Schenardi, Erika Diani, Veronica Andrea Fittipaldo, Alessio Farcomeni, Francesco Scaglione, Daniele Pastori |
| 349 |
[GO] |
2021―Sep―04 |
Favipiravir Versus Arbidol for Clinical Recovery Rate in Moderate and Severe Adult COVID-19 Patients: A Prospective, Multicenter, Open-Label, Randomized Controlled Clinical Trial |
Chang Chen, Yi Zhang, Jianying Huang, Ping Yin, Zhenshun Cheng, Jianyuan Wu, Song Chen, Yongxi Zhang, Bo Chen, Mengxin Lu, Yongwen Luo, Lingao Ju, Jingyi Zhang, Xinghuan Wang |
| 350 |
[GO] |
2021―Sep―04 |
Clinical Progress on Management of Pneumonia Due to COVID-19 With Chinese Traditional Patent Medicines |
Ying Wu, Ping Zhong |
| 351 |
[GO] |
2021―Sep―04 |
Targeting of Protein’s Messenger RNA for Viral Replication, Assembly and Release in SARS-CoV-2 Using Whole Genomic Data From South Africa: Therapeutic Potentials of Cannabis Sativa L |
Ochuko L. Erukainure, Motlalepula G. Matsabisa, Aliyu Muhammad, Musa M. Abarshi, James F. Amaku, Sanusi B. Katsayal, Adeline Lum Nde |
| 352 |
[GO] |
2021―Sep―03 |
Identification of Novel Gene Signatures using Next-Generation Sequencing Data from COVID-19 Infection Models: Focus on Neuro-COVID and Potential Therapeutics |
Peter Natesan Pushparaj, Angham Abdulrahman Abdulkareem, Muhammad Imran Naseer |
| 353 |
[GO] |
2021―Aug―31 |
Kratom Use Within the Context of the Evolving Opioid Crisis and the COVID-19 Pandemic in the United States |
Walter C. Prozialeck, Peter C. Lamar, Michael Krupp, Matthew Moon, Laura E. Phelps, Oliver Grundmann |
| 354 |
[GO] |
2021―Aug―27 |
Ugonin J Acts as a SARS-CoV-2 3C-like Protease Inhibitor and Exhibits Anti-inflammatory Properties |
Wei-Chung Chiou, Hsu-Feng Lu, Nung-Yu Hsu, Tein-Yao Chang, Yuan-Fan Chin, Ping-Cheng Liu, Jir-Mehng Lo, Yeh B Wu, Jinn-Moon Yang, Cheng Huang |
| 355 |
[GO] |
2021―Aug―24 |
Editorial: Drug Repurposing for COVID-19 Therapy |
Rafael Maldonado, Filippo Drago |
| 356 |
[GO] |
2021―Aug―23 |
mTOR-Inhibition and COVID-19 in Kidney Transplant Recipients: Focus on Pulmonary Fibrosis |
Simona Granata, Pierluigi Carraté, Giovanni Stallone, Gianluigi Zaza |
| 357 |
[GO] |
2021―Aug―18 |
Drug-Induced Liver Disturbance During the Treatment of COVID-19 |
Guanghua Zhai, Meifen Li, Ying Wang, Jian Wu |
| 358 |
[GO] |
2021―Aug―17 |
Natural Bioactive Molecules as Potential Agents Against SARS-CoV-2 |
Wei Chen, Zhihao Wang, Yawen Wang, Yiping Li |
| 359 |
[GO] |
2021―Aug―13 |
Remdesivir and Cyclosporine Synergistically Inhibit the Human Coronaviruses OC43 and SARS-CoV-2 |
Hsing-Yu Hsu, Cheng-Wei Yang, Yue-Zhi Lee, Yi-Ling Lin, Sui-Yuan Chang, Ruey-Bing Yang, Jian-Jong Liang, Tai-Ling Chao, Chun-Che Liao, Han-Chieh Kao, Szu-Huei Wu, Jang-Yang Chang, Huey-Kang Sytwu, Chiung-Tong Chen, Shiow-Ju Lee |
| 360 |
[GO] |
2021―Aug―12 |
Beneficial Treatment Outcomes of Severe COVID-19 Patients Treated Entirely in Primary Care Settings With Dexamethasone Including Regimen-Case Series Report |
Damir Vukoja, Andrea Jurić, Zdravka Erkapić, Tomislav Pejić, Željko Zovko, Josipa Juričić, Jelena Pejić, Matea Ćorluka |
| 361 |
[GO] |
2021―Aug―12 |
Efficacy and Safety of Qingfei Paidu Decoction for Treating COVID-19: A Systematic Review and Meta-Analysis |
Qi Wang, Hongfei Zhu, Mengting Li, Yafei Liu, Honghao Lai, Qiuyu Yang, Xiao Cao, Long Ge |
| 362 |
[GO] |
2021―Aug―11 |
A Birds-Eye (Re)View of Acid-Suppression Drugs, COVID-19, and the Highly Variable Literature |
Cameron Mura, Saskia Preissner, Robert Preissner, Philip E. Bourne |
| 363 |
[GO] |
2021―Aug―09 |
Case Report: Can Inhaled Adenosine Attenuate COVID-19? |
Bruce D. Spiess, Michael Sitkovsky, Pierpaolo Correale, Nikolaus Gravenstein, Cynthia Garvan, Timothy E. Morey, Brenda G. Fahy, Leslie Hendeles, Thomas J. Pliura, Thomas D. Martin, Velyn Wu, Corey Astrom, Danielle S. Nelson |
| 364 |
[GO] |
2021―Aug―06 |
Efficacy and Safety of Traditional Chinese Medicine in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis |
Heping Wang, Bowen Xu, Ying Zhang, Yuanyuan Duan, Ruike Gao, Haoqiang He, Xiuyang Li, Jie Li |
| 365 |
[GO] |
2021―Aug―06 |
Heart Muscle Microphysiological System for Cardiac Liability Prediction of Repurposed COVID-19 Therapeutics |
Bérénice Charrez, Verena Charwat, Brian A. Siemons, Ishan Goswami, Courtney Sakolish, Yu-Syuan Luo, Henrik Finsberg, Andrew G. Edwards, Evan W. Miller, Ivan Rusyn, Kevin E. Healy |
| 366 |
[GO] |
2021―Aug―06 |
The Hyperlipidaemic Drug Fenofibrate Significantly Reduces Infection by SARS-CoV-2 in Cell Culture Models |
Scott P. Davies, Courtney J. Mycroft-West, Isabel Pagani, Harriet J. Hill, Yen-Hsi Chen, Richard Karlsson, Ieva Bagdonaite, Scott E. Guimond, Zania Stamataki, Marcelo Andrade De Lima, Jeremy E. Turnbull, Zhang Yang, Elisa Vicenzi, Mark A. Skidmore, Farhat L. Khanim, Alan Richardson |
| 367 |
[GO] |
2021―Aug―05 |
NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments |
Constant Gillot, Julien Favresse, François Mullier, Thomas Lecompte, Jean-Michel Dogné, Jonathan Douxfils |
| 368 |
[GO] |
2021―Jul―28 |
Expert-Augmented Computational Drug Repurposing Identified Baricitinib as a Treatment for COVID-19 |
Daniel P. Smith, Olly Oechsle, Michael J. Rawling, Ed Savory, Alix M.B. Lacoste, Peter John Richardson |
| 369 |
[GO] |
2021―Jul―28 |
Ten Rules for Conducting Retrospective Pharmacoepidemiological Analyses: Example COVID-19 Study |
Michael Powell, Allison Koenecke, James Brian Byrd, Akihiko Nishimura, Maximilian F. Konig, Ruoxuan Xiong, Sadiqa Mahmood, Vera Mucaj, Chetan Bettegowda, Liam Rose, Suzanne Tamang, Adam Sacarny, Brian Caffo, Susan Athey, Elizabeth A. Stuart, Joshua T. Vogelstein |
| 370 |
[GO] |
2021―Jul―20 |
Corrigendum: Therapeutic Potentials of Antiviral Plants Used in Traditional African Medicine With COVID-19 in Focus: A Nigerian Perspective |
Alfred Francis Attah, Adeshola Adebayo Fagbemi, Olujide Olubiyi, Hannah Dada-Adegbola, Akinseinde Oluwadotun, Anthony Elujoba, Chinedum Peace Babalola |
| 371 |
[GO] |
2021―Jul―20 |
Medicinal Plants Used for Treating Mild Covid-19 Symptoms Among Thai Karen and Hmong |
Methee Phumthum, Varangrat Nguanchoo, Henrik Balslev |
| 372 |
[GO] |
2021―Jul―16 |
The Role of High-Density Lipoprotein in COVID-19 |
Guyi Wang, Jiayi Deng, Jinxiu Li, Chenfang Wu, Haiyun Dong, Shangjie Wu, Yanjun Zhong |
| 373 |
[GO] |
2021―Jul―16 |
Potentials of Antitussive Traditional Persian Functional Foods for COVID-19 Therapy† |
Ghazaleh Mosleh, Parmis Badr, Meysam Zaeri, Abdolali Mohagheghzadeh |
| 374 |
[GO] |
2021―Jul―15 |
Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review |
Zhi-Hua Yang, Bin Wang, Qian Ma, Lin Wang, Ya-Xin Lin, Hai-Feng Yan, Zi-Xuan Fan, Hao-Jia Chen, Zhao Ge, Feng Zhu, Hui-Jie Wang, Bao-Nan Zhang, Hai-Dong Sun, Li-Min Feng |
| 375 |
[GO] |
2021―Jul―09 |
Glycyrrhizic Acid: A Natural Plant Ingredient as a Drug Candidate to Treat COVID-19 |
Zhong Sun, Guozhong He, Ninghao Huang, Karuppiah Thilakavathy, Jonathan Chee Woei Lim, S. Suresh Kumar, Chenglong Xiong |
| 376 |
[GO] |
2021―Jul―08 |
Exploring Phytochemicals of Traditional Medicinal Plants Exhibiting Inhibitory Activity Against Main Protease, Spike Glycoprotein, RNA-dependent RNA Polymerase and Non-Structural Proteins of SARS-CoV-2 Through Virtual Screening |
Saranya Nallusamy, Jayakanthan Mannu, Caroline Ravikumar, Kandavelmani Angamuthu, Bharathi Nathan, Kumaravadivel Nachimuthu, Gnanam Ramasamy, Raveendran Muthurajan, Mohankumar Subbarayalu, Kumar Neelakandan |
| 377 |
[GO] |
2021―Jul―07 |
Herbal Medicine, Gut Microbiota, and COVID-19 |
Ziqi Chen, Yiwen Lv, Huachong Xu, Li Deng |
| 378 |
[GO] |
2021―Jul―07 |
Remdesivir Strongly Binds to RNA-Dependent RNA Polymerase, Membrane Protein, and Main Protease of SARS-CoV-2: Indication From Molecular Modeling and Simulations |
Faez Iqbal Khan, Tongzhou Kang, Haider Ali, Dakun Lai |
| 379 |
[GO] |
2021―Jul―05 |
Targeting SARS-CoV-2-Platelet Interactions in COVID-19 and Vaccine-Related Thrombosis |
Dermot Cox |
| 380 |
[GO] |
2021―Jul―02 |
Efficacy and Safety of Leflunomide for Refractory COVID-19: A Pilot Study |
Qiang Wang, Haipeng Guo, Yu Li, Xiangdong Jian, Xinguo Hou, Ning Zhong, Jianchun Fei, Dezhen Su, Zhouyan Bian, Yi Zhang, Yingying Hu, Yan Sun, Xueyuan Yu, Yuan Li, Bei Jiang, Yan Li, Fengping Qin, Yingying Wu, Yanxia Gao, Zhao Hu |
| 381 |
[GO] |
2021―Jul―01 |
High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19 |
Mario Karolyi, Sara Omid, Erich Pawelka, Bernd Jilma, Thomas Stimpfl, Christian Schoergenhofer, Hermann Laferl, Tamara Seitz, Marianna Traugott, Christoph Wenisch, Alexander Zoufaly |
| 382 |
[GO] |
2021―Jul―01 |
Tocilizumab in COVID-19: Factors Associated With Mortality Before and After Treatment |
Luis Sarabia De Ardanaz, Jose M. Andreu-Ubero, Miriam Navidad-Fuentes, Miguel Ángel Ferrer-González, Victor Ruíz del Valle, Inmaculada Salcedo-Bellido, Rocío Barrios-Rodríguez, Rafael Cáliz-Cáliz, Pilar Requena |
| 383 |
[GO] |
2021―Jun―29 |
The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19 |
Shengguang Wang, Zhen Li, Xinyu Wang, Shiming Zhang, Peng Gao, Zuorong Shi |
| 384 |
[GO] |
2021―Jun―29 |
Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection |
Seyed Abdulmajid Ayatollahi, Javad Sharifi-Rad, Patrick Valere Tsouh Fokou, Gail B. Mahady, Hafiz Ansar Rasul Suleria, Shivani Krishna Kapuganti, Kundlik Gadhave, Rajanish Giri, Neha Garg, Rohit Sharma, Daniel Ribeiro, Célia F. Rodrigues, Željko Reiner, Yasaman Taheri, Natália Cruz-Martins |
| 385 |
[GO] |
2021―Jun―24 |
Serratiopeptidase, A Serine Protease Anti-Inflammatory, Fibrinolytic, and Mucolytic Drug, Can Be a Useful Adjuvant for Management in COVID-19 |
Charu Sharma, Niraj Kumar Jha, M. F. Nagoor Meeran, Chandragouda R. Patil, Sameer N. Goyal, Shreesh Ojha |
| 386 |
[GO] |
2021―Jun―23 |
Prevention and Recovery of COVID-19 Patients With Kampo Medicine: Review of Case Reports and Ongoing Clinical Trials |
Shin Takayama, Takao Namiki, Hiroshi Odaguchi, Ryutaro Arita, Akito Hisanaga, Kazuo Mitani, Takashi Ito |
| 387 |
[GO] |
2021―Jun―21 |
Overview of Viral Pneumonia Associated With Influenza Virus, Respiratory Syncytial Virus, and Coronavirus, and Therapeutics Based on Natural Products of Medicinal Plants |
Ziwei Hu, Jinhong Lin, Jintao Chen, Tengxi Cai, Lixin Xia, Ying Liu, Xun Song, Zhendan He |
| 388 |
[GO] |
2021―Jun―18 |
He-Jie-Shen-Shi Decoction as an Adjuvant Therapy on Severe Coronavirus Disease 2019: A Retrospective Cohort and Potential Mechanistic Study |
Haibo Hu, Kun Wang, Li Wang, Yanjun Du, Juan Chen, Yongchun Li, Chuanbo Fan, Ning Li, Ying Sun, Shenghao Tu, Xuechao Lu, Zhaoshan Zhou, Huantian Cui |
| 389 |
[GO] |
2021―Jun―17 |
The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19 |
M. Ekholm, T. Kahan |
| 390 |
[GO] |
2021―Jun―17 |
Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting Mpro and Ameliorates Pulmonary Inflammation |
Ting Xiao, Mengqi Cui, Caijuan Zheng, Ming Wang, Ronghao Sun, Dandi Gao, Jiali Bao, Shanfa Ren, Bo Yang, Jianping Lin, Xiaoping Li, Dongmei Li, Cheng Yang, Honggang Zhou |
| 391 |
[GO] |
2021―Jun―16 |
Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences |
Elena Campione, Caterina Lanna, Terenzio Cosio, Luigi Rosa, Maria Pia Conte, Federico Iacovelli, Alice Romeo, Mattia Falconi, Claudia Del Vecchio, Elisa Franchin, Maria Stella Lia, Marilena Minieri, Carlo Chiaramonte, Marco Ciotti, Marzia Nuccetelli, Alessandro Terrinoni, Ilaria Iannuzzi, Luca Coppeda, Andrea Magrini, Sergio Bernardini, Stefano Sabatini, Felice Rosapepe, Pier Luigi Bartoletti, Nicola Moricca, Andrea Di Lorenzo, Massimo Andreoni, Loredana Sarmati, Alessandro Miani, Prisco Piscitelli, Piera Valenti, Luca Bianchi |
| 392 |
[GO] |
2021―Jun―14 |
A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2 |
Kaleb B. Tsegay, Christiana M. Adeyemi, Edward P. Gniffke, D. Noah Sather, John K. Walker, Stephen E. P. Smith |
| 393 |
[GO] |
2021―Jun―14 |
Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021 |
Safaet Alam, Taslima Binte Kamal, Md. Moklesur Rahman Sarker, Jin-Rong Zhou, S. M. Abdur Rahman, Isa Naina Mohamed |
| 394 |
[GO] |
2021―Jun―11 |
A Dual-Route Perspective of SARS-CoV-2 Infection: Lung- vs. Gut-specific Effects of ACE-2 Deficiency |
Elizabeth M. Sajdel-Sulkowska |
| 395 |
[GO] |
2021―Jun―10 |
Glycyrrhizic Acid for COVID-19: Findings of Targeting Pivotal Inflammatory Pathways Triggered by SARS-CoV-2 |
Wenjiang Zheng, Xiufang Huang, Yanni Lai, Xiaohong Liu, Yong Jiang, Shaofeng Zhan |
| 396 |
[GO] |
2021―Jun―07 |
Therapeutic Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19 |
Clarissa S. Santoso, Zhaorong Li, Jaice T. Rottenberg, Xing Liu, Vivian X. Shen, Juan I. Fuxman Bass |
| 397 |
[GO] |
2021―Jun―07 |
A Cross-Sectional Survey on Medication Management Practices for Noncommunicable Diseases in Europe During the Second Wave of the COVID-19 Pandemic |
Tamás Ágh, Job FM van Boven, Björn Wettermark, Enrica Menditto, Hilary Pinnock, Ioanna Tsiligianni, Guenka Petrova, Ines Potočnjak, Fatjona Kamberi, Przemyslaw Kardas |
| 398 |
[GO] |
2021―Jun―07 |
Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential |
Xinyu Cui, Wuyue Chen, Haoyan Zhou, Yuan Gong, Bowen Zhu, Xiang Lv, Hongbo Guo, Jinao Duan, Jing Zhou, Edyta Marcon, Hongyue Ma |
| 399 |
[GO] |
2021―Jun―04 |
The Role of Regional Anesthesia During the SARS-CoV2 Pandemic: Appraisal of Clinical, Pharmacological and Organizational Aspects |
Gianluca Cappelleri, Andrea Fanelli, Daniela Ghisi, Gianluca Russo, Antonio Giorgi, Vito Torrano, Giuliano Lo Bianco, Salvatore Salomone, Roberto Fumagalli |
| 400 |
[GO] |
2021―Jun―03 |
Adverse Effects Associated With the Use of Antimalarials During The COVID-19 Pandemic in a Tertiary Care Center in Mexico City |
Oscar Arturo Lozano-Cruz, José Víctor Jiménez, Antonio Olivas-Martinez, Edgar Ortiz-Brizuela, José Luis Cárdenas-Fragoso, Daniel Azamar-Llamas, Sergio Rodríguez-Rodríguez, Jorge Carlos Oseguera-Moguel, Joel Dorantes-García, Clemente Barrón-Magdaleno, Aldo C Cázares-Diazleal, Carla Marina Román-Montes, Karla María Tamez-Torres, Bernardo Alfonso Martínez-Guerra, Alfonso Gulias-Herrero, María Fernanda González-Lara, Alfredo Ponce-de-León-Garduño, David Kershenobich-Stalnikowitz, José Sifuentes-Osornio |
| 401 |
[GO] |
2021―May―28 |
Oral Curcumin With Piperine as Adjuvant Therapy for the Treatment of COVID-19: A Randomized Clinical Trial |
Kirti S Pawar, Rahul N Mastud, Satheesh K Pawar, Samragni S Pawar, Rahul R Bhoite, Ramesh R Bhoite, Meenal V Kulkarni, Aditi R Deshpande |
| 402 |
[GO] |
2021―May―28 |
Traditional Herbal Medicines, Bioactive Metabolites, and Plant Products Against COVID-19: Update on Clinical Trials and Mechanism of Actions |
Safaet Alam, Md. Moklesur Rahman Sarker, Sadia Afrin, Fahmida Tasnim Richi, Chao Zhao, Jin-Rong Zhou, Isa Naina Mohamed |
| 403 |
[GO] |
2021―May―26 |
The Therapeutic Effect of Traditional Chinese Medicine on Inflammatory Diseases Caused by Virus, Especially on Those Caused by COVID-19 |
Peng Li, Shuang Hu, Cheng Qian, Yan Yao, Liang-yun Li, Jun-fa Yang, Li Yang, Chen-chen Yang, Hong Zhou, Shu-xian Wang, Ying Hu, Xing-yu Zhu, Jing Zhou, Lin-xin Pan, Chuan-pu Shen, Huan Zhou |
| 404 |
[GO] |
2021―May―26 |
Systemic Corticosteroid Administration in Coronavirus Disease 2019 Outcomes: An Umbrella Meta-Analysis Incorporating Both Mild and Pulmonary Fibrosis-Manifested Severe Disease |
Bin Cheng, Jinxiu Ma, Yani Yang, Tingting Shao, Binghao Zhao, Linxiang Zeng |
| 405 |
[GO] |
2021―May―25 |
COVID-19-Associated Pneumonia: Radiobiological Insights |
Sabine François, Carole Helissey, Sophie Cavallero, Michel Drouet, Nicolas Libert, Jean-Marc Cosset, Eric Deutsch, Lydia Meziani, Cyrus Chargari |
| 406 |
[GO] |
2021―May―20 |
A Large Impact of Obesity on the Disposition of Ivermectin, Moxidectin and Eprinomectin in a Canine Model: Relevance for COVID-19 Patients |
Alain Bousquet-Mélou, Anne Lespine, Jean-François Sutra, Isabelle Bargues, Pierre-Louis Toutain |
| 407 |
[GO] |
2021―May―14 |
β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19 |
Niraj Kumar Jha, Charu Sharma, Hebaallah Mamdouh Hashiesh, Seenipandi Arunachalam, MF Nagoor Meeran, Hayate Javed, Chandragouda R. Patil, Sameer N. Goyal, Shreesh Ojha |
| 408 |
[GO] |
2021―May―14 |
Broad Anti-Viral Capacities of Lian-Hua-Qing-Wen Capsule and Jin-Hua-Qing-Gan Granule and Rational use Against COVID-19 Based on Literature Mining |
Mingfei Shi, Bo Peng, An Li, Ziyun Li, Ping Song, Jing Li, Ruodan Xu, Ning Li |
| 409 |
[GO] |
2021―May―13 |
Synergy Between Vitamin D and Sex Hormones in Respiratory Functionality of Patients Affected by COVID-19 |
Daniela Peruzzu, Maria Teresa Pagano, Marina Pierdominici, Anna Ruggieri, Andrea Antinori, Gianpiero D’Offizi, Nicola Petrosillo, Fabrizio Palmieri, Pierluca Piselli, Evangelo Boumis, Stefania Notari, Emanuele Nicastri, Chiara Agrati, Giuseppe Ippolito, Maria Cristina Gagliardi, Maria Rosaria Capobianchi, Elena Ortona |
| 410 |
[GO] |
2021―May―12 |
Multi-Omics Approach in the Identification of Potential Therapeutic Biomolecule for COVID-19 |
Rachana Singh, Pradhyumna Kumar Singh, Rajnish Kumar, Md. Tanvir Kabir, Mohammad Amjad Kamal, Abdur Rauf, Ghadeer M. Albadrani, Amany A. Sayed, Shaker A. Mousa, Mohamed M. Abdel-Daim, Md. Sahab Uddin |
| 411 |
[GO] |
2021―May―07 |
Curcumin as a Potential Treatment for COVID-19 |
Bruna A. C. Rattis, Simone G. Ramos, Mara R. N. Celes |
| 412 |
[GO] |
2021―May―07 |
The Anti-Viral and Anti-Inflammatory Properties of Edible Bird’s Nest in Influenza and Coronavirus Infections: From Pre-Clinical to Potential Clinical Application |
Kien Hui Chua, Isa Naina Mohamed, Mohd Heikal Mohd Yunus, Norefrina Shafinaz Md Nor, Khidhir Kamil, Azizah Ugusman, Jaya Kumar |
| 413 |
[GO] |
2021―May―06 |
The Rise and Fall of Chloroquine/Hydroxychloroquine as Compassionate Therapy of COVID-19 |
Elangovan Manivannan, Chandrabose Karthikeyan, N. S. Hari Narayana Moorthy, Subash Chandra Chaturvedi |
| 414 |
[GO] |
2021―May―03 |
Withania somnifera (L.) Dunal: Opportunity for Clinical Repurposing in COVID-19 Management |
Akash Saggam, Kirti Limgaokar, Swapnil Borse, Preeti Chavan-Gautam, Santosh Dixit, Girish Tillu, Bhushan Patwardhan |
| 415 |
[GO] |
2021―May―03 |
A Survey Among Italian Physicians During COVID-19 Outbreak. Could Bacillus Calmette-Guérin Vaccine Be Effective Against SARS-CoV2? |
Vincenzo Patella, Alessandro Sanduzzi, Dario Bruzzese, Giovanni Florio, Raffaele Brancaccio, Gabriella Fabbrocini, Gabriele Delfino |
| 416 |
[GO] |
2021―May―03 |
Natural Products Modulating Angiotensin Converting Enzyme 2 (ACE2) as Potential COVID-19 Therapies |
Murtala Bello Abubakar, Dawoud Usman, Gaber El-Saber Batiha, Natália Cruz-Martins, Ibrahim Malami, Kasimu Ghandi Ibrahim, Bilyaminu Abubakar, Muhammad Bashir Bello, Aliyu Muhammad, Siew Hua Gan, Aliyu Ibrahim Dabai, M Alblihed, Arabinda Ghosh, Reem H. Badr, Devarajan Thangadurai, Mustapha Umar Imam |
| 417 |
[GO] |
2021―May―03 |
Comparative Effectiveness of Pharmacological Interventions for Covid-19: A Systematic Review and Network Meta-Analysis |
Franco De Crescenzo, Laura Amato, Fabio Cruciani, Luke P Moynihan, Gian Loreto D’Alò, Simona Vecchi, Rosella Saulle, Zuzana Mitrova, Valeria Di Franco, Antonio Addis, Marina Davoli |
| 418 |
[GO] |
2021―Apr―30 |
Intermittent Hypoxic Preconditioning: A Potential New Powerful Strategy for COVID-19 Rehabilitation |
Ming Cai, Xuan Chen, Jieling Shan, Ruoyu Yang, Qi Guo, Xia Bi, Ping Xu, Xiangrong Shi, Lixi Chu, Liyan Wang |
| 419 |
[GO] |
2021―Apr―28 |
Edible and Herbal Plants for the Prevention and Management of COVID-19 |
Sha Li, Chien-Shan Cheng, Cheng Zhang, Guo-Yi Tang, Hor-Yue Tan, Hai-Yong Chen, Ning Wang, Agnes Yuen-Kwan Lai, Yibin Feng |
| 420 |
[GO] |
2021―Apr―26 |
Therapeutic Potentials of Antiviral Plants Used in Traditional African Medicine With COVID-19 in Focus: A Nigerian Perspective |
Alfred Francis Attah, Adeshola Adebayo Fagbemi, Olujide Olubiyi, Hannah Dada-Adegbola, Akinseinde Oluwadotun, Anthony Elujoba, Chinedum Peace Babalola |
| 421 |
[GO] |
2021―Apr―26 |
Phytochemicals as Potential Therapeutics for SARS-CoV-2-Induced Cardiovascular Complications: Thrombosis and Platelet Perspective |
Samir K. Beura, Abhishek R. Panigrahi, Pooja Yadav, Sunil K. Singh |
| 422 |
[GO] |
2021―Apr―23 |
Pleiotropic Effects of Tetracyclines in the Management of COVID-19: Emerging Perspectives |
Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Mohammed Alqarni, Natália Cruz-Martins, Gaber El-Saber Batiha |
| 423 |
[GO] |
2021―Apr―22 |
SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models |
G. Kanimozhi, B. Pradhapsingh, Charan Singh Pawar, Haseeb A. Khan, Salman H. Alrokayan, N. Rajendra Prasad |
| 424 |
[GO] |
2021―Apr―22 |
High Dose Intravenous Vitamin C for Preventing The Disease Aggravation of Moderate COVID-19 Pneumonia. A Retrospective Propensity Matched Before-After Study |
Bing Zhao, Min Liu, Ping Liu, Yibing Peng, Jun Huang, Mengjiao Li, Yihui Wang, LiLi Xu, Silei Sun, Xing Qi, Yun Ling, Jian Li, Wenhong Zhang, Enqiang Mao, Jieming Qu |
| 425 |
[GO] |
2021―Apr―22 |
No Efficacy of the Combination of Lopinavir/Ritonavir Plus Hydroxychloroquine Versus Standard of Care in Patients Hospitalized With COVID-19: A Non-Randomized Comparison |
Roberta Gagliardini, Alessandro Cozzi-Lepri, Andrea Mariano, Fabrizio Taglietti, Alessandra Vergori, Amina Abdeddaim, Francesco Di Gennaro, Valentina Mazzotta, Alessandra Amendola, Giampiero D’Offizi, Fabrizio Palmieri, Luisa Marchioni, Pierluca Piselli, Chiara Agrati, Emanuele Nicastri, Maria Rosaria Capobianchi, Nicola Petrosillo, Giuseppe Ippolito, Francesco Vaia, Enrico Girardi, Andrea Antinori |
| 426 |
[GO] |
2021―Apr―20 |
The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19 |
Annamaria Mascolo, Cristina Scavone, Concetta Rafaniello, Antonella De Angelis, Konrad Urbanek, Gabriella di Mauro, Donato Cappetta, Liberato Berrino, Francesco Rossi, Annalisa Capuano |
| 427 |
[GO] |
2021―Apr―20 |
Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19 |
Vikas P. Sukhatme, Angela M. Reiersen, Sharat J. Vayttaden, Vidula V. Sukhatme |
| 428 |
[GO] |
2021―Apr―20 |
SARS-CoV-2 Switches ‘on’ MAPK and NFκB Signaling via the Reduction of Nuclear DUSP1 and DUSP5 Expression |
Swati Goel, Fatemeh Saheb Sharif-Askari, Narjes Saheb Sharif Askari, Bushra Madkhana, Ahmad Munzer Alwaa, Bassam Mahboub, Adel M Zakeri, Elaref Ratemi, Qutayba Hamid, Rabih Halwani, Rifat Hamoudi |
| 429 |
[GO] |
2021―Apr―19 |
Giloy Ghanvati (Tinospora cordifolia (Willd.) Hook. f. and Thomson) Reversed SARS-CoV-2 Viral Spike-Protein Induced Disease Phenotype in the Xenotransplant Model of Humanized Zebrafish |
Acharya Balkrishna, Lakshmipathi Khandrika, Anurag Varshney |
| 430 |
[GO] |
2021―Apr―16 |
Na+/K+-ATPase as a Target of Cardiac Glycosides for the Treatment of SARS-CoV-2 Infection |
Kauê Francisco Corrêa Souza e Souza, Bianca Portugal Tavares Moraes, Izabel Christina Nunes de Palmer Paixão, Patrícia Burth, Adriana Ribeiro Silva, Cassiano Felippe Gonçalves-de-Albuquerque |
| 431 |
[GO] |
2021―Apr―12 |
Evolving Treatment Paradigm in the Management of Diabetic Macular Edema in the Era of COVID-19 |
Claudio Iovino, Enrico Peiretti, Giuseppe Giannaccare, Vincenzo Scorcia, Adriano Carnevali |
| 432 |
[GO] |
2021―Apr―12 |
Commentary: Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated With Coronavirus Disease-2019 |
Maurizio Bifulco, Donatella Fiore, Chiara Piscopo, Patrizia Gazzerro, Maria Chiara Proto |
| 433 |
[GO] |
2021―Apr―12 |
Repurposing Chloroquine Against Multiple Diseases With Special Attention to SARS-CoV-2 and Associated Toxicity |
Siya Kamat, Madhuree Kumari |
| 434 |
[GO] |
2021―Apr―12 |
Potential Mechanism Prediction of Herbal Medicine for Pulmonary Fibrosis Associated with SARS-CoV-2 Infection Based on Network Analysis and Molecular Docking |
De Jin, Xuedong An, Yuqing Zhang, Shenghui Zhao, Liyun Duan, Yingying Duan, Fengmei Lian, Xiaolin Tong |
| 435 |
[GO] |
2021―Apr―12 |
Phytoconstituents, In Vitro Anti-Infective Activity of Buddleja indica Lam., and In Silico Evaluation of its SARS-CoV-2 Inhibitory Potential |
Fadia S. Youssef, Ahmed E. Altyar, Abdelsattar M. Omar, Mohamed L. Ashour |
| 436 |
[GO] |
2021―Apr―01 |
Pathological Findings in COVID-19 as a Tool to Define SARS-CoV-2 Pathogenesis. A Systematic Review |
Cristina Mondello, Salvatore Roccuzzo, Orazio Malfa, Daniela Sapienza, Patrizia Gualniera, Elvira Ventura Spagnolo, Nunzio Di Nunno, Monica Salerno, Cristoforo Pomara, Alessio Asmundo |
| 437 |
[GO] |
2021―Mar―29 |
Angiotensin Receptor Blockers for COVID-19: Pathophysiological and Pharmacological Considerations About Ongoing and Future Prospective Clinical Trials |
Rodolfo Pedro Rothlin, Mariano Duarte, Facundo Germán Pelorosso, Liliana Nicolosi, M. Victoria Salgado, Héctor Miguel Vetulli, Eduardo Spitzer |
| 438 |
[GO] |
2021―Mar―26 |
Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen |
Jordi Rodon, Jordana Muñoz-Basagoiti, Daniel Perez-Zsolt, Marc Noguera-Julian, Roger Paredes, Lourdes Mateu, Carles Quiñones, Carles Perez, Itziar Erkizia, Ignacio Blanco, Alfonso Valencia, Víctor Guallar, Jorge Carrillo, Julià Blanco, Joaquim Segalés, Bonaventura Clotet, Júlia Vergara-Alert, Nuria Izquierdo-Useros |
| 439 |
[GO] |
2021―Mar―25 |
Head-to-Head Comparison of Sedation and Somnolence Among 37 Antipsychotics in Schizophrenia, Bipolar Disorder, Major Depression, Autism Spectrum Disorders, Delirium, and Repurposed in COVID-19, Infectious Diseases, and Oncology From the FAERS, 2004-2020 |
Andy R. Eugene, Beata Eugene, Marek Masiak, Jolanta Sylwia Masiak |
| 440 |
[GO] |
2021―Mar―24 |
Medicinal Plants in COVID-19: Potential and Limitations |
Xin Yi Lim, Bee Ping Teh, Terence Yew Chin Tan |
| 441 |
[GO] |
2021―Mar―23 |
COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms |
Robert W. Malone, Philip Tisdall, Philip Fremont-Smith, Yongfeng Liu, Xi-Ping Huang, Kris M. White, Lisa Miorin, Elena Moreno, Assaf Alon, Elise Delaforge, Christopher D. Hennecker, Guanyu Wang, Joshua Pottel, Robert V. Blair, Chad J. Roy, Nora Smith, Julie M. Hall, Kevin M Tomera, Gideon Shapiro, Anthony Mittermaier, Andrew C. Kruse, Adolfo García-Sastre, Bryan L. Roth, Jill Glasspool-Malone, Darrell O. Ricke |
| 442 |
[GO] |
2021―Mar―23 |
Proactive Measures to Combat a SARS-CoV-2 Transmission Among High Risk Patients and Health Care Workers in an Outpatient Dialysis Facility |
Jayandiran Pillai, Pagollang Motloba, Keolebogile Shirley Caroline Motaung, Carole Wallis, Lovelyn Uzoma Ozougwu, Debashis Basu |
| 443 |
[GO] |
2021―Mar―22 |
Comparing the Value of Cystatin C and Serum Creatinine for Evaluating the Renal Function and Predicting the Prognosis of COVID-19 Patients |
Sichao Chen, Jinpeng Li, Zeming Liu, Danyang Chen, Ling Zhou, Di Hu, Man Li, Wei Long, Yihui Huang, Jianglong Huang, Shipei Wang, Qianqian Li, Wen Zeng, Liang Guo, Xiaohui Wu |
| 444 |
[GO] |
2021―Mar―19 |
Repurposing Anti-Malaria Phytomedicine Artemisinin as a COVID-19 Drug |
Fatih M. Uckun, Saran Saund, Hitesh Windlass, Vuong Trieu |
| 445 |
[GO] |
2021―Mar―15 |
Evaluation of the Current Therapeutic Approaches for COVID-19: A Systematic Review and a Meta-analysis |
Zeinab Abdelrahman, Qian Liu, Shanmei Jiang, Mengyuan Li, Qingrong Sun, Yue Zhang, Xiaosheng Wang |
| 446 |
[GO] |
2021―Mar―10 |
Modeling of SARS-CoV-2 Treatment Effects for Informed Drug Repurposing |
Charlotte Kern, Verena Schöning, Carlos Chaccour, Felix Hammann |
| 447 |
[GO] |
2021―Mar―09 |
Anti-IL5 Drugs in COVID-19 Patients: Role of Eosinophils in SARS-CoV-2-Induced Immunopathology |
Daniele Pala, Marco Pistis |
| 448 |
[GO] |
2021―Mar―09 |
Plant Products as Inhibitors of Coronavirus 3CL Protease |
Anirban Mandal, Ajeet Kumar Jha, Banasri Hazra |
| 449 |
[GO] |
2021―Mar―09 |
The Anti-inflammatory Effect of the Tricyclic Antidepressant Clomipramine and Its High Penetration in the Brain Might Be Useful to Prevent the Psychiatric Consequences of SARS-CoV-2 Infection |
B. Nobile, M. Durand, E. Olié, S. Guillaume, J. P. Molès, E. Haffen, P. Courtet |
| 450 |
[GO] |
2021―Mar―08 |
An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come? |
Omkar Indari, Shweta Jakhmola, Elangovan Manivannan, Hem Chandra Jha |
| 451 |
[GO] |
2021―Mar―04 |
1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection |
Rui Hong Chen, Li Jun Yang, Sami Hamdoun, Sookja Kim Chung, Christopher Wai-kei Lam, Kai Xi Zhang, Xiaoling Guo, Chenglai Xia, Betty Yuen Kwan Law, Vincent Kam Wai Wong |
| 452 |
[GO] |
2021―Mar―02 |
Repurposing Treatment of Wernicke-Korsakoff Syndrome for Th-17 Cell Immune Storm Syndrome and Neurological Symptoms in COVID-19: Thiamine Efficacy and Safety, In-Vitro Evidence and Pharmacokinetic Profile |
Vatsalya Vatsalya, Fengyuan Li, Jane Frimodig, Khushboo S. Gala, Shweta Srivastava, Maiying Kong, Vijay A. Ramchandani, Wenke Feng, Xiang Zhang, Craig J. McClain |
| 453 |
[GO] |
2021―Mar―02 |
Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis |
Benedicto Crespo-Facorro, Miguel Ruiz-Veguilla, Javier Vázquez-Bourgon, Ana C. Sánchez-Hidalgo, Nathalia Garrido-Torres, Jose M. Cisneros, Carlos Prieto, Jesus Sainz |
| 454 |
[GO] |
2021―Mar―02 |
Indian Medicinal Plants and Formulations and Their Potential Against COVID-19-Preclinical and Clinical Research |
Sayeed Ahmad, Sultan Zahiruddin, Bushra Parveen, Parakh Basist, Abida Parveen, Rabea Parveen, Minhaj Ahmad |
| 455 |
[GO] |
2021―Mar―01 |
A Journey From SARS-CoV-2 to COVID-19 and Beyond: A Comprehensive Insight of Epidemiology, Diagnosis, Pathogenesis, and Overview of the Progress into Its Therapeutic Management |
Muhammad Harris Shoaib, Farrukh Rafiq Ahmed, Muhammad Sikandar, Rabia Ismail Yousuf, Muhammad Talha Saleem |
| 456 |
[GO] |
2021―Feb―26 |
In silico Analyses of Immune System Protein Interactome Network, Single-Cell RNA Sequencing of Human Tissues, and Artificial Neural Networks Reveal Potential Therapeutic Targets for Drug Repurposing Against COVID-19 |
Andrés López-Cortés, Patricia Guevara-Ramírez, Nikolaos C. Kyriakidis, Carlos Barba-Ostria, Ángela León Cáceres, Santiago Guerrero, Esteban Ortiz-Prado, Cristian R. Munteanu, Eduardo Tejera, Doménica Cevallos-Robalino, Ana María Gómez-Jaramillo, Katherine Simbaña-Rivera, Adriana Granizo-Martínez, Gabriela Pérez-M, Silvana Moreno, Jennyfer M. García-Cárdenas, Ana Karina Zambrano, Yunierkis Pérez-Castillo, Alejandro Cabrera-Andrade, Lourdes Puig San Andrés, Carolina Proaño-Castro, Jhommara Bautista, Andreina Quevedo, Nelson Varela, Luis Abel Quiñones, César Paz-y-Miño |
| 457 |
[GO] |
2021―Feb―26 |
A Scoping Insight on Potential Prophylactics, Vaccines and Therapeutic Weaponry for the Ongoing Novel Coronavirus (COVID-19) Pandemic- A Comprehensive Review |
Priyanka Dash, Subhashree Mohapatra, Sayantan Ghosh, Bismita Nayak |
| 458 |
[GO] |
2021―Feb―26 |
Chinese Herbal Medicine Used With or Without Conventional Western Therapy for COVID-19: An Evidence Review of Clinical Studies |
Shi-Bing Liang, Ying-Ying Zhang, Chen Shen, Chang-Hao Liang, Bao-Yong Lai, Ning Dai, Yu-Qi Li, Zi-Yu Tian, Xiao-Wen Zhang, Yue Jiang, Min Xiong, Ya-Peng Zhang, Ying Zhang, Nicola Robinson, Jian-Ping Liu |
| 459 |
[GO] |
2021―Feb―26 |
Discovering Potential RNA Dependent RNA Polymerase Inhibitors as Prospective Drugs Against COVID-19: An in silico Approach |
Satabdi Saha, Rajat Nandi, Poonam Vishwakarma, Amresh Prakash, Diwakar Kumar |
| 460 |
[GO] |
2021―Feb―25 |
Prospective: Evolution of Chinese Medicine to Treat COVID-19 Patients in China |
Jieya Wu, Baoguo Sun, Li Hou, Fulan Guan, Liyuan Wang, Peikwen Cheng, Sophia Scobell, Yung-Chi Cheng, Wing Lam |
| 461 |
[GO] |
2021―Feb―23 |
The Potential Therapeutic Effect of RNA Interference and Natural Products on COVID-19: A Review of the Coronaviruses Infection |
Mohammad Reza Kalhori, Fatemeh Saadatpour, Ehsan Arefian, Masoud Soleimani, Mohammad Hosien Farzaei, Ina Yosifova Aneva, Javier Echeverría |
| 462 |
[GO] |
2021―Feb―22 |
Drug Repurposing and Polypharmacology to Fight SARS-CoV-2 Through Inhibition of the Main Protease |
Luca Pinzi, Annachiara Tinivella, Fabiana Caporuscio, Giulio Rastelli |
| 463 |
[GO] |
2021―Feb―13 |
Development of a Physiologically Based Pharmacokinetic Model for Hydroxychloroquine and Its Application in Dose Optimization in Specific COVID-19 Patients |
Miao Zhang, Xueting Yao, Zhe Hou, Xuan Guo, Siqi Tu, Zihan Lei, Zhiheng Yu, Xuanlin Liu, Cheng Cui, Xijing Chen, Ning Shen, Chunli Song, Jie Qiao, Xiaoqiang Xiang, Haiyan Li, Dongyang Liu |
| 464 |
[GO] |
2021―Feb―13 |
Molecular Mechanism of Action of Repurposed Drugs and Traditional Chinese Medicine Used for the Treatment of Patients Infected With COVID-19: A Systematic Scoping Review |
Fui Fui Lem, Fernandes Opook, Dexter Jiunn Herng Lee, Fong Tyng Chee, Fahcina P. Lawson, Su Na Chin |
| 465 |
[GO] |
2021―Feb―09 |
COVIEdb: A Database for Potential Immune Epitopes of Coronaviruses |
Jingcheng Wu, Wenfan Chen, Jingjing Zhou, Wenyi Zhao, Yisheng Sun, Hanping Zhu, Pingping Yao, Shuqing Chen, Jianmin Jiang, Zhan Zhou |
| 466 |
[GO] |
2021―Feb―08 |
Modalities and Mechanisms of Treatment for Coronavirus Disease 2019 |
Zhihong Zuo, Ting Wu, Liangyu Pan, Chenzhe Zuo, Yingchuo Hu, Xuan Luo, Liping Jiang, Zanxian Xia, Xiaojuan Xiao, Jing Liu, Mao Ye, Meichun Deng |
| 467 |
[GO] |
2021―Feb―05 |
Yindan Jiedu Granules, a Traditional Chinese Medicinal Formulation, as a Potential Treatment for Coronavirus Disease 2019 |
Jingyuan Liu, Yuyong Jiang, Yao Liu, Lin Pu, Chunjing Du, Yuxin Li, Xiaojing Wang, Jie Ren, Wei Liu, Zhiyun Yang, Zhihai Chen, Rui Song, Wen Xie, Xianbo Wang |
| 468 |
[GO] |
2021―Feb―05 |
Several FDA-Approved Drugs Effectively Inhibit SARS-CoV-2 Infection in vitro |
Hua-Long Xiong, Jia-Li Cao, Chen-Guang Shen, Jian Ma, Xiao-Yang Qiao, Tian-Shu Shi, Sheng-Xiang Ge, Hui-Ming Ye, Jun Zhang, Quan Yuan, Tian-Ying Zhang, Ning-Shao Xia |
| 469 |
[GO] |
2021―Feb―04 |
Chemokine Regulation During Epidemic Coronavirus Infection |
Shamik Majumdar, Philip M. Murphy |
| 470 |
[GO] |
2021―Feb―01 |
Potency, Safety, and Pharmacokinetic Profiles of Potential Inhibitors Targeting SARS-CoV-2 Main Protease |
Hylemariam Mihiretie Mengist, Daniel Mekonnen, Ahmed Mohammed, Ronghua Shi, Tengchuan Jin |
| 471 |
[GO] |
2021―Jan―29 |
Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19 |
Nina V. Vorobjeva, Galina F. Sud'ina, Boris V. Chernyak |
| 472 |
[GO] |
2021―Jan―29 |
What Is the Difference Between Observed Association and Causal Association, Signals and Evidence? Examples Related to COVID-19 |
Vicki Osborne, Saad A. W. Shakir |
| 473 |
[GO] |
2021―Jan―29 |
HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons |
Andrey A. Poloznikov, Stepan A. Nersisyan, Dmitry M. Hushpulian, Eliot H. Kazakov, Alexander G. Tonevitsky, Sergey V. Kazakov, Valery I. Vechorko, Sergey V. Nikulin, Julia A. Makarova, Irina G. Gazaryan |
| 474 |
[GO] |
2021―Jan―29 |
Perspectives of Antidiabetic Drugs in Diabetes With Coronavirus Infections |
Bao Sun, Shiqiong Huang, Jiecan Zhou |
| 475 |
[GO] |
2021―Jan―27 |
Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19 |
Angela E. Peter, B. V. Sandeep, B. Ganga Rao, V. Lakshmi Kalpana |
| 476 |
[GO] |
2021―Jan―26 |
Potential of Immune-Related Therapy in COVID-19 |
Chunjue Yuan, Ruoyun Li, Guohong Liu, Yunbao Pan |
| 477 |
[GO] |
2021―Jan―26 |
Commentary: Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness? |
Sergio Verd, Mateo Verd |
| 478 |
[GO] |
2021―Jan―25 |
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2 |
Catherine Z. Chen, Paul Shinn, Zina Itkin, Richard T. Eastman, Robert Bostwick, Lynn Rasmussen, Ruili Huang, Min Shen, Xin Hu, Kelli M. Wilson, Brianna M. Brooks, Hui Guo, Tongan Zhao, Carleen Klump-Thomas, Anton Simeonov, Samuel G. Michael, Donald C. Lo, Matthew D. Hall, Wei Zheng |
| 479 |
[GO] |
2021―Jan―20 |
Targeting Neurological Manifestations of Coronaviruses by Candidate Phytochemicals: A Mechanistic Approach |
Sajad Fakhri, Sana Piri, Mohammad Bagher Majnooni, Mohammad Hosein Farzaei, Javier Echeverría |
| 480 |
[GO] |
2021―Jan―19 |
Statins as Adjuvant Therapy for COVID-19 to Calm the Stormy Immunothrombosis and Beyond |
Alpo Vuorio, Petri T. Kovanen |
| 481 |
[GO] |
2021―Jan―15 |
Rapid Assessment of the Potential Paucity and Price Increases for Suggested Medicines and Protection Equipment for COVID-19 Across Developing Countries With a Particular Focus on Africa and the Implications |
Israel Abebrese Sefah, Olayinka O. Ogunleye, Darius Obeng Essah, Sylvia A. Opanga, Nadia Butt, Annie Wamaitha, Anastasia Nkatha Guantai, Ibrahim Chikowe, Felix Khuluza, Dan Kibuule, Lahya Nambahu, Abdullahi Rabiu Abubakar, Ibrahim Haruna Sani, Zikria Saleem, Aubrey C. Kalungia, Thuy Nguyen Thi Phuong, Mainul Haque, Salequl Islam, Santosh Kumar, Jacqueline Sneddon, Joshua Wamboga, Janney Wale, Nenad Miljković, Amanj Kurdi, Antony P. Martin, Brian Godman |
| 482 |
[GO] |
2021―Jan―15 |
Utilisation, Availability and Price Changes of Medicines and Protection Equipment for COVID-19 Among Selected Regions in India: Findings and Implications |
Mainul Haque, Santosh Kumar, Jaykaran Charan, Rohan Bhatt, Salequl Islam, Siddhartha Dutta, Jha Pallavi Abhayanand, Yesh Sharma, Israel Sefah, Amanj Kurdi, Janney Wale, Brian Godman |
| 483 |
[GO] |
2021―Jan―15 |
TLR9 and COVID-19: A Multidisciplinary Theory of a Multifaceted Therapeutic Target |
Gillina F. G. Bezemer, Johan Garssen |
| 484 |
[GO] |
2021―Jan―14 |
Methylene Blue Inhibits the SARS-CoV-2 Spike-ACE2 Protein-Protein Interaction-a Mechanism that can Contribute to its Antiviral Activity Against COVID-19 |
Damir Bojadzic, Oscar Alcazar, Peter Buchwald |
| 485 |
[GO] |
2021―Jan―14 |
3-Hydroxyphthalic Anhydride-Modified Chicken Ovalbumin as a Potential Candidate Inhibits SARS-CoV-2 Infection by Disrupting the Interaction of Spike Protein With Host ACE2 Receptor |
Taizhen Liang, Jiayin Qiu, Xiaoge Niu, Qinhai Ma, Chenliang Zhou, Pei Chen, Qiao Zhang, Meiyun Chen, Zifeng Yang, Shuwen Liu, Lin Li |
| 486 |
[GO] |
2021―Jan―14 |
Tissue Distribution of ACE2 Protein in Syrian Golden Hamster (Mesocricetus auratus) and Its Possible Implications in SARS-CoV-2 Related Studies |
Voddu Suresh, Deepti Parida, Aliva P. Minz, Manisha Sethi, Bhabani S. Sahoo, Shantibhusan Senapati |
| 487 |
[GO] |
2021―Jan―11 |
A Review on Plant Bioactive Compounds and Their Modes of Action Against Coronavirus Infection |
Juwairiah Remali, Wan Mohd Aizat |
| 488 |
[GO] |
2021―Jan―10 |
The Large Action of Chlorpromazine: Translational and Transdisciplinary Considerations in the Face of COVID-19 |
Emmanuel Stip, Tahir A. Rizvi, Farah Mustafa, Syed Javaid, Salahdein Aburuz, Nahida Nayaz Ahmed, Karim Abdel Aziz, Danilo Arnone, Aravinthan Subbarayan, Fadwa Al Mugaddam, Gulfaraz Khan |
| 489 |
[GO] |
2021―Jan―10 |
Repurposing Approved Drugs for Guiding COVID-19 Prophylaxis: A Systematic Review |
Bruno Silva Andrade, Fernanda de Souza Rangel, Naiane Oliveira Santos, Andria dos Santos Freitas, Wagner Rodrigues de Assis Soares, Sérgio Siqueira, Debmalya Barh, Aristóteles Góes-Neto, Alexander Birbrair, Vasco Ariston de Carvalho Azevedo |
| 490 |
[GO] |
2021―Jan―10 |
Current Evidence of Interleukin-6 Signaling Inhibitors in Patients With COVID-19: A Systematic Review and Meta-Analysis |
Qi Han, Mingyue Guo, Yue Zheng, Ying Zhang, Yanshan De, Changchang Xu, Lin Zhang, Ruru Sun, Ying Lv, Yan Liang, Feng Xu, Jiaojiao Pang, Yuguo Chen |
| 491 |
[GO] |
2021―Jan―10 |
Commentary: Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report |
Christopher E. Rudd |
| 492 |
[GO] |
2021―Jan―07 |
Hydroxychloroquine as a Chemoprophylactic Agent for COVID-19: A Clinico-Pharmacological Review |
Mudit Agarwal, Piyush Ranjan, Upendra Baitha, Ankit Mittal |
| 493 |
[GO] |
2020―Dec―28 |
Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic |
Giulio Cavalli, Nicola Farina, Corrado Campochiaro, Giacomo De Luca, Emanuel Della-Torre, Alessandro Tomelleri, Lorenzo Dagna |
| 494 |
[GO] |
2020―Dec―23 |
Case Report: Central Retinal Artery Occlusion in a COVID-19 Patient |
Andrea Montesel, Claudio Bucolo, Victoria Mouvet, Emmanuelle Moret, Chiara M. Eandi |
| 495 |
[GO] |
2020―Dec―21 |
D-Dimer as a Prognostic Indicator in Critically Ill Patients Hospitalized With COVID-19 in Leishenshan Hospital, Wuhan, China |
Jinpeng Li, Zeming Liu, Gaosong Wu, Meilin Yi, Yongfeng Chen, Kun Li, Xiaoming Xu, Linqi Xiao, Qian Wu, Jincao Chen, Xiaohui Wu |
| 496 |
[GO] |
2020―Dec―21 |
COVID-19 Incidence in Patients With Immunomediated Inflammatory Diseases: Influence of Immunosuppressant Treatments |
Natalia Soldevila-Domenech, Laura Tío, Jone Llorente-Onaindia, Elena Martín-García, Pau Nebot, Rafael de la Torre, Alba Gurt, Rafael Maldonado, Jordi Monfort |
| 497 |
[GO] |
2020―Dec―18 |
COVID-19 Disease and Vitamin D: A Mini-Review |
Mohamed Said Boulkrane, Victoria Ilina, Roman Melchakov, Julia Fedotova, Filippo Drago, Lucia Gozzo, Undurti Narasimha Das, A. M. Abd El-Aty, Denis Baranenko |
| 498 |
[GO] |
2020―Dec―14 |
Inhibition of SARS-CoV-2 by Highly Potent Broad-Spectrum Anti-Coronaviral Tylophorine-Based Derivatives |
Cheng-Wei Yang, Yue-Zhi Lee, Hsing-Yu Hsu, Jia-Tsrong Jan, Yi-Ling Lin, Sui-Yuan Chang, Tzu-Ting Peng, Ruey-Bing Yang, Jian-Jong Liang, Chun-Che Liao, Tai-Ling Chao, Yu-Hau Pang, Han-Chieh Kao, Wen-Zheng Huang, Jiunn-Horng Lin, Chun-Ping Chang, Guang-Hao Niu, Szu-Huei Wu, Huey-Kang Sytwu, Chiung-Tong Chen, Shiow-Ju Lee |
| 499 |
[GO] |
2020―Dec―14 |
A New Crystal Form of the SARS-CoV-2 Receptor Binding Domain: CR3022 Complex-An Ideal Target for In-Crystal Fragment Screening of the ACE2 Binding Site Surface |
Charlie Nichols, Joseph Ng, Annika Keshu, Franca Fraternali, Gian F. De Nicola |
| 500 |
[GO] |
2020―Dec―11 |
Alpha-1 Antitrypsin for COVID-19 Treatment: Dual Role in Antiviral Infection and Anti-Inflammation |
Chengliang Yang, Shaf Keshavjee, Mingyao Liu |
| 501 |
[GO] |
2020―Dec―11 |
Nutraceutical Targeting of Inflammation-Modulating microRNAs in Severe Forms of COVID-19: A Novel Approach to Prevent the Cytokine Storm |
Michel Desjarlais, Maëlle Wirth, Isabelle Lahaie, Pakiza Ruknudin, Pierre Hardy, Alain Rivard, Sylvain Chemtob |
| 502 |
[GO] |
2020―Dec―11 |
SARS-CoV-2 Spike-Heat Shock Protein A5 (GRP78) Recognition may be Related to the Immersed Human Coronaviruses |
Abdo A. Elfiky |
| 503 |
[GO] |
2020―Dec―10 |
Multidisciplinary Approach to the Diagnosis and In-Hospital Management of COVID-19 Infection: A Narrative Review |
Giuliano Lo Bianco, Santi Di Pietro, Emilia Mazzuca, Aurelio Imburgia, Luca Tarantino, Giuseppe Accurso, Vincenzo Benenati, Federica Vernuccio, Claudio Bucolo, Salvatore Salomone, Marianna Riolo |
| 504 |
[GO] |
2020―Dec―09 |
Prognostic Genetic Markers for Thrombosis in COVID-19 Patients: A Focused Analysis on D-Dimer, Homocysteine and Thromboembolism |
Mohamed Abu-Farha, Salman Al-Sabah, Maha M. Hammad, Prashantha Hebbar, Arshad Mohamed Channanath, Sumi Elsa John, Ibrahim Taher, Abdulrahman Almaeen, Amany Ghazy, Anwar Mohammad, Jehad Abubaker, Hossein Arefanian, Fahd Al-Mulla, Thangavel Alphonse Thanaraj |
| 505 |
[GO] |
2020―Dec―07 |
Hydroxychloroquine in COVID-19 Patients: Pros and Cons |
Nour K. Younis, Rana O. Zareef, Sally N. Al Hassan, Fadi Bitar, Ali H. Eid, Mariam Arabi |
| 506 |
[GO] |
2020―Dec―03 |
Hydroxychloroquine as Prophylaxis for COVID-19: A Review |
Manuela Monti, Bernadette Vertogen, Carla Masini, Caterina Donati, Claudia Lilli, Chiara Zingaretti, Gerardo Musuraca, Ugo De Giorgi, Claudio Cerchione, Alberto Farolfi, Pietro Cortesi, Pierluigi Viale, Giovanni Martinelli, Oriana Nanni |
| 507 |
[GO] |
2020―Dec―03 |
Perspectives in Peptide-Based Vaccination Strategies for Syndrome Coronavirus 2 Pandemic |
Concetta Di Natale, Sara La Manna, Ilaria De Benedictis, Paola Brandi, Daniela Marasco |
| 508 |
[GO] |
2020―Nov―30 |
Dexamethasone Treatment for Covid-19, a Curious Precedent Highlighting a Regulatory Gap |
Lucia Gozzo, Laura Longo, Daniela Cristina Vitale, Filippo Drago |
| 509 |
[GO] |
2020―Nov―30 |
A Retrospective Study on the Use of Chinese Patent Medicine in 24 Medical Institutions for COVID-19 in China |
Nan Zhang, Nannan Shi, Siyu Li, Guoxiu Liu, Yonglong Han, Li Liu, Xin Zhang, Xiangwen Kong, Bihua Zhang, Wenpeng Yuan, Yi Liu, Deqiang Deng, Minxia Zheng, Ying Zhang, Lihua Li, Xiaoping Wang, Jiankun Wu, Xiaolan Lin, Hua Nian, Xiaohong Wu, Hua Wang, Fang Liu, Hongli Wang, Hongshun Wang, Ying Liu, Li Liu, Weixin Zeng, Manqin Yang, Yanping Wang, Huaqiang Zhai, Yongyan Wang |
| 510 |
[GO] |
2020―Nov―30 |
Rationale for COVID-19 Treatment by Nebulized Interferon-β-1b-Literature Review and Personal Preliminary Experience |
Aurélien Mary, Lucie Hénaut, Pierre Yves Macq, Louise Badoux, Arnaud Cappe, Thierry Porée, Myriam Eckes, Hervé Dupont, Michel Brazier |
| 511 |
[GO] |
2020―Nov―26 |
Possible Role of Adenosine in COVID-19 Pathogenesis and Therapeutic Opportunities |
Jonathan D. Geiger, Nabab Khan, Madhuvika Murugan, Detlev Boison |
| 512 |
[GO] |
2020―Nov―26 |
Deciphering the Pharmacological Mechanisms of Ma Xing Shi Gan Decoction against COVID-19 through Integrating Network Pharmacology and Experimental Exploration |
Qianqian Li, Chen Bai, Ruocong Yang, Weiying Xing, Xiaohan Pang, Siying Wu, Shaoyang Liu, Jianxin Chen, Tiegang Liu, Xiaohong Gu |
| 513 |
[GO] |
2020―Nov―26 |
Severe Acute Respiratory Syndrome Coronavirus-2 Induces Cytokine Storm and Inflammation During Coronavirus Disease 19: Perspectives and Possible Therapeutic Approaches |
Federica Mannino, Alessandra Bitto, Natasha Irrera |
| 514 |
[GO] |
2020―Nov―25 |
An Evaluation of Traditional Persian Medicine for the Management of SARS-CoV-2 |
Roodabeh Bahramsoltani, Roja Rahimi |
| 515 |
[GO] |
2020―Nov―20 |
Neuronal and Cerebrovascular Complications in Coronavirus Disease 2019 |
Mudasir S. Andrabi, Shaida A. Andrabi |
| 516 |
[GO] |
2020―Nov―20 |
Rational Drug Repurposing: Focus on Lysosomotropism, Targets in Disease Process, Drug Profile, and Pulmonary Tissue Accumulation in SARS-CoV-2 Infection/COVID-19 |
Markus Blaess, Lars Kaiser, Oliver Sommerfeld, Simone Rentschler, René Csuk, Hans-Peter Deigner |
| 517 |
[GO] |
2020―Nov―19 |
Autophagy Modulation in Lymphocytes From COVID-19 Patients: New Therapeutic Target in SARS-COV-2 Infection |
Marta Vomero, Cristiana Barbati, Tania Colasanti, Alessandra Ida Celia, Mariangela Speziali, Federica Maria Ucci, Claudia Ciancarella, Fabrizio Conti, Cristiano Alessandri |
| 518 |
[GO] |
2020―Nov―18 |
Phytochemicals: Potential Therapeutic Interventions Against Coronavirus-Associated Lung Injury |
Mohammad Bagher Majnooni, Sajad Fakhri, Yalda Shokoohinia, Narges Kiyani, Katrina Stage, Pantea Mohammadi, Mohammad Mehdi Gravandi, Mohammad Hosein Farzaei, Javier Echeverría |
| 519 |
[GO] |
2020―Nov―17 |
A Review of Treatment of Coronavirus Disease 2019 (COVID-19): Therapeutic Repurposing and Unmet Clinical Needs |
Po-Lin Chen, Nan-Yao Lee, Cong-Tat Cia, Wen-Chien Ko, Po-Ren Hsueh |
| 520 |
[GO] |
2020―Nov―13 |
Computational Studies of Hydroxychloroquine and Chloroquine Metabolites as Possible Candidates for Coronavirus (COVID-19) Treatment |
Niteen A. Vaidya, Renu Vyas |
| 521 |
[GO] |
2020―Nov―09 |
Repurposing Sigma-1 Receptor Ligands for COVID-19 Therapy? |
José Miguel Vela |
| 522 |
[GO] |
2020―Nov―09 |
Potential Therapeutic Effect of Traditional Chinese Medicine on Coronavirus Disease 2019: A Review |
Qin Qiu, Yuge Huang, Xiaohua Liu, Fangfang Huang, Xiaoling Li, Liao Cui, Hui Luo, Lianxiang Luo |
| 523 |
[GO] |
2020―Nov―06 |
Challenges for Drug Repurposing in the COVID-19 Pandemic Era |
Janet Sultana, Salvatore Crisafulli, Flic Gabbay, Elizabeth Lynn, Saad Shakir, Gianluca Trifirò |
| 524 |
[GO] |
2020―Nov―06 |
Celebrex Adjuvant Therapy on Coronavirus Disease 2019: An Experimental Study |
Wenxin Hong, Yan Chen, Kai You, Shenglin Tan, Feima Wu, Jiawang Tao, Xudan Chen, Jiaye Zhang, Yue Xiong, Fang Yuan, Zhen Yang, Tingting Chen, Xinwen Chen, Ping Peng, Qiang Tai, Jian Wang, Fuchun Zhang, Yin-Xiong Li |
| 525 |
[GO] |
2020―Nov―06 |
Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019 |
Prakash Nagarkatti, Kathryn Miranda, Mitzi Nagarkatti |
| 526 |
[GO] |
2020―Oct―29 |
Targeting Macrophages as a Therapeutic Option in Coronavirus Disease 2019 |
Maria Gracia-Hernandez, Eduardo M. Sotomayor, Alejandro Villagra |
| 527 |
[GO] |
2020―Oct―29 |
Role of Endolysosomes in Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Coronavirus Disease 2019 Pathogenesis: Implications for Potential Treatments |
Nabab Khan, Xuesong Chen, Jonathan D. Geiger |
| 528 |
[GO] |
2020―Oct―28 |
Systematic Review and Pharmacological Considerations for Chloroquine and Its Analogs in the Treatment for COVID-19 |
Hongwei Peng, Zhangren Chen, Yunyun Wang, Simei Ren, Tiantian Xu, Xin Lai, Jinhua Wen, Mengjun Zhao, Chuanfei Zeng, Lijuan Du, Yanmei Zhang, Li Cao, Jinfang Hu, Xiaohua Wei, Tao Hong |
| 529 |
[GO] |
2020―Oct―28 |
Challenges in Repurposing Drugs in COVID-19 Pandemic. Debating on Potential New Refinements |
Giorgio Frega, Andrea Palloni, Giuseppe Di Pasquale, Gioconda Saccoccio, Alessandro Rizzo, Elisabetta Poluzzi, Primiano Iannone, Giovanni Brandi |
| 530 |
[GO] |
2020―Oct―22 |
Prognostic Value of Pro-Inflammatory Neutrophils and C-Reactive Protein in Cancer Patient With Coronavirus Disease 2019: A Multi-Center, Retrospective Study |
Bo Zhang, Yuanhang Yu, Shawna Herbet, Yue Zhang, Jianhua Lu, Shihua Liu, Fang Xie, Liang Zhao, Xiao Lei, Wei Deng, Jianying Chen, Yunqiao Li |
| 531 |
[GO] |
2020―Oct―22 |
Coronavirus-19: Possible Therapeutic Implications of Spironolactone and Dry Extract of Glycyrrhiza glabra L. (Licorice) |
Decio Armanini, Cristina Fiore, Jens Bielenberg, Chiara Sabbadin, Luciana Bordin |
| 532 |
[GO] |
2020―Oct―16 |
Tempering Macrophage Plasticity for Controlling SARS-CoV-2 Infection for Managing COVID-19 Disease |
Devinder Toor, Aklank Jain, Shivani Kalhan, Harmesh Manocha, Vivek Kumar Sharma, Payal Jain, Vishwas Tripathi, Hridayesh Prakash |
| 533 |
[GO] |
2020―Oct―16 |
COVID-19 Outbreak: Pathogenesis, Current Therapies, and Potentials for Future Management |
Md. Farhad Hossain, Sharifa Hasana, Abdullah Al Mamun, Md. Sahab Uddin, Mir Imam Ibne Wahed, Sabarni Sarker, Tapan Behl, Irfan Ullah, Yesmin Begum, Israt Jahan Bulbul, Md. Shah Amran, Md. Habibur Rahman, May N. Bin-Jumah, Saad Alkahtani, Shaker A. Mousa, Lotfi Aleya, Mohamed M. Abdel-Daim |
| 534 |
[GO] |
2020―Oct―16 |
Current Prevention of COVID-19: Natural Products and Herbal Medicine |
Junqing Huang, Gabriel Tao, Jingwen Liu, Junming Cai, Zhongyu Huang, Jia-xu Chen |
| 535 |
[GO] |
2020―Oct―15 |
Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients |
Fuxun Yang, Ruiming Yue, Xiaoxiu Luo, Rongan Liu, Xiaobo Huang |
| 536 |
[GO] |
2020―Oct―14 |
Vulnerabilities of the SARS-CoV-2 Virus to Proteotoxicity-Opportunity for Repurposed Chemotherapy of COVID-19 Infection |
Maryam S. Al-Motawa, Hafsa Abbas, Patrick Wijten, Alberto de la Fuente, Mingzhan Xue, Naila Rabbani, Paul J. Thornalley |
| 537 |
[GO] |
2020―Oct―09 |
Targeting Neutrophils to Treat Acute Respiratory Distress Syndrome in Coronavirus Disease |
Chih-Chao Chiang, Michal Korinek, Wei-Jen Cheng, Tsong-Long Hwang |
| 538 |
[GO] |
2020―Oct―08 |
Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients |
Vincenzo Russo, Andreina Carbone, Filiberto Fausto Mottola, Rosa Mocerino, Raffaele Verde, Emilio Attena, Nicoletta Verde, Pierpaolo Di Micco, Luigi Nunziata, Francesco Santelli, Gerardo Nigro, Sergio Severino |
| 539 |
[GO] |
2020―Oct―08 |
“Fei Yan No. 1” as a Combined Treatment for COVID-19: An Efficacy and Potential Mechanistic Study |
Zhongzhu Ai, Shanshan Zhou, Weinan Li, Mengfan Wang, Linqun Wang, Gangming Hu, Ran Tao, Xiaoqin Wang, Yinfeng Shen, Lihan Xie, Yuanming Ba, Hezhen Wu, YanFang Yang |
| 540 |
[GO] |
2020―Oct―07 |
COVID-19 Genetic and Environmental Risk Factors: A Look at the Evidence |
Hana Abdelzaher, Basma M. Saleh, Hebatalla A. Ismail, Marwa Hafiz, Macy Abou Gabal, Miranda Mahmoud, Sarah Hashish, Rana M. Abdel Gawad, Rami Y. Gharieb, Anwar Abdelnaser |
| 541 |
[GO] |
2020―Oct―07 |
Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness? |
Piero Sestili, Carmela Fimognari |
| 542 |
[GO] |
2020―Oct―07 |
Positive RT-PCR Test Results in 420 Patients Recovered From COVID-19 in Wuhan: An Observational Study |
Shaobin He, Jiaxing Tian, Xiaodong Li, Yana Zhou, Mingzhong Xiao, Ying Zhang, Xiaojun Min, Xiuyang Li, De Jin, Qing Zhang, Yujiao Zheng, Jia Ke, Qingwei Li, Junxiu Tao, Ping Song, Han Wang, Yi Lv, Qiyou Ding, Shuang Tang, Jiaran Lin, Zhaoyuan Jiang, Zijun Zhang, Juexian Song, Fengmei Lian, Xiaolin Tong |
| 543 |
[GO] |
2020―Oct―06 |
Available Compounds With Therapeutic Potential Against COVID-19: Antimicrobial Therapies, Supportive Care, and Probable Vaccines |
Rajnish Kumar, Janmejai Kumar Srivastava, Rachana Singh, Mohammed Haris Siddiqui, Rasha A. Mansouri, Jawaher A. Abdulhakim, May N. Bin-Jumah, Saad Alkahtani, Mohamed M. Abdel-Daim, Md. Sahab Uddin |
| 544 |
[GO] |
2020―Oct―02 |
Mapping Evidence of Pharmacy Services for COVID-19 in China |
Zhan-Miao Yi, Yang Hu, Guan-Ru Wang, Rong-Sheng Zhao |
| 545 |
[GO] |
2020―Sep―25 |
Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19) |
Surjeet Verma, Danielle Twilley, Tenille Esmear, Carel B. Oosthuizen, Anna-Mari Reid, Marizé Nel, Namrita Lall |
| 546 |
[GO] |
2020―Sep―25 |
The Important Role of Volatile Components From a Traditional Chinese Medicine Dayuan-Yin Against the COVID-19 Pandemic |
Xiao-rui Zhang, Ting-na Li, Yuan-yuan Ren, Yi-jia Zeng, Hong-yang Lv, Jin Wang, Qin-wan Huang |
| 547 |
[GO] |
2020―Sep―25 |
The Regulatory Challenges for Drug Repurposing During the Covid-19 Pandemic: The Italian Experience |
Lucia Gozzo, Laura Longo, Daniela Cristina Vitale, Filippo Drago |
| 548 |
[GO] |
2020―Sep―24 |
COVID-19: Is There Evidence for the Use of Herbal Medicines as Adjuvant Symptomatic Therapy? |
Dâmaris Silveira, Jose Maria Prieto-Garcia, Fabio Boylan, Omar Estrada, Yris Maria Fonseca-Bazzo, Claudia Masrouah Jamal, Pérola Oliveira Magalhães, Edson Oliveira Pereira, Michal Tomczyk, Michael Heinrich |
| 549 |
[GO] |
2020―Sep―18 |
Efficacy of Early Combination Therapy With Lianhuaqingwen and Arbidol in Moderate and Severe COVID-19 Patients: A Retrospective Cohort Study |
Jie Fang, Hui Li, Wei Du, Ping Yu, Ying-Yun Guan, Shi-Yu Ma, Dong Liu, Wei Chen, Guo-Chao Shi, Xiao-Lan Bian |
| 550 |
[GO] |
2020―Sep―17 |
Pathophysiology and Potential Therapeutic Candidates for COVID-19: A Poorly Understood Arena |
Arghadip Samaddar, Malika Grover, Vijaya Lakshmi Nag |
| 551 |
[GO] |
2020―Sep―16 |
In Silico Prediction of Molecular Targets of Astragaloside IV for Alleviation of COVID-19 Hyperinflammation by Systems Network Pharmacology and Bioinformatic Gene Expression Analysis |
Chenliang Ge, Yan He |
| 552 |
[GO] |
2020―Sep―16 |
Outcomes and Laboratory and Clinical Findings of Asthma and Allergic Patients Admitted With Covid-19 in a Spanish University Hospital |
Jesús Miguel García-Menaya, Concepción Cordobés-Durán, Juan Francisco Rangel-Mayoral, Elena García-Martín, José A. G. Agúndez |
| 553 |
[GO] |
2020―Sep―16 |
Use of Enoxaparin to Counteract COVID-19 Infection and Reduce Thromboembolic Venous Complications: A Review of the Current Evidence |
Filippo Drago, Lucia Gozzo, Li Li, Andrea Stella, Benilde Cosmi |
| 554 |
[GO] |
2020―Sep―15 |
Systems Pharmacology and Verification of ShenFuHuang Formula in Zebrafish Model Reveal Multi-Scale Treatment Strategy for Septic Syndrome in COVID-19 |
Tengwen Liu, Yuhong Guo, Jingxia Zhao, Shasha He, Yunjing Bai, Ning Wang, Yan Lin, Qingquan Liu, Xiaolong Xu |
| 555 |
[GO] |
2020―Sep―15 |
The Potential of Antiviral Peptides as COVID-19 Therapeutics |
Arun Suria Karnan Mahendran, Yin Sze Lim, Chee-Mun Fang, Hwei-San Loh, Cheng Foh Le |
| 556 |
[GO] |
2020―Sep―15 |
Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives |
Chandan Sarkar, Milon Mondal, Muhammad Torequl Islam, Miquel Martorell, Anca Oana Docea, Alfred Maroyi, Javad Sharifi-Rad, Daniela Calina |
| 557 |
[GO] |
2020―Sep―11 |
Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future |
Olayinka O. Ogunleye, Debashis Basu, Debjani Mueller, Jacqueline Sneddon, R. Andrew Seaton, Adesola F. Yinka-Ogunleye, Joshua Wamboga, Nenad Miljković, Julius C. Mwita, Godfrey Mutashambara Rwegerera, Amos Massele, Okwen Patrick, Loveline Lum Niba, Melaine Nsaikila, Wafaa M. Rashed, Mohamed Ali Hussein, Rehab Hegazy, Adefolarin A. Amu, Baffour Boaten Boahen-Boaten, Zinhle Matsebula, Prudence Gwebu, Bongani Chirigo, Nongabisa Mkhabela, Tenelisiwe Dlamini, Siphiwe Sithole, Sandile Malaza, Sikhumbuzo Dlamini, Daniel Afriyie, George Awuku Asare, Seth Kwabena Amponsah, Israel Sefah, Margaret Oluka, Anastasia N. Guantai, Sylvia A. Opanga, Tebello Violet Sarele, Refeletse Keabetsoe Mafisa, Ibrahim Chikowe, Felix Khuluza, Dan Kibuule, Francis Kalemeera, Mwangana Mubita, Joseph Fadare, Laurien Sibomana, Gwendoline Malegwale Ramokgopa, Carmen Whyte, Tshegofatso Maimela, Johannes Hugo, Johanna C. Meyer, Natalie Schellack, Enos M. Rampamba, Adel Visser, Abubakr Alfadl, Elfatih M. Malik, Oliver Ombeva Malande, Aubrey C. Kalungia, Chiluba Mwila, Trust Zaranyika, Blessmore Vimbai Chaibva, Ioana D. Olaru, Nyasha Masuka, Janney Wale, Lenias Hwenda, Regina Kamoga, Ruaraidh Hill, Corrado Barbui, Tomasz Bochenek, Amanj Kurdi, Stephen Campbell, Antony P. Martin, Thuy Nguyen Thi Phuong, Binh Nguyen Thanh, Brian Godman |
| 558 |
[GO] |
2020―Sep―11 |
Research Progress on Main Symptoms of Novel Coronavirus Pneumonia Improved by Traditional Chinese Medicine |
Chuan-hong Luo, Le-le Ma, Hui-min Liu, Wei Liao, Run-chun Xu, Zhi-min Ci, Jun-zhi Lin, Li Han, Ding-kun Zhang |
| 559 |
[GO] |
2020―Sep―10 |
Clinical Studies on the Treatment of Novel Coronavirus Pneumonia With Traditional Chinese Medicine-A Literature Analysis |
Zhihuan Zhou, Ning Gao, Yumeng Wang, Pengcheng Chang, Yi Tong, Shufei Fu |
| 560 |
[GO] |
2020―Sep―09 |
Age-Dependent Assessment of Genes Involved in Cellular Senescence, Telomere, and Mitochondrial Pathways in Human Lung Tissue of Smokers, COPD, and IPF: Associations With SARS-CoV-2 COVID-19 ACE2-TMPRSS2-Furin-DPP4 Axis |
Krishna P. Maremanda, Isaac K. Sundar, Dongmei Li, Irfan Rahman |
| 561 |
[GO] |
2020―Sep―09 |
Efficacy and Safety of Corticosteroid Treatment in Patients With COVID-19: A Systematic Review and Meta-Analysis |
Wenwen Cheng, Yufeng Li, Liyan Cui, Ying Chen, Sharui Shan, Duan Xiao, Xiaoyun Chen, Zhuoming Chen, Anding Xu |
| 562 |
[GO] |
2020―Sep―04 |
Montelukast Drug May Improve COVID-19 Prognosis: A Review of Evidence |
Jean Barré, Jean-Marc Sabatier, Cédric Annweiler |
| 563 |
[GO] |
2020―Sep―04 |
Potential Application of Drosophila melanogaster as a Model Organism in COVID-19-Related Research |
Firzan Nainu, Dini Rahmatika, Talha Bin Emran, Harapan Harapan |
| 564 |
[GO] |
2020―Sep―03 |
Skin Hyperpigmentation in Coronavirus Disease 2019 Patients: Is Polymyxin B the Culprit? |
Cuicui Lu, Ning Hou |
| 565 |
[GO] |
2020―Sep―02 |
Coronavirus Disease 2019 Related Clinical Studies: A Cross-Sectional Analysis |
Lin-Lu Ma, Xuan Yin, Bing-Hui Li, Jia-Yu Yang, Ying-Hui Jin, Di Huang, Tong Deng, Yun-Yun Wang, Xue-Qun Ren, Jianguang Ji, Xian-Tao Zeng |
| 566 |
[GO] |
2020―Aug―28 |
Immunosuppressive Drugs and COVID-19: A Review |
Tessa S. Schoot, Angèle P. M. Kerckhoffs, Luuk B. Hilbrands, Rob J. van Marum |
| 567 |
[GO] |
2020―Aug―28 |
Mitochondria Targeted Viral Replication and Survival Strategies-Prospective on SARS-CoV-2 |
Priya Gatti, Hema Saranya Ilamathi, Kiran Todkar, Marc Germain |
| 568 |
[GO] |
2020―Aug―27 |
Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report |
Carlos Spuch, Marta López-García, Tania Rivera-Baltanás, Daniela Rodrígues-Amorím, José M. Olivares |
| 569 |
[GO] |
2020―Aug―27 |
Quality Assessment of the Chinese Clinical Trial Protocols Regarding Treatments for Coronavirus Disease 2019 |
Jiaxing Zhang, Yiling Lu, Joey Sum-wing Kwong, Xiaosi Li, Wenyi Zheng, Rui He |
| 570 |
[GO] |
2020―Aug―27 |
Research Progress of Genetic Structure, Pathogenic Mechanism, Clinical Characteristics, and Potential Treatments of Coronavirus Disease 2019 |
Chunsheng Zhu, Bao Sun, Xiaochuan Zhang, Bing Zhang |
| 571 |
[GO] |
2020―Aug―26 |
SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus |
Simona Iacob, Diana Gabriela Iacob |
| 572 |
[GO] |
2020―Aug―21 |
Evaluation of Remote Pharmacist-Led Outpatient Service for Geriatric Patients on Rivaroxaban for Nonvalvular Atrial Fibrillation During the COVID-19 Pandemic |
Xiaoye Li, Chengchun Zuo, Wenjing Lu, Ye Zou, Qing Xu, Xiaoyu Li, Qianzhou Lv |
| 573 |
[GO] |
2020―Aug―21 |
The Potential Role of Heparin in Patients With COVID-19: Beyond the Anticoagulant Effect. A Review |
Lucia Gozzo, Pierluigi Viale, Laura Longo, Daniela Cristina Vitale, Filippo Drago |
| 574 |
[GO] |
2020―Aug―20 |
Harnessing Memory NK Cell to Protect Against COVID-19 |
Saeede Soleimanian, Ramin Yaghobi |
| 575 |
[GO] |
2020―Aug―19 |
Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19 |
Rudra P. Saha, Ashish Ranjan Sharma, Manoj K. Singh, Saikat Samanta, Swarnav Bhakta, Snehasish Mandal, Manojit Bhattacharya, Sang-Soo Lee, Chiranjib Chakraborty |
| 576 |
[GO] |
2020―Aug―14 |
COVID-19 Usurps Host Regulatory Networks |
Colleen S. Curran, Donna R. Rivera, Jeffrey B. Kopp |
| 577 |
[GO] |
2020―Aug―13 |
A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes |
Colin D. Funk, Ali Ardakani |
| 578 |
[GO] |
2020―Aug―13 |
COVID-19 Therapeutic Options Under Investigation |
Malak Kaddoura, Malak AlIbrahim, Ghina Hijazi, Nadia Soudani, Amani Audi, Habib Alkalamouni, Salame Haddad, Ali Eid, Hassan Zaraket |
| 579 |
[GO] |
2020―Aug―12 |
Corticosteroid Use in the Treatment of COVID-19: A Multicenter Retrospective Study in Hunan, China |
Yiming Ma, Huihui Zeng, Zijie Zhan, Huanhuan Lu, Zihang Zeng, Chenjie He, Xiangming Liu, Chen Chen, Qingwu Qin, Jia He, Zhiguo Zhou, Peng Huang, Mingyan Jiang, Dingding Deng, Xin Liao, Zhi Xiang, Xiaoying Huang, Yan Chen, Ping Chen |
| 580 |
[GO] |
2020―Aug―11 |
Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients |
Pasquale Paolisso, Luca Bergamaschi, Emanuela Concetta D’Angelo, Francesco Donati, Maddalena Giannella, Sara Tedeschi, Renato Pascale, Michele Bartoletti, Giulia Tesini, Mauro Biffi, Benilde Cosmi, Carmine Pizzi, Pierluigi Viale, Nazzareno Galié |
| 581 |
[GO] |
2020―Aug―07 |
Medicinal Plants as Sources of Active Molecules Against COVID-19 |
Bachir Benarba, Atanasio Pandiella |
| 582 |
[GO] |
2020―Aug―07 |
DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications? |
Inés Valencia, Concepción Peiró, Óscar Lorenzo, Carlos F. Sánchez-Ferrer, Jürgen Eckel, Tania Romacho |
| 583 |
[GO] |
2020―Aug―05 |
DPP-4 Inhibitors in the Prevention/Treatment of Pulmonary Fibrosis, Heart and Kidney Injury Caused by COVID-19-A Therapeutic Approach of Choice in Type 2 Diabetic Patients? |
Andrija Smelcerovic, Gordana Kocic, Mihajlo Gajic, Katarina Tomovic, Vukica Djordjevic, Dobrila Stankovic-Djordjevic, Marko Anderluh |
| 584 |
[GO] |
2020―Jul―31 |
Research Progress of Chloroquine and Hydroxychloroquine on the COVID-19 and Their Potential Risks in Clinic Use |
Yan Chen, TaiPeng Shen, LiJun Zhong, ZhiXi Liu, XinWei Dong, TingWenLi Huang, QiuJu Wang, HongTao Xiao |
| 585 |
[GO] |
2020―Jul―29 |
Cellular and Molecular Pathways of COVID-19 and Potential Points of Therapeutic Intervention |
John P. Hussman |
| 586 |
[GO] |
2020―Jul―29 |
Rationale for Considering Oral Idasanutlin as a Therapeutic Option for COVID-19 Patients |
Giorgio Zauli, Veronica Tisato, Paola Secchiero |
| 587 |
[GO] |
2020―Jul―17 |
Dynamic Interleukin-6 Level Changes as a Prognostic Indicator in Patients With COVID-19 |
Zeming Liu, Jinpeng Li, Danyang Chen, Rongfen Gao, Wen Zeng, Sichao Chen, Yihui Huang, Jianglong Huang, Wei Long, Man Li, Liang Guo, Xinghuan Wang, Xiaohui Wu |
| 588 |
[GO] |
2020―Jul―17 |
Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China |
Wei Zhuang, Zheng Fan, Yanqi Chu, Haizheng Wang, Ying Yang, Li Wu, Nan Sun, Ge Sun, Yuqiao Shen, Xiaolan Lin, Guiming Guo, Shengyan Xi |
| 589 |
[GO] |
2020―Jul―16 |
The Folate Concentration and/or Folic Acid Metabolites in Plasma as Factor for COVID-19 Infection |
Jesus Acosta-Elias, Ricardo Espinosa-Tanguma |
| 590 |
[GO] |
2020―Jul―15 |
Selective Estrogen Receptor Modulators in COVID-19: A Possible Therapeutic Option? |
Alba Calderone, Francesco Menichetti, Ferruccio Santini, Luciano Colangelo, Ersilia Lucenteforte, Vincenzo Calderone |
| 591 |
[GO] |
2020―Jul―14 |
No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective Study |
Yin-Qiu Huang, Sheng-Quan Tang, Xiao-Lei Xu, Yan-Ming Zeng, Xiao-Qing He, Yao Li, Vijay Harypursat, Yan-Qiu Lu, Yan Wan, Lu Zhang, Qiang-Zhong Sun, Nan-Nan Sun, Gui-Xue Wang, Zhong-Ping Yang, Yao-Kai Chen |
| 592 |
[GO] |
2020―Jul―10 |
Pathological Aspects of COVID-19 as a Conformational Disease and the Use of Pharmacological Chaperones as a Potential Therapeutic Strategy |
Tomohiko Aoe |
| 593 |
[GO] |
2020―Jul―09 |
BCG Against SARS-CoV-2: Second Youth of an Old Age Vaccine? |
Siya Kamat, Madhuree Kumari |
| 594 |
[GO] |
2020―Jul―02 |
Turning the Tide: Natural Products and Natural-Product-Inspired Chemicals as Potential Counters to SARS-CoV-2 Infection |
Zhonglei Wang, Liyan Yang |
| 595 |
[GO] |
2020―Jun―24 |
Pharmacotherapics Advice in Guidelines for COVID-19 |
Zhang-Ren Chen, Ying Zhou, Jin Liu, Hong-Wei Peng, Jian Zhou, Hai-Li Zhong, Li-Li Liu, Ming-Fang Lai, Xiao-Hua Wei, Jin-Hua Wen |
| 596 |
[GO] |
2020―Jun―24 |
Convalescent Plasma Coupled With Medications for the Treatment of a Severe COVID-19 Patient: Drugs Analysis and Pharmaceutical Care Based on the Newly Established Guidelines for COVID-19 Remedy |
Ying Wang, Yang Zhang, Qian Yu, Kun Zhu |
| 597 |
[GO] |
2020―Jun―19 |
Potential Benefits of Tryptophan Metabolism to the Efficacy of Tocilizumab in COVID-19 |
Maria Laura Belladonna, Ciriana Orabona |
| 598 |
[GO] |
2020―Jun―19 |
A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic |
Colin D. Funk, Craig Laferrière, Ali Ardakani |
| 599 |
[GO] |
2020―Jun―12 |
New Strategy for COVID-19: An Evolutionary Role for RGD Motif in SARS-CoV-2 and Potential Inhibitors for Virus Infection |
Shijia Yan, Haixia Sun, Xianzhang Bu, Guohui Wan |
| 600 |
[GO] |
2020―Jun―05 |
Repositioning Chromones for Early Anti-inflammatory Treatment of COVID-19 |
Piero Sestili, Vilberto Stocchi |
| 601 |
[GO] |
2020―Jun―05 |
Neutrophilia and NETopathy as Key Pathologic Drivers of Progressive Lung Impairment in Patients With COVID-19 |
Teluguakula Narasaraju, Benjamin M. Tang, Martin Herrmann, Sylviane Muller, Vincent T. K. Chow, Marko Radic |
| 602 |
[GO] |
2020―Jun―05 |
Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study |
Valentina Giudice, Pasquale Pagliano, Alessandro Vatrella, Alfonso Masullo, Sergio Poto, Benedetto Maria Polverino, Renato Gammaldi, Angelantonio Maglio, Carmine Sellitto, Carolina Vitale, Bianca Serio, Bianca Cuffa, Anna Borrelli, Carmine Vecchione, Amelia Filippelli, Carmine Selleri |
| 603 |
[GO] |
2020―May―29 |
An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy? |
Giuseppe Terrazzano, Valentina Rubino, Anna Teresa Palatucci, Angela Giovazzino, Flavia Carriero, Giuseppina Ruggiero |
| 604 |
[GO] |
2020―May―26 |
Available Evidence and Ongoing Clinical Trials of Remdesivir: Could It Be a Promising Therapeutic Option for COVID-19? |
Mekonnen Sisay |
| 605 |
[GO] |
2020―May―26 |
Reducing the Fatality Rate of COVID-19 by Applying Clinical Insights From Immuno-Oncology and Lung Transplantation |
Fatih M. Uckun |
| 606 |
[GO] |
2020―May―01 |
The Zebrafish Disease and Drug Screening Model: A Strong Ally Against Covid-19 |
Jorge Galindo-Villegas |
|
